10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission file number 000-22418

ITRON, INC.

(Exact name of registrant as specified in its charter)

Washington	91-1011792
(State of Incorporation)	(I.R.S. Employer Identification No.)

2111 N Molter Road, Liberty Lake, Washington 99019

(509) 924-9900

(Address and telephone number of registrant's principal executive offices) 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, no par value	ITRI	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of October 31, 2021, there were outstanding 45,272,251 shares of the registrant's common stock, no par value, which is the only class of common stock of the registrant.

Itron, Inc.

Table of Contents

 

	Page
PART I: FINANCIAL INFORMATION
Item 1: Financial Statements (Unaudited)
Consolidated Statements of Operations	1
Consolidated Statements of Comprehensive Income (Loss)	2
Consolidated Balance Sheets	3
Consolidated Statements of Equity	4
Consolidated Statements of Cash Flows	5
Notes to Consolidated Financial Statements	6
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 3: Quantitative and Qualitative Disclosures About Market Risk	52
Item 4: Controls and Procedures	52
PART II: OTHER INFORMATION
Item 1: Legal Proceedings	53
Item 1A: Risk Factors	53
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds	53
Item 5: Other Information	53
Item 6: Exhibits	54
SIGNATURE	55

PART I: FINANCIAL INFORMATION

Item 1:    Financial Statements (Unaudited)

ITRON, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands, except per share data	2021		2020		2021		2020
Revenues
Product revenues	$	410,947	$	470,658	$	1,265,470	$	1,437,780
Service revenues	76,002		69,526		230,465		210,413
Total revenues	486,949		540,184		1,495,935		1,648,193
Cost of revenues
Product cost of revenues	306,168		358,297		908,923		1,072,271
Service cost of revenues	45,818		38,636		135,130		122,588
Total cost of revenues	351,986		396,933		1,044,053		1,194,859
Gross profit	134,963		143,251		451,882		453,334
Operating expenses
Sales, general and administrative	71,838		64,982		221,974		215,018
Research and development	46,889		46,224		147,379		148,999
Amortization of intangible assets	8,944		11,183		26,914		33,488
Restructuring	958		44,462		(830)		41,531
Loss on sale of business	2,171		380		28,274		57,295
Total operating expenses	130,800		167,231		423,711		496,331
Operating income (loss)	4,163		(23,980)		28,171		(42,997)
Other income (expense)
Interest income	352		354		1,326		2,165
Interest expense	(2,628)		(10,810)		(27,107)		(33,771)
Other income (expense), net	(1,761)		(2,607)		(16,684)		(3,414)
Total other income (expense)	(4,037)		(13,063)		(42,465)		(35,020)
Income (loss) before income taxes	126		(37,043)		(14,294)		(78,017)
Income tax benefit (provision)	(1,136)		11,985		(5,581)		(366)
Net loss	(1,010)		(25,058)		(19,875)		(78,383)
Net income attributable to noncontrolling interests	859		299		2,514		1,092
Net loss attributable to Itron, Inc.	$	(1,869)	$	(25,357)	$	(22,389)	$	(79,475)
Net loss per common share - Basic	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)
Net loss per common share - Diluted	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)
Weighted average common shares outstanding - Basic	45,240		40,337		43,983		40,199
Weighted average common shares outstanding - Diluted	45,240		40,337		43,983		40,199

The accompanying notes are an integral part of these consolidated financial statements.

1

ITRON, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Net loss	$	(1,010)	$	(25,058)	$	(19,875)	$	(78,383)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(7,764)		13,988		(17,118)		(147)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	510		(1)		1,818		(2,157)
Pension benefit obligation adjustment	687		(159)		2,087		889
Total other comprehensive income (loss), net of tax	(6,567)		13,814		(13,213)		50,659
Total comprehensive income (loss), net of tax	(7,577)		(11,244)		(33,088)		(27,724)
Comprehensive income attributable to noncontrolling interests, net of tax	859		299		2,514		1,092
Comprehensive income (loss) attributable to Itron, Inc.	$	(8,436)	$	(11,543)	$	(35,602)	$	(28,816)

The accompanying notes are an integral part of these consolidated financial statements.

2

ITRON, INC.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

In thousands	September 30, 2021		December 31, 2020
ASSETS
Current assets
Cash and cash equivalents	$	188,691	$	206,933
Accounts receivable, net	320,994		369,828
Inventories	175,432		182,377
Other current assets	117,270		171,124
Total current assets	802,387		930,262
Property, plant, and equipment, net	189,748		207,816
Deferred tax assets, net	101,907		76,142
Other long-term assets	41,666		51,656
Operating lease right-of-use assets, net	67,599		76,276
Intangible assets, net	103,763		132,955
Goodwill	1,115,697		1,131,916
Total assets	$	2,422,767	$	2,607,023
LIABILITIES AND EQUITY
Current liabilities
Accounts payable	$	188,663	$	215,639
Other current liabilities	74,718		72,591
Wages and benefits payable	99,347		86,249
Taxes payable	13,674		15,804
Current portion of debt	—		18,359
Current portion of warranty	18,089		28,329
Unearned revenue	101,263		112,928
Total current liabilities	495,754		549,899
Long-term debt, net	449,629		902,577
Long-term warranty	16,598		13,061
Pension benefit obligation	114,771		119,457
Deferred tax liabilities, net	1,792		1,921
Operating lease liabilities	59,149		66,823
Other long-term obligations	85,248		113,012
Total liabilities	1,222,941		1,766,750
Equity
Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding	—		—
Common stock, no par value, 75,000 shares authorized, 45,260 and 40,444 shares issued and outstanding	1,782,060		1,389,419
Accumulated other comprehensive loss, net	(151,739)		(138,526)
Accumulated deficit	(456,734)		(434,345)
Total Itron, Inc. shareholders' equity	1,173,587		816,548
Noncontrolling interests	26,239		23,725
Total equity	1,199,826		840,273
Total liabilities and equity	$	2,422,767	$	2,607,023

The accompanying notes are an integral part of these consolidated financial statements.

3

ITRON, INC.

CONSOLIDATED STATEMENTS OF EQUITY

(UNAUDITED)

	Common Stock			Accumulated Other Comprehensive Loss		Accumulated Deficit		Total Itron, Inc. Shareholders' Equity		Noncontrolling Interests		Total Equity
In thousands	Shares	Amount
Balances at January 1, 2021	40,444	$	1,389,419	$	(138,526)	$	(434,345)	$	816,548	$	23,725	$	840,273
Net income						12,603		12,603		977		13,580
Other comprehensive income (loss), net of tax				(11,783)				(11,783)				(11,783)
Net stock issued and repurchased	206	2,009						2,009				2,009
Stock-based compensation expense		6,270						6,270				6,270
Stock issued related to equity offering	4,472	389,419						389,419				389,419
Proceeds from sale of warrants		45,349						45,349				45,349
Purchases of convertible note hedge contracts, net of tax		(63,576)						(63,576)				(63,576)
Registration fee		(373)						(373)				(373)
Balances at March 31, 2021	45,122	1,768,517		(150,309)		(421,742)		1,196,466		24,702		1,221,168
Net income (loss)						(33,123)		(33,123)		678		(32,445)
Other comprehensive income (loss), net of tax				5,137				5,137				5,137
Net stock issued and repurchased	28	458						458				458
Stock-based compensation expense		6,316						6,316				6,316
Registration fee		24						24				24
Balances at June 30, 2021	45,150	1,775,315		(145,172)		(454,865)		1,175,278		25,380		1,200,658
Net income (loss)						(1,869)		(1,869)		859		(1,010)
Other comprehensive income (loss), net of tax				(6,567)				(6,567)				(6,567)
Net stock issued and repurchased	110	1,080						1,080				1,080
Stock-based compensation expense		5,665						5,665				5,665
Balances at September 30, 2021	45,260	$	1,782,060	$	(151,739)	$	(456,734)	$	1,173,587	$	26,239	$	1,199,826

	Common Stock			Accumulated Other Comprehensive Loss		Accumulated Deficit		Total Itron, Inc. Shareholders' Equity		Noncontrolling Interests		Total Equity
In thousands	Shares	Amount
Balances at January 1, 2020	39,941	$	1,357,600	$	(204,672)	$	(376,390)	$	776,538	$	24,277	$	800,815
Net income						8,684		8,684		478		9,162
Other comprehensive income (loss), net of tax				(25,211)				(25,211)				(25,211)
Net stock issued and repurchased	235	2,247						2,247				2,247
Stock-based compensation expense		8,482						8,482				8,482
Balances at March 31, 2020	40,176	1,368,329		(229,883)		(367,706)		770,740		24,755		795,495
Net income (loss)						(62,802)		(62,802)		315		(62,487)
Other comprehensive income (loss), net of tax				62,056				62,056				62,056
Net stock issued and repurchased	58	706						706				706
Stock-based compensation expense		7,099						7,099				7,099
Balances at June 30, 2020	40,234	1,376,134		(167,827)		(430,508)		777,799		25,070		802,869
Net income (loss)						(25,357)		(25,357)		299		(25,058)
Other comprehensive income (loss), net of tax				13,814				13,814				13,814
Net stock issued and repurchased	122	583						583				583
Stock-based compensation expense		5,057						5,057				5,057
Balances at September 30, 2020	40,356	$	1,381,774	$	(154,013)	$	(455,865)	$	771,896	$	25,369	$	797,265

The accompanying notes are an integral part of these consolidated financial statements.

4

ITRON, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended September 30,
In thousands	2021		2020
Operating activities
Net loss	$	(19,875)	$	(78,383)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	64,252		72,306
Non-cash operating lease expense	12,962		15,252
Stock-based compensation	18,251		20,638
Amortization of prepaid debt fees	17,383		3,029
Deferred taxes, net	(5,170)		(9,439)
Loss on sale of business	28,274		57,295
Loss on extinguishment of debt	10,000		—
Restructuring, non-cash	951		6,518
Other adjustments, net	3,720		3,856
Changes in operating assets and liabilities, net of sale of business:
Accounts receivable	40,624		82,087
Inventories	2,150		8,978
Other current assets	26,072		(12,862)
Other long-term assets	5,058		(2,547)
Accounts payable, other current liabilities, and taxes payable	(27,124)		(82,775)
Wages and benefits payable	14,110		(28,446)
Unearned revenue	(13,158)		15,098
Warranty	(5,969)		(10,894)
Other operating, net	(31,364)		10,860
Net cash provided by operating activities	141,147		70,571
Investing activities
Net proceeds (payments) related to the sale of business	3,142		(748)
Acquisitions of property, plant, and equipment	(27,781)		(36,297)
Other investing, net	2,820		3,573
Net cash used in investing activities	(21,819)		(33,472)
Financing activities
Proceeds from borrowings	460,000		400,000
Payments on debt	(946,094)		—
Issuance of common stock	4,351		5,059
Proceeds from common stock offering	389,419		—
Proceeds from sale of warrants	45,349		—
Purchases of convertible note hedge contracts	(84,139)		—
Prepaid debt fees	(12,021)		(184)
Other financing, net	6,327		(2,285)
Net cash (used in) provided by financing activities	(136,808)		402,590
Effect of foreign exchange rate changes on cash and cash equivalents	(762)		(3,426)
Increase (decrease) in cash and cash equivalents	(18,242)		436,263
Cash and cash equivalents at beginning of period	206,933		149,904
Cash and cash equivalents at end of period	$	188,691	$	586,167
Supplemental disclosure of cash flow information:
Cash paid (received) during the period for:
Income taxes, net	$	5,989	$	(349)
Interest	8,655		34,327

The accompanying notes are an integral part of these consolidated financial statements.

5

ITRON, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(UNAUDITED)

In this Quarterly Report on Form 10-Q, the terms "we", "us", "our", "Itron", and the "Company" refer to Itron, Inc. and its subsidiaries.

Note 1:    Summary of Significant Accounting Policies

Financial Statement Preparation

The consolidated financial statements presented in this Quarterly Report on Form 10-Q are unaudited and reflect entries necessary for the fair presentation of the Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2021 and 2020, Consolidated Statements of Equity for the three months ended September 30, 2021 and 2020, June 30, 2021 and 2020, and March 31, 2021 and 2020, the Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020, and the Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020, of Itron, Inc. and its subsidiaries. All entries required for the fair presentation of the financial statements are of a normal recurring nature, except as disclosed. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results expected for the full year or for any other period.

Certain information and notes normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been partially or completely omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim results. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2020 filed with the SEC in our Annual Report on Form 10-K on February 24, 2021 (2020 Annual Report). There have been no significant changes in financial statement preparation or significant accounting policies since December 31, 2020.

Risks and Uncertainties

The COVID-19 pandemic has had global economic impacts including disrupting customer demand and global supply chains, resulting in market volatility. The extent of the recent pandemic and its ongoing impact on our operations is volatile, but is being monitored closely by our management. During portions of the first half of 2020 certain of our European factories were closed due to government actions and local conditions, and any further closures that may be imposed on us could impact our results for 2021. New variants of the virus may cause previously lifted restrictions to be reinstated, which could result in more disruptions. Incremental costs we have incurred related to COVID-19, such as personal protective equipment, increased cleaning and sanitizing of our facilities, and other such items, have not been material to date. As economies have reopened, global supply chains have struggled to keep pace with rapidly changing demand. The resulting supply constraints have manifested across a variety of areas including mechanical, electrical and logistics portions of the supply chain, which has impacted our ability to ship products in a timely manner. In particular, our ability to obtain adequate supply of semiconductor components has impacted our ability to service recovering customer demand. While the current imbalance in supply and demand is temporal, the timeline to recovery is uncertain. Efforts are ongoing with suppliers to increase supply, including the approval of alternate sources. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. However, certain of our customer projects have experienced delay in deliveries, with originally forecasted 2021 revenue pushed to future periods.

Recently Adopted Accounting Standards

In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which modifies certain provisions of Accounting Standards Codification (ASC) 740, to reduce the complexity of accounting for income taxes. ASU 2019-12 was effective for us beginning with our interim financial reports in 2021. The adoption of this standard had no impact to our year-to-date consolidated financial position, results of operations, or cash flows and is not expected to have a material impact on full year 2021 financial results.

6

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (ASU 2020-06). This amendment simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. We chose to early adopt ASU 2020-06 beginning January 1, 2021, due to the issuance of our convertible debt on March 9, 2021. This amendment had no retrospective changes but impacts how our newly issued convertible debt is both recognized and disclosed. ASU 2020-06 also amends the diluted earnings per share calculation for convertible instruments by requiring the use of the if-converted method. The treasury stock method is no longer available.

Recent Accounting Standards Not Yet Adopted

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. ASU 2020-04 applies to contracts that reference LIBOR or another reference rate expected to be terminated because of reference rate reform. An entity may elect certain optional expedients for hedging relationships that exist as of December 31, 2022 and maintain those optional expedients through the end of the hedging relationship. ASU 2020-04 could be adopted as of March 12, 2020 or thereafter. In January 2021, the FASB issued ASU 2021-01, which further updates the scope of Topic 848. We do not currently have any contracts that have been changed to a new reference rate, but we will continue to evaluate our contracts and the effects of this standard on our consolidated financial position, results of operations, and cash flows prior to adoption.

In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. The amendments in this update modify the lease classification requirements for lessors to align them with practice under Topic 840, particularly in the area of day-one loss accounting. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if certain criteria are met. The effective date for this amendment is January 1, 2022 and all interim periods thereafter. We have determined under existing leases where we are the lessor, this amendment will not have a material impact on our financial statements.

Note 2:    Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (EPS):

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands, except per share data	2021		2020		2021		2020
Net loss available to common shareholders	$	(1,869)	$	(25,357)	$	(22,389)	$	(79,475)
Weighted average common shares outstanding - Basic	45,240		40,337		43,983		40,199
Dilutive effect of stock-based awards	—		—		—		—
Dilutive effect of convertible notes	—		—		—		—
Weighted average common shares outstanding - Diluted	45,240		40,337		43,983		40,199
Net loss per common share - Basic	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)
Net loss per common share - Diluted	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)

7

Stock-based Awards

For stock-based awards, the dilutive effect is calculated using the treasury stock method. Under this method, the dilutive effect is computed as if the awards were exercised at the beginning of the period (or at time of issuance, if later) and assumes the related proceeds were used to repurchase our common stock at the average market price during the period. Related proceeds include the amount the employee must pay upon exercise and the future compensation cost associated with the stock award. Approximately 0.4 million and 0.5 million stock-based awards were excluded from the calculation of diluted EPS for the three and nine months ended September 30, 2021 because they were anti-dilutive. Approximately 0.8 million stock-based awards were excluded from the calculation of diluted EPS for the three and nine months ended September 30, 2020 because they were anti-dilutive. These stock-based awards could be dilutive in future periods.

Convertible Notes and Warrants

For our Convertible Notes issued in March 2021, the dilutive effect is calculated using the if-converted method. We are required, pursuant to the indenture governing our Convertible Notes, to settle the principal amount of the Convertible Notes in cash and may elect to settle the remaining conversion obligation (stock price in excess of conversion price) in cash, shares, or a combination thereof. Under the if-converted method, we include the number of shares required to satisfy the remaining conversion obligation, assuming all the Convertible Notes were converted. The average closing price of our common stock for the quarter ended September 30, 2021 is used as the basis for determining the dilutive effect on EPS. The average price of our common stock for the quarter ended September 30, 2021 was less than the conversion price of $126.00, and all associated shares were anti-dilutive.

In conjunction with the issuance of the Convertible Notes, we sold warrants to purchase 3.7 million shares of Itron common stock. The warrants have a strike price of $180.00 per share. For calculating the dilutive effect of the warrants, we use the treasury stock method. With this method, we assume exercise of the warrants at the beginning of the period, or at time of issuance if later, and the issuance of common stock upon exercise. Proceeds from the exercise of the warrants are assumed to be used to repurchase shares of our stock at the average market price during the period. The incremental shares, representing the number of shares assumed to be exercised with the warrants less the number of shares repurchased, are included in diluted weighted average common shares outstanding. For periods where the warrants strike price of $180.00 per share is greater than the average share price of Itron stock for the period, the warrants would be anti-dilutive. For the three and nine months ended September 30, 2021, the average share price was below the warrant strike price and therefore 3.7 million shares were considered anti-dilutive.

Convertible Note Hedge Transactions

In connection with the issuance of the Convertible Notes, we entered into privately negotiated call option contracts on our common stock (the Convertible Note Hedge Transactions) with certain commercial banks (the Counterparties). We paid an aggregate amount of $84.1 million for the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Convertible Notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the Convertible Notes, at a strike price of approximately $126.00, subject to customary adjustments. The Convertible Note Hedge Transactions will expire upon the maturity of the Convertible Notes, subject to earlier exercise or termination. Exercise of the Convertible Note Hedge Transactions would reduce the number of shares of our common stock outstanding and therefore would be anti-dilutive.

8

Note 3:    Certain Balance Sheet Components

A summary of accounts receivable from contracts with customers is as follows:

Accounts receivable, net
In thousands	September 30, 2021		December 31, 2020
Trade receivables (net of allowance of $2,798 and $1,312)	$	274,385	$	318,269
Unbilled receivables	46,609		51,559
Total accounts receivable, net	$	320,994	$	369,828

Allowance for credit losses account activity	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Beginning balance	$	1,107	$	2,102	$	1,312	$	3,064
Provision for (release of) doubtful accounts, net	2,164		(21)		2,122		318
Accounts written-off	(440)		(278)		(582)		(1,489)
Effect of change in exchange rates	(33)		43		(54)		(47)
Ending balance	$	2,798	$	1,846	$	2,798	$	1,846

Inventories
In thousands	September 30, 2021		December 31, 2020
Raw materials	$	117,549	$	114,058
Work in process	8,539		8,094
Finished goods	49,344		60,225
Total inventories	$	175,432	$	182,377

Property, plant, and equipment, net
In thousands	September 30, 2021		December 31, 2020
Machinery and equipment	$	333,584	$	334,050
Computers and software	117,067		115,776
Buildings, furniture, and improvements	146,052		155,676
Land	11,976		14,303
Construction in progress, including purchased equipment	40,082		31,425
Total cost	648,761		651,230
Accumulated depreciation	(459,013)		(443,414)
Property, plant, and equipment, net	$	189,748	$	207,816

Depreciation expense	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Depreciation expense	$	12,389	$	12,893	$	37,338	$	38,818

9

Note 4:    Intangible Assets and Liabilities

The gross carrying amount and accumulated amortization (accretion) of our intangible assets and liabilities, other than goodwill, were as follows:

	September 30, 2021						December 31, 2020
In thousands	Gross		Accumulated (Amortization) Accretion		Net		Gross		Accumulated (Amortization) Accretion		Net
Intangible Assets
Core-developed technology	$	511,885	$	(495,799)	$	16,086	$	525,051	$	(498,113)	$	26,938
Customer contracts and relationships	376,572		(291,783)		84,789		383,245		(280,497)		102,748
Trademarks and trade names	78,448		(75,933)		2,515		79,716		(76,912)		2,804
Other	12,023		(11,650)		373		12,025		(11,560)		465
Total intangible assets	$	978,928	$	(875,165)	$	103,763	$	1,000,037	$	(867,082)	$	132,955
Intangible Liabilities
Customer contracts and relationships	$	(23,900)	$	22,950	$	(950)	$	(23,900)	$	21,479	$	(2,421)

A summary of intangible assets and liabilities activity is as follows:

	Nine Months Ended September 30,
In thousands	2021		2020
Intangible assets, gross beginning balance	$	1,000,037	$	979,814
Intangibles disposed in sale of business	—		(18,140)
Effect of change in exchange rates	(21,109)		9,974
Intangible assets, gross ending balance	$	978,928	$	971,648
Intangible liabilities, gross beginning balance	$	(23,900)	$	(23,900)
Effect of change in exchange rates	—		—
Intangible liabilities, gross ending balance	$	(23,900)	$	(23,900)

Assumed intangible liabilities reflect the present value of the projected cash outflows for an existing contract where remaining costs are expected to exceed projected revenues.

The disposal of intangible assets was related to the sale of our Latin America business in June 2020. The net book value of these assets was $0.8 million at the disposal date. Refer to Note 17: Sale of Business for additional information on the transaction.

Estimated future annual amortization (accretion) is as follows:

Year Ending December 31,	Amortization		Accretion		Estimated Annual Amortization, net
In thousands
2021 (amount remaining at September 30, 2021)	$	9,450	$	(491)	$	8,959
2022	27,393		(459)		26,934
2023	19,811		—		19,811
2024	15,631		—		15,631
2025	14,655		—		14,655
Thereafter	16,823		—		16,823
Total intangible assets subject to amortization (accretion)	$	103,763	$	(950)	$	102,813

10

Note 5:    Goodwill

The following table reflects changes in the carrying amount of goodwill for the nine months ended September 30, 2021:

In thousands	Device Solutions		Networked Solutions		Outcomes		Total Company
Goodwill balance at January 1, 2021	$	53,214	$	933,814	$	144,888	$	1,131,916
Effect of change in exchange rates	(658)		(13,467)		(2,094)		(16,219)
Goodwill balance at September 30, 2021	$	52,556	$	920,347	$	142,794	$	1,115,697

Note 6:    Debt

The components of our borrowings were as follows:

In thousands	September 30, 2021		December 31, 2020
Credit facility
USD denominated term loan	$	—	$	536,094
Multicurrency revolving line of credit	—		—
Senior notes	—		400,000
Convertible notes	460,000		—
Total debt	460,000		936,094
Less: current portion of debt	—		18,359
Less: unamortized prepaid debt fees - term loan	—		3,469
Less: unamortized prepaid debt fees - senior notes	—		11,689
Less: unamortized prepaid debt fees - convertible notes	10,371		—
Long-term debt, net	$	449,629	$	902,577

Credit Facility

On October 18, 2019, we amended our credit facility that was initially entered on January 5, 2018 (as amended the 2018 credit facility). The 2018 credit facility provides for committed credit facilities in the amount of $1.2 billion U.S. dollars. The 2018 credit facility consists of a $650 million U.S. dollar term loan (the term loan) and a multicurrency revolving line of credit (the revolver) with a principal amount of up to $500 million. The revolver also contains a $300 million standby letter of credit sub-facility and a $50 million swingline sub-facility. The October 18, 2019 amendment extended the maturity date to October 18, 2024 and re-amortized the term loan based on the new balance as of the amendment date. The amendment also modified the required interest payments and made it based on total net leverage instead of total leverage. Through the third quarter of 2020, amounts not borrowed under the revolver were subject to a commitment fee, which was paid in arrears on the last day of each fiscal quarter, ranging from 0.15% to 0.25% and drawn amounts were subject to a margin ranging from 1.00% to 1.75%.

On October 19, 2020, we completed a second amendment to our 2018 credit facility. This amendment adjusts the maximum total net leverage ratio thresholds for the period beginning with the fourth quarter of 2020 through the fourth quarter of 2021 to allow for increased operational flexibility. The maximum leverage ratio is increased to 4.75:1 for the fourth quarter of 2020 and the first quarter of 2021 and 4.50:1 for the second quarter through the fourth quarter of 2021. An additional level of pricing was added to the existing pricing grid and is effective throughout the remaining term of the 2018 credit facility. Beginning with the fourth quarter of 2020, the commitment fee ranges from 0.15% to 0.30% and drawn amounts are subject to a margin ranging from 1.00% to 2.00%. Debt fees of approximately $1.4 million were incurred for the amendment, as well as other legal and advisory fees. Both the term loan and the revolver can be repaid without penalty. Amounts repaid on the term loan may not be reborrowed, and amounts borrowed under the revolver may be repaid and reborrowed until the revolver's maturity, at which time all outstanding loans together with all accrued and unpaid interest must be repaid.

On March 8, 2021, we entered into a third amendment to our 2018 credit facility, which modified provisions to permit cash settlement upon the conversion of the Convertible Notes, the Convertible Senior Note Hedge Transactions and Warrant Transactions and also to adjust certain settlement provisions for convertible indebtedness. See Note 7: Derivative Financial Instruments for further details of the Convertible Note Hedge Transactions and Warrant Transactions.

The 2018 credit facility permits us and certain of our foreign subsidiaries to borrow in U.S. dollars, euros, British pounds, or, with lender approval, other currencies readily convertible into U.S. dollars. All obligations under the 2018 credit facility are guaranteed by Itron, Inc. and material U.S. domestic subsidiaries and are secured by a pledge of substantially all of the assets of Itron, Inc. and material U.S. domestic subsidiaries. This includes a pledge of 100% of the capital stock of material U.S.

11

domestic subsidiaries and up to 66% of the voting stock (100% of the non-voting stock) of first-tier foreign subsidiaries. In addition, the obligations of any foreign subsidiary who is a foreign borrower, as defined by the 2018 credit facility, are guaranteed by the foreign subsidiary and by its direct and indirect foreign parents. The 2018 credit facility includes debt covenants, which contain certain financial thresholds and place certain restrictions on the incurrence of debt, investments, and the issuance of dividends. We were in compliance with the debt covenants under the 2018 credit facility at September 30, 2021.

Under the 2018 credit facility, we elect applicable market interest rates for both the term loan and any outstanding revolving loans. We also pay an applicable margin, which is based on our total net leverage ratio as defined in the credit agreement. The applicable rates per annum may be based on either: (1) the LIBOR rate or EURIBOR rate (subject to a floor of 0%), plus an applicable margin, or (2) the Alternate Base Rate, plus an applicable margin. The Alternate Base Rate election is equal to the greatest of three rates: (i) the prime rate, (ii) the Federal Reserve effective rate plus 0.50%, or (iii) one-month LIBOR plus 1.00%. On August 12, 2021, the term loan was fully paid. At September 30, 2021, there were no outstanding loan balances under the Credit Facility.

In March 2020, we drew $400 million in U.S. dollars under the revolving line of credit within the 2018 credit facility to increase our cash position and preserve future financial flexibility, which was fully repaid as of December 31, 2020. At September 30, 2021, there was no amount outstanding under the revolver, and $64.4 million was utilized by outstanding standby letters of credit, resulting in $435.6 million available for additional borrowings or standby letters of credit. At September 30, 2021, $235.6 million was available for additional standby letters of credit under the letter of credit sub-facility, and no amounts were outstanding under the swingline sub-facility.

Senior Notes

In December 2017 and January 2018, we issued $300 million and $100 million of aggregate principal amount of 5.00% senior notes maturing January 15, 2026 (Senior Notes). The proceeds were used to refinance existing indebtedness related to the acquisition of Silver Spring Networks, Inc., pay related fees and expenses, and for general corporate purposes. Interest on the Senior Notes was payable semi-annually in arrears on January 15 and July 15. The Senior Notes were fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by each of our subsidiaries that guarantee the senior credit facilities.

On March 9, 2021, we submitted a Notice of Redemption to the trustee to redeem all outstanding Senior Notes at a redemption price of 102.50%, in accordance with the indenture governing the Senior Notes, totaling $410.0 million. As of April 8, 2021 the Senior Notes were fully discharged, and no principal or unpaid interest remains outstanding. The 2.5%, or $10.0 million, early redemption premium and write off of $11.1 million prepaid debt fees were recognized upon redemption in the second quarter of 2021.

Convertible Notes

On March 12, 2021, we closed the sale of the Convertible Notes in a private placement to qualified institutional buyers, resulting in net proceeds to us of $448.5 million after deducting initial purchasers’ discounts of the offering. The Convertible Notes do not bear regular interest, and the principal amount does not accrete. The Convertible Notes will mature on March 15, 2026, unless earlier repurchased, redeemed, or converted in accordance with their terms. No sinking fund is provided for the Convertible Notes.

The initial conversion rate of the Convertible Notes is 7.9365 shares of our common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $126.00 per share. The conversion rate of the Convertible Notes is subject to adjustment upon the occurrence of certain specified events. In addition, upon the occurrence of a make-whole fundamental change (as defined in the indenture governing the Convertible Notes) or upon a notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change or notice of redemption, as the case may be.

Prior to the close of business on the business day immediately preceding December 15, 2025, the Convertible Notes are convertible at the option of the holders only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business-day period after any five consecutive trading-day period (the measurement period) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3) upon the occurrence of specified corporate events; or (4) upon redemption by us. On or after December 15, 2025, until the close of business on the second scheduled trading day immediately preceding March 15, 2026,

12

holders of the Convertible Notes may convert all or a portion of their notes at any time. Upon conversion, we will pay cash up to the aggregate principal amount of Convertible Notes to be converted and pay and/or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at our election, in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted.

On or after March 20, 2024 and prior to December 15, 2025, we may redeem for cash all or part of the Convertible Notes, at our option, if the last reported sales price of common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading days ending on, and including, the trading day immediately before the date we send the related notice of the redemption. The redemption price of each Convertible Notes to be redeemed will be the principal amount of such note, plus accrued and unpaid special interest, if any. Upon the occurrence of a fundamental change (as defined in the indenture governing the Convertible Notes), subject to a limited exception described in the indenture governing the Convertible Notes, holders may require us to repurchase all or a portion of their notes for cash at a price equal to plus accrued and unpaid special interest to, but not including, the fundamental change repurchase date (as defined in the indenture governing the Convertible Notes).

The Convertible Notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future unsubordinated debt and senior in right of payment to any future debt that is expressly subordinated in right of payment to the Convertible Notes. The Convertible Notes will be effectively subordinated to any of our existing and future secured debt to the extent of the assets securing such indebtedness. The Convertible Notes will be structurally subordinated to all existing debt and any future debt and any other liabilities of our subsidiaries.

Debt Maturities

The amount of required minimum principal payments on our debt in aggregate over the next five years is as follows:

Year Ending December 31,	Minimum Payments
In thousands
2021 (amount remaining at September 30, 2021)	$	—
2022	—
2023	—
2024	—
2025	—
Thereafter	460,000
Total minimum payments on debt	$	460,000

Note 7:    Derivative Financial Instruments

As part of our risk management strategy, we use derivative instruments to hedge certain foreign currency and interest rate exposures. Refer to Note 13: Shareholders' Equity and Note 14: Fair Value of Financial Instruments for additional disclosures on our derivative instruments.

The fair values of our derivative instruments are determined using the income approach and significant other observable inputs (and are classified as "Level 2" in the fair value hierarchy). We have used observable market inputs based on the type of derivative and the nature of the underlying instrument. The key inputs include interest rate yield curves (swap rates and futures) and foreign exchange spot and forward rates, all of which are available in an active market. We have utilized the mid-market pricing convention for these inputs. We include, as a discount to the derivative asset, the effect of our counterparty credit risk based on current published credit default swap rates when the net fair value of our derivative instruments is in a net asset position. We consider our own nonperformance risk when the net fair value of our derivative instruments is in a net liability position by discounting our derivative liabilities to reflect the potential credit risk to our counterparty through applying a current market indicative credit spread to all cash flows.

13

The fair values of our derivative instruments were as follows:

		Fair Value
Derivatives Assets	Balance Sheet Location	September 30, 2021		December 31, 2020
Derivatives designated as hedging instruments under ASC 815-20		In thousands
Foreign exchange options	Other current assets	$	329	$	—
Derivatives not designated as hedging instruments under ASC 815-20
Foreign exchange forward contracts	Other current assets	49		52
Total asset derivatives		$	378	$	52
Derivatives Liabilities
Derivatives designated as hedging instruments under ASC 815-20
Interest rate swap contracts	Other current liabilities	$	—	$	1,025
Interest rate swap contracts	Other long-term obligations	—		957
Cross currency swap contract	Other current liabilities	—		526
Derivatives not designated as hedging instruments under ASC 815-20
Foreign exchange forward contracts	Other current liabilities	166		128
Total liability derivatives		$	166	$	2,636

The changes in accumulated other comprehensive income (loss) (AOCI), net of tax, for our derivative and nonderivative hedging instruments designated as hedging instruments, net of tax, were as follows:

In thousands	2021		2020
Net unrealized loss on hedging instruments at January 1,	$	(16,001)	$	(15,103)
Unrealized gain (loss) on derivative instruments	1,085		(4,727)
Realized (gains) losses reclassified into net income (loss)	733		2,570
Net unrealized loss on hedging instruments at September 30,	$	(14,183)	$	(17,260)

Reclassification of amounts related to hedging instruments are included in interest expense in the Consolidated Statements of Operations. Included in the net unrealized gain (loss) on hedging instruments at September 30, 2021 and 2020 is a loss of $14.4 million, net of tax, related to our nonderivative net investment hedge, which terminated in 2011. This loss on our net investment hedge will remain in AOCI until earnings are impacted by a sale or liquidation of the associated foreign operation.

A summary of the effect of netting arrangements on our financial position related to the offsetting of our recognized derivative assets and liabilities under master netting arrangements or similar agreements is as follows:

Offsetting of Derivative Assets	Gross Amounts of Recognized Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the Consolidated Balance Sheets
In thousands			Derivative Financial Instruments		Cash Collateral Received		Net Amount
September 30, 2021	$	378	$	(28)	$	—	$	350
December 31, 2020	52		(52)		—		—

Offsetting of Derivative Liabilities	Gross Amounts of Recognized Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the Consolidated Balance Sheets
In thousands			Derivative Financial Instruments		Cash Collateral Pledged		Net Amount
September 30, 2021	$	166	$	(28)	$	—	$	138
December 31, 2020	2,636		(52)		—		2,584

Our derivative assets and liabilities subject to netting arrangements include foreign exchange forward and interest rate contracts with four counterparties at September 30, 2021 and six counterparties at December 31, 2020. No derivative asset or liability balance with any of our counterparties was individually significant at September 30, 2021 or December 31, 2020. Our derivative contracts with each of these counterparties exist under agreements that provide for the net settlement of all contracts through a single payment in a single currency in the event of default. We have no pledges of cash collateral against our

14

obligations, and we have not received pledges of cash collateral from our counterparties under the associated derivative contracts.

Cash Flow Hedges

As a result of our floating rate debt under our current credit facility, we are exposed to variability in our cash flows from changes in the applicable interest rate index. We enter into interest rate caps and swaps to reduce the variability of cash flows from increases in the LIBOR-based borrowing rates on our floating rate credit facility. These instruments do not protect us from changes to the applicable margin under our credit facility. On August 12, 2021, the term loan under the credit facility was fully repaid. At September 30, 2021, we have no LIBOR-based debt.

In October 2015, we entered into one interest rate swap, which was effective from August 31, 2016 and expired on June 23, 2020, to convert $214 million of our LIBOR-based debt from a floating LIBOR interest rate to a fixed interest rate of 1.42% (excluding the applicable margin on the debt). The notional balance amortized to maturity at the same rate as required minimum payments on the outstanding term loan. This cash flow hedge was expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk through the term of the hedge. Consequently, effective changes in the fair value of the interest rate swap were recognized as a component of other comprehensive income (loss) (OCI) and recognized in earnings when the hedged item affected earnings. The amounts paid or received on the hedge were recognized as adjustment to interest expense.

In March 2020, we entered into one interest rate swap, which was effective from June 30, 2020 to June 30, 2023, and converted $240 million of our LIBOR-based debt from a floating LIBOR interest rate to a fixed interest rate of 0.617% (excluding the applicable margin). The notional balance amortized to maturity at the same rate of originally required amortizations on our outstanding term loan. Changes in the fair value of the interest rate swap were recognized as a component of OCI and recognized in earnings when the hedged item affected earnings. The amounts paid or received on the hedge was recognized as an adjustment to interest expense along with the earnings effect of the hedged item. On March 17, 2021 following the paydown of the term loan within the 2018 credit facility, we terminated the interest rate swap, and paid a fee of $1.7 million to settle it, since the likelihood of LIBOR-based interest payments was no longer probable of occurring.

In April 2018, we entered into one cross-currency swap, which converted $56.0 million of floating LIBOR-based U.S. dollar- denominated debt into 1.38% fixed rate euro-denominated debt. This cross-currency swap matured on April 30, 2021 and mitigated the risk associated with fluctuations in currency rates impacting cash flows related to U.S. dollar-denominated debt in a euro functional currency entity. Changes in the fair value of the cross-currency swap were recognized as a component of OCI and were recognized in earnings when the hedged item affected earnings. The amounts paid or received on the hedge were recognized as an adjustment to interest expense along with the earnings effect of the hedged item.

As a result of our forecasted inventory purchases in a non-functional currency, we are exposed to foreign exchange risk. We hedge portions of these purchases. During February 2021, we entered into foreign exchange option contracts for a total notional amount of $77 million at a cost of $1.1 million. The contracts mature ratably through the year with final maturity in October 2021. Changes in the fair values of the option contracts are recognized as a component of OCI and are recognized in product cost of revenues when the hedged item affects earnings.

15

The before-tax effects of our accounting for derivative instruments designated as hedges on AOCI were as follows:

Derivatives in ASC 815-20 Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivative				Gain (Loss) Reclassified from  AOCI into Income
					Location	Amount
In thousands	2021		2020			2021		2020
Three Months Ended September 30,
Interest rate swap contracts	$	—	$	(302)	Interest expense	$	—	$	(274)
Foreign exchange options	478		(252)		Product cost of revenues	(32)		(450)
Cross currency swap contract	—		(2,326)		Interest expense	—		88
Cross currency swap contract	—		—		Other income (expense), net	—		(2,242)
Nine Months Ended September 30,
Interest rate swap contract	$	73	$	(2,818)	Interest expense	$	(229)	$	(467)
Interest rate swap contract	—		—		Other income (expense), net	(1,681)		—
Interest rate cap contracts	—		782		Interest expense	—		392
Foreign exchange options	367		(1,221)		Product cost of revenues	(40)		(612)
Cross currency swap contract	669		(1,969)		Interest expense	94		537
Cross currency swap contract	—		—		Other income (expense), net	656		(2,438)

Derivatives Not Designated as Hedging Relationships

We are also exposed to foreign exchange risk when we enter into non-functional currency transactions, both intercompany and third party. At each period-end, non-functional currency monetary assets and liabilities are revalued with the change recognized within other income (expense) in our Consolidated Statements of Operations. We enter into monthly foreign exchange forward contracts, which are not designated for hedge accounting, with the intent to reduce earnings volatility associated with currency exposures. As of September 30, 2021, a total of 37 contracts were offsetting our exposures from the euro, pound sterling, Indonesian rupiah, Canadian dollar, Australian dollar and various other currencies, with notional amounts ranging from $150,000 to $56.4 million.

The effect of our derivative instruments not designated as hedges on the Consolidated Statements of Operations was as follows:

Derivatives Not Designated as Hedging Instrument under ASC 815-20	Location	Gain (Loss) Recognized on Derivatives in Other Income (Expense)
In thousands		2021		2020
Three Months Ended September 30,
Foreign exchange forward contracts	Other income (expense), net	$	673	$	(1,646)
Nine Months Ended September 30,
Foreign exchange forward contracts	Other income (expense), net	$	210	$	(1,056)

We will continue to monitor and assess our interest rate and foreign exchange risk and may institute additional derivative instruments to manage such risk in the future.

Convertible Note Hedge Transactions

We paid an aggregate amount of $84.1 million for the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Convertible Notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the Convertible Notes, at a strike price of approximately $126.00, subject to customary adjustments. The Convertible Note Hedge Transactions will expire upon the maturity of the Convertible Notes, subject to earlier exercise or termination. The Convertible Note Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of the Convertible Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the Convertible Note Hedge Transactions, is greater than the strike price of those Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions meet the

16

criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore the transactions are not revalued after their issuance.

We made a tax election to integrate the Convertible Notes and the call options. We are retaining the identification statements in our books and records, together with a schedule providing the accruals on the synthetic debt instruments. The accounting impact of this tax election makes the call options deductible as original issue discount for tax purposes over the term of the Convertible Note, and results in a $20.6 million deferred tax asset recognized through equity.

Warrant Transactions

In addition, concurrently with entering into the Convertible Note Hedge Transactions, we separately entered into privately-negotiated Warrant Transactions (the Warrant Transactions), whereby we sold to the Counterparties warrants to acquire, collectively, subject to anti-dilution adjustments, 3.7 million shares of our common stock at an initial strike price of $180.00 per share, which represents a premium of 100% over the public offering price in the common stock issuance. We received aggregate proceeds of $45.3 million from the Warrant Transactions with the Counterparties, with such proceeds partially offsetting the costs of entering into the Convertible Note Hedge Transactions. The warrants expire in June 2026. If the market value per share of our common stock, as measured under the Warrants Transactions, exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless we elect, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, therefore the warrants are not revalued after issuance.

Note 8:    Defined Benefit Pension Plans

We sponsor both funded and unfunded defined benefit pension plans offering death and disability, retirement, and special termination benefits for certain of our international employees, primarily in Germany, France, Indonesia, India, and Italy. The defined benefit obligation is calculated annually by using the projected unit credit method. The measurement date for the pension plans was December 31, 2020.

Amounts recognized on the Consolidated Balance Sheets consist of:

In thousands	September 30, 2021		December 31, 2020
Liabilities
Current portion of pension benefit obligation in wages and benefits payable	$	3,822	$	3,069
Long-term portion of pension benefit obligation	114,771		119,457
Pension benefit obligation, net	$	118,593	$	122,526

Our asset investment strategy focuses on maintaining a portfolio using primarily insurance funds, which are accounted for as investments and measured at fair value, in order to achieve our long-term investment objectives on a risk-adjusted basis. Our general funding policy for these qualified pension plans is to contribute amounts sufficient to satisfy regulatory funding standards of the respective countries for each plan.

Net periodic pension benefit cost for our plans include the following components:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Service cost	$	1,125	$	1,007	$	3,376	$	3,000
Interest cost	345		434		1,046		1,364
Expected return on plan assets	(87)		(85)		(264)		(365)
Amortization of prior service costs	17		17		51		49
Amortization of actuarial net loss	681		482		2,070		1,390
Settlement	—		286		—		286
Net periodic benefit cost	$	2,081	$	2,141	$	6,279	$	5,724

The components of net periodic benefit cost, other than the service cost component, are included in total other income (expense) on the Consolidated Statements of Operations.

17

Note 9:    Stock-Based Compensation

We grant stock-based compensation awards, including stock options, restricted stock units, phantom stock, and unrestricted stock units, under the Second Amended and Restated 2010 Stock Incentive Plan (Stock Incentive Plan). In the Stock Incentive Plan, we have 12,623,538 shares of common stock reserved and authorized for issuance subject to stock splits, dividends, and other similar events. At September 30, 2021, 5,346,245 shares were available for grant. We issue new shares of common stock upon the exercise of stock options or when vesting conditions on restricted stock units are fully satisfied. These shares are subject to a fungible share provision such that the authorized share available for grant is reduced by (i) one share for every one share subject to a stock option or share appreciation right granted under the Plan and (ii) 1.7 shares for every one share of common stock that was subject to an award other than an option or share appreciation right.

We also periodically award phantom stock units, which are settled in cash upon vesting and accounted for as liability-based awards, with no impact to the shares available for grant.

In addition, we maintain the Employee Stock Purchase Plan (ESPP), for which 151,221 shares of common stock were available for future issuance at September 30, 2021.

ESPP activity and stock-based grants other than stock options and restricted stock units were not significant for the three and nine months ended September 30, 2021 and 2020.

Stock-Based Compensation Expense

Total stock-based compensation expense and the related tax benefit were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Stock options	$	344	$	452	$	1,055	$	1,445
Restricted stock units	5,104		4,399		16,546		18,575
Unrestricted stock awards	217		206		650		618
Phantom stock units	519		582		2,861		2,075
Total stock-based compensation	$	6,184	$	5,639	$	21,112	$	22,713
Related tax benefit	$	1,159	$	1,070	$	3,840	$	4,257

Stock Options

A summary of our stock option activity is as follows:

	Shares	Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value		Weighted Average Grant Date Fair Value
	(in thousands)			(years)	(in thousands)
Outstanding, January 1, 2020	458	$	56.38	7.0	$	12,641
Granted	80	84.38					$	26.21
Exercised	(49)	50.90			1,189
Forfeited	(5)	83.80
Outstanding, September 30, 2020	484	$	61.30	7.0	$	3,816
Outstanding, January 1, 2021	433	$	61.95	6.9	$	14,697
Granted	—						$	—
Exercised	(34)	67.21			1,215
Forfeited	(6)	83.33
Outstanding, September 30, 2021	393	$	61.18	6.1	$	6,496
Exercisable, September 30, 2021	317	$	56.51	5.6	$	6,361

At September 30, 2021, total unrecognized stock-based compensation expense related to nonvested stock options was $1.4 million, which is expected to be recognized over a weighted average period of approximately 1.3 years.

18

The weighted average assumptions used to estimate the fair value of stock options granted and the resulting weighted average fair value are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Expected volatility	—	%	41.5	%	—	%	32.1	%
Risk-free interest rate	—	%	0.3	%	—	%	1.3	%
Expected term (years)	N/A		5.3		N/A		5.3

There were no employee stock options granted for the three and nine months ended September 30, 2021.

Restricted Stock Units

The following table summarizes restricted stock unit activity:

In thousands, except fair value	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Outstanding, January 1, 2020	684
Granted	209	$	83.34
Released (1)	(338)			$	21,947
Forfeited	(23)
Outstanding, September 30, 2020	532
Outstanding, January 1, 2021	544	$	71.79
Granted	212	97.96
Released (1)	(288)	70.20		$	28,494
Forfeited	(46)	77.79
Outstanding, September 30, 2021	422	85.75
Vested but not released, September 30, 2021	10			$	733

(1)     Shares released is presented as gross shares and does not reflect shares withheld by us for employee payroll tax obligations.

At September 30, 2021, total unrecognized compensation expense on restricted stock units was $30.9 million, which is expected to be recognized over a weighted average period of approximately 1.8 years.

The weighted average assumptions used to estimate the fair value of performance-based restricted stock units granted with a service and market condition and the resulting weighted average fair value are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Expected volatility	—		%	52.6		%	50.5		%	38.2		%
Risk-free interest rate	—		%	0.2		%	0.2		%	1.5		%
Expected term (years)	N/A			2.3			2.9			1.8
Weighted average fair value	$	—		$	61.45		$	113.75		$	93.05

There were no performance-based restricted stock units granted for the three months ended September 30, 2021.

19

Note 10: Income Taxes

We determine the interim tax benefit (provision) by applying an estimate of the annual effective tax rate to the year-to-date pretax book income (loss) and adjusting for discrete items during the reporting period, if any. Tax jurisdictions with losses for which tax benefits cannot be realized are excluded.

Our tax rate for the three and nine months ended September 30, 2021 of 902% and (39)%, respectively, differed from the federal statutory rate of 21% due to losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets, the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to stock-based compensation, uncertain tax positions, and reserves recognized on deferred purchase price receivables.

Our tax rate for the three and nine months ended September 30, 2020 of 32% and 0%, respectively, differed from the federal statutory rate of 21% primarily due to a significant loss recognized in the second quarter for the divestiture of the majority of our Latin American business activities. This loss was recognized for tax as a discrete item and resulted in no tax benefit. A discrete tax benefit was recognized in the third quarter for $10.1 million related to the release of a valuation allowance on U.S. foreign tax credit deferred tax assets. This release was triggered by the carryforward of tax attributes due to the filing of amended tax returns in the third quarter. Other rate drivers included losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to stock-based compensation, and uncertain tax positions.

We classify interest expense and penalties related to unrecognized tax liabilities and interest income on tax overpayments as components of income tax expense. The net interest and penalties expense amounts recognized were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Net interest and penalties expense	$	195	$	(198)	$	153	$	422

Accrued interest and penalties recognized were as follows:

In thousands	September 30, 2021		December 31, 2020
Accrued interest	$	3,663	$	3,432
Accrued penalties	1,405		1,645

Unrecognized tax benefits related to uncertain tax positions and the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate were as follows:

In thousands	September 30, 2021		December 31, 2020
Unrecognized tax benefits related to uncertain tax positions	$	134,110	$	135,910
The amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate	132,992		134,473

At September 30, 2021, we are under examination by certain tax authorities. We believe we have appropriately accrued for the expected outcome of all tax matters and do not currently anticipate that the ultimate resolution of these examinations will have a material adverse effect on our financial condition, future results of operations, or cash flows.

Based upon the timing and outcome of examinations, litigation, the impact of legislative, regulatory, and judicial developments, and the impact of these items on the statute of limitations, it is reasonably possible that the related unrecognized tax benefits could change from those recognized within the next twelve months. However, at this time, an estimate of the range of reasonably possible adjustments to the balance of unrecognized tax benefits cannot be made.

We file income tax returns in various jurisdictions. The material jurisdictions where we are subject to examination include, among others, the United States, France, Germany, Italy, Indonesia, and the United Kingdom.

On March 27, 2020, the U.S. Federal government passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act to provide economic relief from COVID-19. The CARES Act contains significant business tax provisions, which the Company has evaluated and determined will not have a material impact on the Company's financial statements or related disclosures.

20

The CARES Act also provides employer payroll tax credits for wages paid to employees who are unable to work during the COVID-19 outbreak and options to defer payroll tax payments. The Company has elected to defer remittances of payroll and other taxes into the future as provided for under the Act.

On October 8, 2021 the G20/OECD Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") published a statement on the components of global tax reform agreed to by most member countries. The key components would allocate a portion of profits of the largest businesses amongst their markets, curtail new digital services taxes, and introduce a new global minimum tax of 15%. These components do not result in any financial impact until enacted, which is not currently expected until 2023. The Company is monitoring developments and additional details as they are released to determine the impacts these new components will have on our business.

Note 11:    Commitments and Contingencies

Guarantees and Indemnifications

We are often required to obtain standby letters of credit (LOCs) or bonds in support of our obligations for customer contracts. These standby LOCs or bonds typically provide a guarantee to the customer for our future performance, which usually covers the installation phase of a contract and may, on occasion, cover the operations and maintenance phase of outsourcing contracts.

Our available lines of credit, outstanding standby LOCs, and bonds were as follows:

In thousands	September 30, 2021		December 31, 2020
Credit facility
Multicurrency revolving line of credit	$	500,000	$	500,000
Standby LOCs issued and outstanding	(64,448)		(64,948)
Net available for additional borrowings under the multicurrency revolving line of credit	$	435,552	$	435,052
Net available for additional standby LOCs under sub-facility	$	235,552	$	235,052
Unsecured multicurrency revolving lines of credit with various financial institutions
Multicurrency revolving lines of credit	$	97,113	$	99,201
Standby LOCs issued and outstanding	(24,245)		(24,966)
Short-term borrowings	(8,764)		—
Net available for additional borrowings and LOCs	$	64,104	$	74,235
Unsecured surety bonds in force	$	169,293	$	162,912

In the event any such standby LOC or bond is called, we would be obligated to reimburse the issuer of the standby LOC or bond; however, as of November 4, 2021, we do not believe any outstanding standby LOCs or bonds will be called.

We generally provide an indemnification related to the infringement of any patent, copyright, trademark, or other intellectual property right on software or equipment within our sales contracts, which indemnifies the customer from, and pays the resulting costs, damages, and attorney's fees awarded against a customer with respect to, such a claim provided that (a) the customer promptly notifies us in writing of the claim and (b) we have the sole control of the defense and all related settlement negotiations. We may also provide an indemnification to our customers for third-party claims resulting from damages caused by the negligence or willful misconduct of our employees/agents in connection with the performance of certain contracts. The terms of our indemnifications generally do not limit the maximum potential payments. It is not possible to predict the maximum potential amount of future payments under these or similar agreements.

Legal Matters

We are subject to various legal proceedings and claims of which the outcomes are subject to significant uncertainty. Our policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. A determination of the amount of the liability required, if any, for these contingencies is made after an analysis of each known issue. A liability would be recognized and charged to operating expense when we determine that a loss is probable and the amount can be reasonably estimated. Additionally, we disclose contingencies for which a material loss is reasonably possible, but not probable.

21

Warranty

A summary of the warranty accrual account activity is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Beginning balance	$	36,210	$	44,757	$	41,390	$	53,242
New product warranties	1,925		785		3,611		2,855
Other adjustments and expirations, net	(975)		1,643		631		5,436
Claims activity	(2,156)		(5,044)		(10,040)		(19,349)
Effect of change in exchange rates	(317)		946		(905)		903
Ending balance	34,687		43,087		34,687		43,087
Less: current portion of warranty	18,089		32,118		18,089		32,118
Long-term warranty	$	16,598	$	10,969	$	16,598	$	10,969

Total warranty expense is classified within cost of revenues and consists of new product warranties issued, costs related to insurance and supplier recoveries, other changes and adjustments to warranties, and customer claims. Warranty expense was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Total warranty expense	$	950	$	2,428	$	4,242	$	8,321

Warranty expense decreased during the nine months ended September 30, 2021 compared with the same period in 2020. The lower costs in 2021 are primarily the result of incremental specific reserves recognized in 2020, including $1.7 million for electric and gas products in Europe, Middle East, and Africa (EMEA) Device Solutions and $1.1 million for electric and water products in North America (NAM) Networked Solutions.

Note 12:    Restructuring

2020 Projects

In September 2020, our Board of Directors approved a restructuring plan (the 2020 Projects), which includes activities that continue our efforts to optimize our global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are scheduled to be substantially complete by the end of 2022. Many of the affected employees are represented by unions or works councils, which require consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of charges, total expected charges, cost recognized, and planned savings in certain jurisdictions.

In the third quarter of 2021, expected remaining costs to be recognized were reduced by $13.0 million due to the removal of a previously planned non-cash cumulative translation adjustment charge, resulting from our recent reassessment of the legal entity and its related operations.

The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2020 Projects were as follows:

In thousands	Total Expected Costs at September 30, 2021		Costs Recognized in Prior Periods		Costs Recognized During the Nine Months Ended  September 30, 2021		Expected Remaining Costs to be Recognized at September 30, 2021
Employee severance costs	$	32,583	$	36,225	$	(3,642)	$	—
Asset impairments & net loss (gain) on sale or disposal	6,893		6,944		(51)		—
Other restructuring costs	4,546		63		1,920		2,563
Total	$	44,022	$	43,232	$	(1,773)	$	2,563

2018 Projects

In February 2018, our Board of Directors approved a restructuring plan (the 2018 Projects) to continue our efforts to optimize our global supply chain and manufacturing operations, research and development, and sales and marketing organizations. Actions under the 2018 Projects were substantially completed as of the end of 2020.

22

During the nine months ended September 30, 2021, we incurred additional legal costs related to a facility closure, partially offset by reduced severance costs.

The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2018 Projects were as follows:

In thousands	Total Expected Costs at September 30, 2021		Costs Recognized in Prior Periods		Costs Recognized During the Nine Months Ended  September 30, 2021		Expected Remaining Costs to be Recognized at September 30, 2021
Employee severance costs	$	59,229	$	63,173	$	(3,944)	$	—
Asset impairments & net loss (gain) on sale or disposal	3,788		2,786		1,002		—
Other restructuring costs	19,752		15,217		3,885		650
Total	$	82,769	$	81,176	$	943	$	650

The following table summarizes the activity within the restructuring-related balance sheet accounts for the 2020 Projects and 2018 Projects during the nine months ended September 30, 2021:

In thousands	Accrued Employee Severance		Asset Impairments & Net Loss (Gain) on Sale or Disposal		Other Accrued Costs		Total
Beginning balance, January 1, 2021	$	70,005	$	—	$	2,621	$	72,626
Costs charged to expense	(7,586)		951		5,805		(830)
Cash payments	(16,431)		—		(4,725)		(21,156)
Cash receipts	—		2,007		—		2,007
Net assets disposed and impaired	—		(2,958)		—		(2,958)
Effect of change in exchange rates	(2,377)		—		(47)		(2,424)
Ending balance, September 30, 2021	$	43,611	$	—	$	3,654	$	47,265

Asset impairments are determined at the asset group level. Revenues and net operating income from the activities we have exited or will exit under the restructuring projects are not material to our operating segments or consolidated results.

Other restructuring costs include expenses for employee relocation, professional fees associated with employee severance, costs to exit the facilities once the operations in those facilities have ceased, and other costs associated with the liquidation of any affected legal entities. Costs associated with restructuring activities are generally presented in the Consolidated Statements of Operations as restructuring, except for certain costs associated with inventory write-downs, which are classified within cost of revenues, and accelerated depreciation expense, which is recognized according to the use of the asset. Restructuring expense is part of the Corporate unallocated segment and does not impact the results of our operating segments.

The current portions of restructuring liabilities were $28.7 million and $31.7 million as of September 30, 2021 and December 31, 2020 and are classified within other current liabilities on the Consolidated Balance Sheets. The long-term portions of restructuring liabilities were $18.6 million and $40.9 million as of September 30, 2021 and December 31, 2020. The long-term portions of restructuring liabilities are classified within other long-term obligations on the Consolidated Balance Sheet and includes severance accruals and facility exit costs.

Note 13:    Shareholders' Equity

Preferred Stock

We have authorized the issuance of 10 million shares of preferred stock with no par value. In the event of a liquidation, dissolution, or winding up of the affairs of the corporation, whether voluntary or involuntary, the holders of any outstanding preferred stock would be entitled to be paid a preferential amount per share to be determined by the Board of Directors prior to any payment to holders of common stock. There was no preferred stock issued or outstanding at September 30, 2021 or December 31, 2020.

23

Issuance of Common Stock

On March 12, 2021, we closed the sale of 4,472,222 shares of our common stock in a public offering, resulting in net proceeds to us of approximately $389.4 million, after deducting underwriters’ discounts of the offering.

Convertible Note Hedge Transactions

We paid an aggregate amount of $84.1 million for the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Convertible Notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the Convertible Notes, at a strike price of approximately $126.00, subject to customary adjustments. The Convertible Note Hedge Transactions will expire upon the maturity of the Convertible Notes, subject to earlier exercise or termination. The Convertible Note Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of our Convertible Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted notes, as the case may be, in the event the price per share of our common stock, as measured under the terms of the Convertible Note Hedge Transactions, is greater than the strike price of the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, therefore the Convertible Note Hedge Transactions are not revalued after their issuance.

We made a tax election to integrate the Convertible Notes and the call options. We are retaining the identification statements in our books and records, together with a schedule providing the accruals on the synthetic debt instruments. The accounting impact of this tax election makes the call options deductible as original issue discount for tax purposes over the term of the Convertible Note, and results in a $20.6 million deferred tax asset recognized through equity.

Warrant Transactions

In addition, concurrently with entering into the Convertible Note Hedge Transactions, we separately entered into privately-negotiated Warrant Transactions, whereby we sold to the Counterparties warrants to acquire, collectively, subject to anti-dilution adjustments, 3.7 million shares of our common stock at an initial strike price of $180.00 per share, which represents a premium of 100% over the public offering price in the common stock issuance. We received aggregate proceeds of $45.3 million from the Warrant Transactions with the Counterparties, with such proceeds partially offsetting the costs of entering into the Convertible Note Hedge Transactions. The warrants expire in June 2026. If the market value per share of our common stock, as measured under the Warrant Transactions, exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless we elect, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore the warrants are not revalued after issuance.

Accumulated Other Comprehensive Income (Loss)

The changes in the components of AOCI, net of tax, were as follows:

In thousands	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) on Derivative Instruments		Net Unrealized Gain (Loss) on Nonderivative Instruments		Pension Benefit Obligation Adjustments		Accumulated Other Comprehensive Income (Loss)
Balances at January 1, 2020	$	(157,999)	$	(723)	$	(14,380)	$	(31,570)	$	(204,672)
OCI before reclassifications	(147)		(4,727)		—		(1,151)		(6,025)
Amounts reclassified from AOCI	52,074		2,570		—		2,040		56,684
Total other comprehensive income (loss)	51,927		(2,157)		—		889		50,659
Balances at September 30, 2020	$	(106,072)	$	(2,880)	$	(14,380)	$	(30,681)	$	(154,013)
Balances at January 1, 2021	$	(84,843)	$	(1,621)	$	(14,380)	$	(37,682)	$	(138,526)
OCI before reclassifications	(17,118)		1,085		—		—		(16,033)
Amounts reclassified from AOCI	—		733		—		2,087		2,820
Total other comprehensive income (loss)	(17,118)		1,818		—		2,087		(13,213)
Balances at September 30, 2021	$	(101,961)	$	197	$	(14,380)	$	(35,595)	$	(151,739)

24

The before-tax, income tax (provision) benefit, and net-of-tax amounts related to each component of OCI were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Before-tax amount
Foreign currency translation adjustment	$	(7,827)	$	15,521	$	(16,941)	$	(387)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478		(2,887)		1,103		(5,228)
Net hedging (gain) loss reclassified to net income (loss)	32		2,879		1,200		2,588
Net unrealized gain (loss) on defined benefit plans	—		(893)		—		(812)
Net defined benefit plan (gain) loss reclassified to net income (loss)	698		499		2,121		1,439
Total other comprehensive income (loss), before tax	$	(6,619)	$	15,105	$	(12,517)	$	49,674
Tax (provision) benefit
Foreign currency translation adjustment	$	63	$	(1,533)	$	(177)	$	240
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		—		—		—
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	—		74		(18)		501
Net hedging (gain) loss reclassified to net income (loss)	—		(67)		(467)		(18)
Net unrealized gain (loss) on defined benefit plans	—		(341)		—		(339)
Net defined benefit plan (gain) loss reclassified to net income (loss)	(11)		576		(34)		601
Total other comprehensive income (loss) tax (provision) benefit	$	52	$	(1,291)	$	(696)	$	985
Net-of-tax amount
Foreign currency translation adjustment	$	(7,764)	$	13,988	$	(17,118)	$	(147)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478		(2,813)		1,085		(4,727)
Net hedging (gain) loss reclassified to net income (loss)	32		2,812		733		2,570
Net unrealized gain (loss) on defined benefit plans	—		(1,234)		—		(1,151)
Net defined benefit plan (gain) loss reclassified to net income (loss)	687		1,075		2,087		2,040
Total other comprehensive income (loss), net of tax	$	(6,567)	$	13,814	$	(13,213)	$	50,659

25

Note 14:    Fair Value of Financial Instruments

The fair values at September 30, 2021 and December 31, 2020 do not reflect subsequent changes in the economy, interest rates, tax rates, and other variables that may affect the determination of fair value.

	September 30, 2021				December 31, 2020
In thousands	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Credit facility
USD denominated term loan	$	—	$	—	$	532,625	$	520,347
Multicurrency revolving line of credit	—		—		—		—
Senior notes	—		—		388,311		410,000
Convertible notes	449,629		434,130		—		—

The following methods and assumptions were used in estimating fair values:

Cash and cash equivalents: Due to the liquid nature of these instruments, the carrying amount approximates fair value (Level 1).

Credit Facility - term loan and multicurrency revolving line of credit: The term loan and the revolver are not traded publicly. The fair values, which are determined based upon a hypothetical market participant, are calculated using a discounted cash flow model with Level 2 inputs, including estimates of incremental borrowing rates for debt with similar terms, maturities, and credit profiles. Refer to Note 6: Debt for a further discussion of our debt.

Senior Notes and Convertible Notes: The Senior Notes and Convertible Notes are not registered securities nor listed on any securities exchange but may be actively traded by qualified institutional buyers. The fair value is estimated using Level 1 inputs, as it is based on quoted prices for these instruments in active markets.

Derivatives: See Note 7: Derivative Financial Instruments for a description of our methods and assumptions in determining the fair value of our derivatives, which were determined using Level 2 inputs. Each derivative asset and liability has a carrying value equal to fair value.

Note 15:    Segment Information

We operate under the Itron brand worldwide and manage and report under three operating segments: Device Solutions, Networked Solutions, and Outcomes.

We have three GAAP measures of segment performance: revenues, gross profit (gross margin), and operating income (operating margin). Intersegment revenues are minimal. Certain operating expenses are allocated to the operating segments based upon internally established allocation methodologies. Corporate operating expenses, interest income, interest expense, other income (expense), and the income tax provision (benefit) are neither allocated to the segments, nor are they included in the measure of segment performance. In addition, we allocate only certain production assets and intangible assets to our operating segments. We do not manage the performance of the segments on a balance sheet basis.

Segment Products

Device Solutions – This segment primarily includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with our broader Itron systems, i.e., hardware-based products not part of a complete end-to-end solution. Examples from the Device Solutions portfolio include: standard endpoints that are shipped without Itron communications, such as our standard gas, electricity, and water meters for a variety of global markets and adhering to regulations and standards within those markets, as well as our heat and allocation products; communicating meters that are not a part of an Itron end-to-end solution such as Smart Spec meters and the implementation and installation of non-communicating devices, such as gas regulators.

Networked Solutions – This segment primarily includes a combination of communicating devices (e.g., smart meters, modules, endpoints, and sensors), network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. Networked Solutions includes products and software for the implementation, installation, and management of communicating devices and data networks. Examples from the Networked

26

Solutions portfolio include: communicating measurement, control, or sensing endpoints such as our Itron® OpenWay® Centron and Riva meters, Itron traditional ERT® technology, Intelis smart gas meters, 500G gas communication modules, 500W water communication modules; GenX networking infrastructure products and network interface cards (NICs); Smart City control and management software; Distribution Automation bridge devices, and specific network control and management software applications. The Industrial Internet of Things (IIoT) solutions supported by this segment include automated meter reading (AMR), advanced metering infrastructure (AMI), smart grid and distribution automation, smart street lighting and an ever-growing set of smart city applications such as traffic management, smart parking, air quality monitoring, electric vehicle charging, customer engagement, digital signage, acoustic (e.g., gunshot) detection, and leak detection and mitigation for both gas and water systems. Our IIoT platform allows all of these industry and smart city applications to be run and managed on a single, multi-purpose network.

Outcomes – This segment primarily includes our value-added, enhanced software and services in which we manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. Outcomes places an emphasis on delivering to Itron customers high-value, turn-key, digital experiences by leveraging the footprint of our Device Solutions and Networked Solutions segments. The revenues from these offerings are primarily recurring in nature and would include any direct management of Device Solutions, Networked Solutions, and other products on behalf of our end customers. Examples from the Outcomes portfolio include: our meter data management and analytics offerings; our managed service solutions including Network-as-a-Service (NaaS) and Platform-as-a-Service (PaaS), forecasting software and services; our Distributed Intelligence suite of applications and services; and any consulting-based engagement. Within the Outcomes segment, we also identify new business models, including performance-based contracting, to drive broader portfolio offerings across utilities and cities.

27

Revenues, gross profit, and operating income associated with our operating segments were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Product revenues
Device Solutions	$	149,830	$	174,039	$	480,808	$	501,157
Networked Solutions	242,527		282,677		736,397		898,465
Outcomes	18,590		13,942		48,265		38,158
Total Company	$	410,947	$	470,658	$	1,265,470	$	1,437,780
Service revenues
Device Solutions	$	2,404	$	2,089	$	7,174	$	6,415
Networked Solutions	31,971		23,982		91,473		73,519
Outcomes	41,627		43,455		131,818		130,479
Total Company	$	76,002	$	69,526	$	230,465	$	210,413
Total revenues
Device Solutions	$	152,234	$	176,128	$	487,982	$	507,572
Networked Solutions	274,498		306,659		827,870		971,984
Outcomes	60,217		57,397		180,083		168,637
Total Company	$	486,949	$	540,184	$	1,495,935	$	1,648,193
Gross profit
Device Solutions	$	22,480	$	20,528	$	85,228	$	64,843
Networked Solutions	89,915		102,295		298,627		332,368
Outcomes	22,568		20,428		68,027		56,123
Total Company	$	134,963	$	143,251	$	451,882	$	453,334
Operating income (loss)
Device Solutions	$	12,095	$	11,017	$	53,784	$	28,095
Networked Solutions	61,150		71,404		205,071		237,466
Outcomes	11,774		12,044		34,647		29,468
Corporate unallocated	(80,856)		(118,445)		(265,331)		(338,026)
Total Company	4,163		(23,980)		28,171		(42,997)
Total other income (expense)	(4,037)		(13,063)		(42,465)		(35,020)
Income (loss) before income taxes	$	126	$	(37,043)	$	(14,294)	$	(78,017)

For the three and nine months ended September 30, 2021 and the three months ended September 30, 2020, no customer represented more than 10% of total company revenue. During the nine months ended September 30, 2020, one customer represented 11% of total company revenues.

28

Revenues by region were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
United States and Canada	$	323,784	$	354,841	$	957,993	$	1,110,028
Europe, Middle East, and Africa	126,548		156,810		437,768		431,593
Asia Pacific and Latin America(1)	36,617		28,533		100,174		106,572
Total Company	$	486,949	$	540,184	$	1,495,935	$	1,648,193

(1) On June 25, 2020, we sold our Latin American operations. We continue to sell into the region through an exclusive distributor.

Depreciation expense is allocated to the operating segments based upon each segment's use of the assets. All amortization expense is recognized within Corporate unallocated. Depreciation and amortization of intangible assets expense associated with our operating segments was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Device Solutions	$	5,911	$	5,926	$	17,708	$	18,423
Networked Solutions	4,274		4,377		12,801		12,447
Outcomes	1,068		1,327		3,431		4,132
Corporate unallocated	10,080		12,446		30,312		37,304
Total Company	$	21,333	$	24,076	$	64,252	$	72,306

Note 16: Revenues

A summary of significant net changes in the contract assets and the contract liabilities balances during the period is as follows:

In thousands	Contract Liabilities, Less Contract Assets
Beginning balance, January 1, 2021	$	98,388
Revenues recognized from beginning contract liability	(95,096)
Cumulative catch-up adjustments	16,722
Increases due to amounts collected or due	215,549
Revenues recognized from current period increases	(136,122)
Other	(908)
Ending balance, September 30, 2021	$	98,533

On January 1, 2021, total contract assets were $49.8 million and total contract liabilities were $148.2 million. On September 30, 2021, total contract assets were $35.3 million and total contract liabilities were $133.8 million. The contract assets primarily relate to contracts that include a retention clause and allocations related to contracts with multiple performance obligations. The contract liabilities primarily relate to deferred revenue, such as extended warranty and maintenance cost. The cumulative catch-up adjustments relate to contract modifications, measure-of-progress changes, and changes in the estimate of the transaction price.

Transaction price allocated to the remaining performance obligations

Total transaction price allocated to remaining performance obligations represents committed but undelivered products and services for contracts and purchase orders at period end. Twelve-month remaining performance obligations represent the portion of total transaction price allocated to remaining performance obligations that we estimate will be recognized as revenue over the next 12 months. Total transaction price allocated to remaining performance obligations is not a complete measure of our future revenues as we also receive orders where the customer may have legal termination rights but are not likely to terminate.

Total transaction price allocated to remaining performance obligations related to contracts is approximately $1.3 billion for the next twelve months and approximately $1.5 billion for periods longer than 12 months. The total remaining performance obligations consist of product and service components. The service component relates primarily to maintenance agreements for which customers pay a full year's maintenance in advance, and service revenues are generally recognized over the service period. Total transaction price allocated to remaining performance obligations also includes our extended warranty contracts,

29

for which revenue is recognized over the warranty period, and hardware, which is recognized as units are delivered. The estimate of when remaining performance obligations will be recognized requires significant judgment.

Cost to obtain a contract and cost to fulfill a contract with a customer

Cost to obtain a contract and costs to fulfill a contract were capitalized and amortized using a systematic rational approach to align with the transfer of control of underlying contracts with customers. While amounts were capitalized, they are not material.

Disaggregation of revenue

Refer to Note 15: Segment Information and the Consolidated Statements of Operations for disclosure regarding the disaggregation of revenue into categories, which depict how revenue and cash flows are affected by economic factors. Specifically, our operating segments and geographical regions as disclosed, and categories for products, which include hardware and software and services, are presented.

Note 17: Sale of Business

Latin America Divestiture

On June 25, 2020, we closed on the sale of five subsidiaries comprising our manufacturing and sales operations in Latin America to buyers led by Instalación Profesional y Tecnologías del Centro S.A. de C.V., a Mexican company doing business as Accell in Brazil (Accell), through the execution of various definitive stock purchase agreements. The sale of these Latin America-based operations is part of our continued strategy to improve profitability and focus on growing our Networked Solutions and Outcomes businesses in Latin America and throughout the world. We retained the intellectual property rights to our products sold in Latin America. As part of the transaction, we entered into an intellectual property license agreement whereby Accell pays a royalty on certain products manufactured by Accell using licensed Company intellectual property. In addition, Accell serves as the exclusive distributor for our Device Solutions, Networked Solutions, and Outcomes product and service offerings in Latin America.

The total sales price of $35.0 million included deferred payments of $21.1 million for working capital, which was to be paid in full by December 31, 2020, as evidenced by a promissory note, and the remainder in cash ($4.5 million) and other deferred consideration.

In January 2021, we agreed to extend the payment terms on the remaining outstanding working capital balance of $18.4 million. Accell had agreed to make monthly payments, including interest, through September 2022, under which we received full payments for January through March and partial payments in April and May (totaling $3.8 million including $0.7 million in interest). In July 2021, we received a revised payment plan for the remaining working capital note receivable, as well as the other deferred transaction receivables. Based on Accell's failure to make timely payments, continued requests to defer payments significantly beyond the original maturity of the working capital note, and the unfavorable impact of the COVID-19 pandemic on the Latin American markets, we determined to fully reserve the working capital and other deferred receivables, recognizing an additional loss on sale of business of $24.7 million during the second quarter of 2021.

Note 18:    Subsequent Events

Business Acquisition

Subsequent to September 30, 2021, we completed the acquisition of 100% of the shares of SELC Group Limited (SELC), a private limited company incorporated in Ireland, on October 12, 2021. SELC was previously a technology supplier to Itron. The acquisition provides value to Itron through the leverage of SELC’s streetlight controls technology coupled with Itron’s Smart Cities network and software platform. The acquisition will increase the pace of Smart City growth and innovation within Itron’s Networked Solutions business for the benefit of our customers. The purchase was funded through cash on hand and resulted in immaterial additions of intangible assets and goodwill.

Sale of Business

On November 2, 2021, Itron entered into a definitive securities and asset purchase agreement to sell certain of its Gas device manufacturing and business operations in Europe and North America to Dresser Utility Solutions (Dresser). The sale includes one German subsidiary – Itron GmbH along with its business operations, personnel, and the owned manufacturing facility in Karlsruhe; the business operations, personnel, and assets associated with the leased manufacturing facility in Argenteuil, France; and the business and manufacturing assets maintained at one of our contract manufacturers in North America. The sale of these assets and operations is part of Itron’s continued strategy to improve profitability and focus on growing its higher value businesses throughout the world.

30

Based on the sales price and the net assets of the businesses sold, Itron concluded on November 2, 2021 that it will recognize a pre-tax loss with a range of $30-40 million upon closure of the sale, which is expected in the first half of 2022. The impairment is driven primarily by the required recognition of $58-62 million in foreign currency translation losses accumulated since the acquisition of the German subsidiary in 2007. The base sale price of this divestiture is $75 million, with adjustments for (1) pension liabilities assumed by Dresser for the active employees estimated at $12-13 million and (2) the final working capital balance, which will be determined as of the close date, and, if the balance is outside the targeted amount, the difference will be settled shortly thereafter. Net assets of the businesses, including allocated goodwill, are $35-40 million. Cash proceeds from the sale are currently estimated at $62-63 million.

Restructuring Plan Associated with Sale of Business

On October 29, 2021, the Board of Directors of Itron approved a restructuring plan (the 2021 Projects). The 2021 Projects include activities, in conjunction with the announcement of the sale of certain of our Gas device manufacturing operations, which drive reductions in certain locations and functional support areas. These projects are to be substantially complete by the end of 2024. Itron estimates pre-tax restructuring charges of $65-75 million. Of the total estimated charge, approximately $60-65 million will result in cash expenditures, and the remainder to non-cash impairment charges. The majority of the expense will be recognized during the fourth quarter of 2021. Once the 2021 Projects are substantially completed, Itron estimates $15-20 million in annualized savings. Certain of Itron’s employees are represented by unions or works councils, which requires consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of planned savings in certain jurisdictions.

Approval of Share Repurchase Program

Effective November 1, 2021, the Board of Directors of Itron authorized a new share repurchase program of up to $100 million of Itron’s common stock over a 18-month period. Repurchases will be made in the open market and pursuant to the terms of any Rule 10b5-1 plans that Itron may enter into, and in accordance with applicable securities laws. The repurchase program is intended to comply with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice.

Item 2:    Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the unaudited consolidated financial statements and notes included in this report and with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2020 filed with the Securities and Exchange Commission (SEC) in our Annual Report on Form 10-K on February 24, 2021 (2020 Annual Report).

The objective of Management’s Discussion and Analysis is to provide our assessment of the financial condition and results of operations including an evaluation of our liquidity and capital resources along with material events occurring during the year. The discussion and analysis focuses on material events and uncertainties known to management that are reasonably likely to cause reported financial information not to be necessarily indicative of future operating results or of future financial condition. In addition, we address matters that are reasonably likely based on management’s assessment to have a material impact on future operations. We expect that the analysis will enhance a reader’s understanding of our financial condition, cash flows, and other changes in financial condition and results of operations.

Documents we provide to the SEC are available free of charge under the Investors section of our website at www.itron.com as soon as practicable after they are filed with or furnished to the SEC. In addition, these documents are available at the SEC's website (http://www.sec.gov).

Certain Forward-Looking Statements

This report contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical factors nor assurances of future performance. These statements are based on our expectations about, among others, revenues, operations, financial performance, earnings, liquidity, earnings per share, cash flows and restructuring activities including headcount reductions and other cost savings initiatives. This document reflects our current strategy, plans and expectations and is based on information currently available as of the date of this Quarterly Report on Form 10-Q. When we use words such as "expect", "intend", "anticipate", "believe", "plan", "goal", "seek", "project", "estimate", "future", "strategy", "objective", "may", "likely", "should", "will", "will continue", and similar expressions, including related to future periods, they are intended to identify forward-looking statements. Forward-looking statements rely on a number of assumptions and estimates. Although we believe the estimates and assumptions upon which these forward-looking statements are based are reasonable, any of these estimates or assumptions could prove to be inaccurate and the forward-looking statements based on these estimates and assumptions could be incorrect. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Actual results and trends

31

in the future may differ materially from those suggested or implied by the forward-looking statements depending on a variety of factors. Therefore, you should not rely on any of these forward-looking statements. Some of the factors that we believe could affect our results include our ability to execute on our restructuring plan, our ability to achieve estimated cost savings, the rate and timing of customer demand for our products, rescheduling of current customer orders, changes in estimated liabilities for product warranties, adverse impacts of litigation, changes in laws and regulations, our dependence on new product development and intellectual property, future acquisitions, changes in estimates for stock-based and bonus compensation, increasing volatility in foreign exchange rates, international business risks, uncertainties caused by adverse economic conditions, including, without limitation those resulting from extraordinary events or circumstances such as the COVID-19 pandemic and other factors that are more fully described in Part I, Item 1A: Risk Factors included in our 2020 Annual Report and other reports on file with the SEC. We undertake no obligation to update or revise any forward-looking statement, whether written or oral.

The impact caused by the ongoing COVID-19 pandemic includes uncertainty as to the duration, spread, severity, and any resurgence of the COVID-19 pandemic including other factors contributing to infection rates, such as reinfection or mutation of the virus, the effectiveness or widespread availability and application of vaccines, the duration and scope of related government orders and restrictions, impact on overall demand, impact on our customers’ businesses and workforce levels, disruptions of our business and operations, including the impact on our employees, limitations on, or closures of, our facilities, or the business and operations of our customers or suppliers. Our estimates and statements regarding the impact of COVID-19 are made in good faith to provide insight to our current and future operating and financial environment and any of these may materially change due to factors outside our control. For more information on risks associated with the COVID-19 pandemic, please see our risk in Part I, Item 1A: Risk Factors in our 2020 Annual Report.

Overview

We are a technology and service company, and we are a leader in the Industrial Internet of Things (IIoT). We offer solutions that enable utilities and municipalities to safely, securely and reliably operate their critical infrastructure. Our solutions include the deployment of smart networks, software, services, devices, sensors, and data analytics that allow our customers to manage assets, secure revenue, lower operational costs, improve customer service, improve safety, and enable efficient management of valuable resources. Our comprehensive solutions and data analytics address the unique challenges facing the energy, water, and municipality sectors, including increasing demand on resources, non-technical loss, leak detection, environmental and regulatory compliance, and improved operational reliability.

We operate under the Itron brand worldwide and manage and report under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The product and operating definitions of the three segments are as follows:

Device Solutions – This segment primarily includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with our broader Itron systems, i.e., hardware-based products not part of a complete end-to-end solution. Examples from the Device Solutions portfolio include: standard endpoints that are shipped without Itron communications, such as our standard gas, electricity, and water meters for a variety of global markets and adhering to regulations and standards within those markets, as well as our heat and allocation products; communicating meters that are not a part of an Itron end-to-end solution such as Smart Spec meters and the implementation and installation of non-communicating devices, such as gas regulators.

Networked Solutions – This segment primarily includes a combination of communicating devices (e.g., smart meters, modules, endpoints, and sensors), network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. Networked Solutions includes products and software for the implementation, installation, and management of communicating devices and data networks. Examples from the Networked Solutions portfolio include: communicating measurement, control, or sensing endpoints such as our Itron® OpenWay® Centron and Riva meters, Itron traditional ERT® technology, Intelis smart gas meters, 500G gas communication modules, 500W water communication modules; GenX networking infrastructure products and network interface cards (NICs); Smart City control and management software; Distribution Automation bridge devices, and specific network control and management software applications. The Industrial Internet of Things (IIoT) solutions supported by this segment include automated meter reading (AMR), advanced metering infrastructure (AMI), smart grid and distribution automation, smart street lighting and an ever-growing set of smart city applications such as traffic management, smart parking, air quality monitoring, electric vehicle charging, customer engagement, digital signage, acoustic (e.g., gunshot) detection, and leak detection and mitigation for both gas and water systems. Our IIoT platform allows all of these industry and smart city applications to be run and managed on a single, multi-purpose network.

Outcomes – This segment primarily includes our value-added, enhanced software and services in which we manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and

32

deliver results for consumers, utilities, and smart cities. Outcomes places an emphasis on delivering to Itron customers high-value, turn-key, digital experiences by leveraging the footprint of our Device Solutions and Networked Solutions segments. The revenues from these offerings are primarily recurring in nature and would include any direct management of Device Solutions, Networked Solutions, and other products on behalf of our end customers. Examples from the Outcomes portfolio include: our meter data management and analytics offerings; our managed service solutions including Network-as-a-Service (NaaS) and Platform-as-a-Service (PaaS), forecasting software and services; our Distributed Intelligence suite of applications and services; and any consulting-based engagement. Within the Outcomes segment, we also identify new business models, including performance-based contracting, to drive broader portfolio offerings across utilities and cities.

We have three measures of segment performance: revenues, gross profit (margin), and operating income (margin). Intersegment revenues are minimal. Certain operating expenses are allocated to the operating segments based upon internally established allocation methodologies. Interest income, interest expense, other income (expense), the income tax provision (benefit), and certain corporate operating expenses are neither allocated to the segments nor included in the measures of segment performance.

Non-GAAP Measures

To supplement our consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States (GAAP), we use certain adjusted or non-GAAP financial measures, including non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, non-GAAP diluted earnings per share (EPS), adjusted EBITDA, adjusted EBITDA margin, constant currency, and free cash flow. We provide these non-GAAP financial measures because we believe they provide greater transparency and represent supplemental information used by management in its financial and operational decision making. We exclude certain costs in our non-GAAP financial measures as we believe the net result is a measure of our core business. We believe these measures facilitate operating performance comparisons from period to period by eliminating potential differences caused by the existence and timing of certain expense items that would not otherwise be apparent on a GAAP basis. Non-GAAP performance measures should be considered in addition to, and not as a substitute for, results prepared in accordance with GAAP. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Our non-GAAP financial measures may be different from those reported by other companies.

In our discussions of the operating results below, we sometimes refer to the impact of foreign currency exchange rate fluctuations, which are references to the differences between the foreign currency exchange rates we use to convert operating results from local currencies into U.S. dollars for reporting purposes. We also use the term "constant currency", which represents results adjusted to exclude foreign currency exchange rate impacts. We calculate the constant currency change as the difference between the current period results translated using the current period currency exchange rates and the comparable prior period's results restated using current period currency exchange rates. We believe the reconciliations of changes in constant currency provide useful supplementary information to investors in light of fluctuations in foreign currency exchange rates.

Refer to the Non-GAAP Measures section below on pages 49-51 for information about these non-GAAP measures and the detailed reconciliation of items that impacted free cash flow, non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, adjusted EBITDA, and non-GAAP diluted EPS in the presented periods.

Total Company Highlights

Highlights and significant developments for the three months ended September 30, 2021 compared with the three months ended September 30, 2020

•Revenues were $486.9 million compared with $540.2 million in 2020, a decrease of $53.2 million, or 10%

•Gross margin was 27.7%, compared with 26.5% in 2020

•Operating expenses decreased $36.4 million, or 22%, compared with 2020

•Net loss attributable to Itron, Inc. was $1.9 million compared with net loss of $25.4 million in 2020

•GAAP diluted EPS increased by $0.59 to a diluted loss per share of $0.04 in 2021

•Non-GAAP net income attributable to Itron, Inc. was $9.5 million compared with $24.6 million in 2020

•Non-GAAP diluted EPS was $0.21, a decrease of $0.40 compared with 2020

•Adjusted EBITDA was $26.1 million compared with $39.7 million in 2020

•Total backlog was $3.4 billion and twelve-month backlog was $1.4 billion at September 30, 2021, compared with $2.8 billion and $1.1 billion at September 30, 2020

33

Highlights and significant developments for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020

•Revenues were $1.5 billion compared with $1.6 billion in 2020, a decrease of $152.3 million, or 9%

•Gross margin was 30.2% compared with 27.5% in 2020

•Operating expenses decreased $72.6 million, or 15%, compared with 2020

•Net loss attributable to Itron, Inc. was $22.4 million, compared with net loss of $79.5 million in 2020

•GAAP diluted EPS increased by $1.47 to a diluted loss per share of $0.51 in 2021

•Non-GAAP net income attributable to Itron, Inc. was $44.0 million compared with $48.9 million in 2020

•Non-GAAP diluted EPS was $0.99, a decrease of $0.22 compared with 2020

•Adjusted EBITDA was $112.0 million compared with $122.9 million in 2020

2018 Credit Facility

On August 12, 2021, we fully paid the remaining balance of $31.1 million on the term loan. At September 30, 2021, there were no outstanding loan balances under the 2018 Credit Facility.

Business Acquisition

Subsequent to September 30, 2021, Itron, through its subsidiary Itron Management Services Ireland, Limited, completed the acquisition of 100% of the shares of SELC Group Limited (SELC), a private limited company incorporated in Ireland since 2014, from Sensus Metering Systems (LUXCO3) S.ár.l on October 12, 2021. SELC was previously a technology supplier to Itron. The acquisition provides value to Itron through the leverage of SELC’s streetlight controls technology coupled with Itron’s Smart Cities network and software platform. The acquisition will increase the pace of Smart City growth and innovation within Itron’s Networked Solutions business for the benefit of our customers. The purchase was funded through cash on hand.

Sale of Business

On November 2, 2021, Itron entered into a definitive securities and asset purchase agreement to sell certain of its Gas device manufacturing and business operations in Europe and North America to Dresser Utility Solutions (Dresser). The sale includes one German subsidiary – Itron GmbH along with its business operations, personnel, and the owned manufacturing facility in Karlsruhe; the business operations, personnel, and assets associated with the leased manufacturing facility in Argenteuil, France; and the business and manufacturing assets maintained at one of our contract manufacturers in North America. The sale of these assets and operations is part of Itron’s continued strategy to improve profitability and focus on growing its higher value businesses throughout the world.

Based on the sales price and the net assets of the businesses sold, Itron concluded on November 2, 2021 that it will recognize a pre-tax loss with a range of $30-40 million upon closure of the sale, which is expected in the first half of 2022. The impairment is driven primarily by the required recognition of $58-62 million in foreign currency translation losses accumulated since the acquisition of the German subsidiary in 2007. The base sale price of this divestiture is $75 million, with adjustments for (1) pension liabilities assumed by Dresser for the active employees estimated at $12-13 million and (2) the final working capital balance, which will be determined as of the close date, and, if the balance is outside the targeted amount, the difference will be settled shortly thereafter. Net assets of the businesses, including allocated goodwill, are $35-40 million. Cash proceeds from the sale are currently estimated at $62-63 million.

Restructuring Plan Associated with Sale of Business

On October 29, 2021, the Board of Directors of Itron approved a restructuring plan (the 2021 Projects). The 2021 Projects include activities, in conjunction with the announcement of the sale of certain of our Gas device manufacturing operations, which drive reductions in certain locations and functional support areas. These projects are to be substantially complete by the end of 2024. Itron estimates pre-tax restructuring charges of $65-75 million. Of the total estimated charge, approximately $60-65 million will result in cash expenditures, and the remainder to non-cash impairment charges. The majority of the expense will be recognized during the fourth quarter of 2021. Once the 2021 Projects are substantially completed, Itron estimates $15-20 million in annualized savings. Certain of Itron’s employees are represented by unions or works councils, which requires consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of planned savings in certain jurisdictions.

Approval of Share Repurchase Program

Effective November 1, 2021, the Board of Directors of Itron authorized a new share repurchase program of up to $100 million of Itron’s common stock over an 18-month period. Repurchases will be made in the open market and pursuant to the terms of any Rule 10b5-1 plans that Itron may enter into, and in accordance with applicable securities laws. The repurchase program is

34

intended to comply with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice.

Impact of COVID-19 and Supply Chain Challenges

The COVID-19 pandemic has had global economic impacts including disrupting customer demand and global supply chains, resulting in market volatility. The extent of the recent pandemic and its ongoing impact on our operations is volatile, but is being monitored closely by our management. During portions of the first half of 2020 certain of our European factories were closed due to government actions and local conditions, and any further closures that may be imposed on us could impact our results for 2021. New variants of the virus may cause previously lifted restrictions to be reinstated, which could result in more disruptions. Incremental costs we have incurred related to COVID-19, such as personal protective equipment, increased cleaning and sanitizing of our facilities, and other such items, have not been material to date. As economies have reopened, global supply chains have struggled to keep pace with rapidly changing demand. The resulting supply constraints have manifested across a variety of areas including mechanical, electrical and logistics portions of the supply chain, which has impacted our ability to ship products in a timely manner. In particular, our ability to obtain adequate supply of semiconductor components has impacted our ability to service recovering customer demand. While the current imbalance in supply and demand is temporal, the timeline to recovery is uncertain. Efforts are ongoing with suppliers to increase supply, including the approval of alternate sources. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. However, certain of our customer projects have experienced delay in deliveries, with originally forecasted 2021 revenue pushed to future periods. For more information on risks associated with the COVID-19 pandemic, please see our risk in Part I, Item 1A, Risk Factors in our 2020 Annual Report.

The COVID-19 pandemic remains a rapidly evolving situation with varying impacts on the locations in which we do business. Changes in the mix of earnings or losses from our different geographical operations, as well as any future enactment of tax legislation and other factors, may result in more volatile quarterly and annual effective tax rates. The detrimental impacts to financial results may be partially offset by financial assistance from the U.S. or the municipalities in which we operate, including employer payroll tax credits for wages paid to employees who are unable to work during the COVID-19 pandemic. Other benefits, including options to defer payroll tax payments and additional deductions, resulted in reduced cash costs in 2020, but will increase cash outlays during the fourth quarter of 2021 and into 2022.

35

Total Company GAAP and Non-GAAP Highlights and Unit Shipments:

	Three Months Ended September 30,							Nine Months Ended September 30,
In thousands, except margin and per share data	2021			2020			% Change	2021			2020			% Change
GAAP
Revenues
Product revenues	$	410,947		$	470,658		(13)%	$	1,265,470		$	1,437,780		(12)%
Service revenues	76,002			69,526			9%	230,465			210,413			10%
Total revenues	486,949			540,184			(10)%	1,495,935			1,648,193			(9)%
Gross profit	134,963			143,251			(6)%	451,882			453,334			—%
Operating expenses	130,800			167,231			(22)%	423,711			496,331			(15)%
Operating income (loss)	4,163			(23,980)			NM	28,171			(42,997)			NM
Other income (expense)	(4,037)			(13,063)			(69)%	(42,465)			(35,020)			21%
Income tax benefit (provision)	(1,136)			11,985			NM	(5,581)			(366)			NM
Net loss attributable to Itron, Inc.	(1,869)			(25,357)			(93)%	(22,389)			(79,475)			(72)%
Non-GAAP(1)
Non-GAAP operating expenses	$	118,609		$	113,554		4%	$	369,721		$	364,788		1%
Non-GAAP operating income	16,354			29,697			(45)%	82,161			88,546			(7)%
Non-GAAP net income attributable to Itron, Inc.	9,452			24,634			(62)%	44,043			48,929			(10)%
Adjusted EBITDA	26,123			39,684			(34)%	111,982			122,858			(9)%
GAAP Margins and Earnings Per Share
Gross margin
Product gross margin	25.5		%	23.9		%		28.2		%	25.4		%
Service gross margin	39.7		%	44.4		%		41.4		%	41.7		%
Total gross margin	27.7		%	26.5		%		30.2		%	27.5		%
Operating margin	0.9		%	(4.4)		%		1.9		%	(2.6)		%
Net loss per common share - Basic	$	(0.04)		$	(0.63)			$	(0.51)		$	(1.98)
Net loss per common share - Diluted	$	(0.04)		$	(0.63)			$	(0.51)		$	(1.98)
Non-GAAP Earnings Per Share(1)
Non-GAAP diluted EPS	$	0.21		$	0.61			$	0.99		$	1.21

(1)These measures exclude certain expenses that we do not believe are indicative of our core operating results. See pages 49-51 for information about these non-GAAP measures and reconciliations to the most comparable GAAP measures.

Definition of an Endpoint Under Management

An "endpoint under management" is a unique endpoint, or data from that endpoint, which Itron manages via our networked platform or a third party's platform that is connected to one or multiple types of endpoints. Itron’s management of an endpoint occurs when on behalf of our client, we manage one or more of the physical endpoints, operating system, data, application, data analytics, and/or outcome deriving from this unique endpoint. Itron has the ability to monitor and/or manage endpoints or the data from the endpoints via NaaS, Software-as-a-Service (SaaS), and/or a licensed offering at a remote location designated by our client. Our offerings typically, but not exclusively, provide an Itron product or Itron certified partner product to our clients that has the capability of one-way communication or two-way communication of data that may include remote product configuration and upgradability. Examples of these offerings include our Temetra, OpenWay®, OpenWay® Riva and Gen X.

This metric primarily includes Itron or third-party endpoints deployed within the electricity, water, and gas utility industries, as well as within cities and municipalities around the globe. Endpoints under management also include smart communication modules and network interface cards (NICs) within Itron’s platforms. At times, these NICs are communicating modules that were sold separately from an Itron product directly to our customers or to third party manufacturers for use in endpoints such as

36

electric, water, and gas meters; streetlights and other types of IIoT sensors and actuators; sensors and other capabilities that the end customer would like Itron to connect and manage on their behalf.

The "endpoint under management" metric only accounts for the specific, unique endpoint itself, though that endpoint may have multiple applications, services, outcomes, and higher margin recurring offerings associated with it. This metric does not reflect the multi-application value that can be derived from the individual endpoint itself. Additionally, this metric excludes those endpoints that are non-communicating, non-Itron system hardware component sales or licensed applications that Itron does not manage the unit or the data from that unit directly.

While the one-time sale of the platform and endpoints are primarily delivered via our Networked Solutions segment, our enhanced solutions, on-going monitoring, maintenance, software, analytics, and distributed intelligent applications are predominantly recognized in our Outcomes segment. We would anticipate the opportunity to increase our penetration of Outcomes applications, software, and managed applications will increase as our endpoints under management increases. Management believes using the endpoints under management metric enhances insight to the strategic and operational direction of our Networked Solutions and Outcomes segments to serve clients for years after their one-time installation of an endpoint.

A summary of our endpoints under management is as follows:

	September 30,
Units in thousands	2021	2020
Endpoints under management	78,487	74,652

Results of Operations

Revenues and Gross Margin

The actual results of and effects of changes in foreign currency exchange rates on revenues and gross profit were as follows:

						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Three Months Ended September 30,
In thousands		2021		2020
Total Company
	Revenues	$	486,949	$	540,184	$	4,157	$	(57,392)	$	(53,235)
	Gross profit	134,963		143,251		557		(8,845)		(8,288)
						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Nine Months Ended September 30,
In thousands		2021		2020
Total Company
	Revenues	$	1,495,935	$	1,648,193	$	37,455	$	(189,713)	$	(152,258)
	Gross profit	451,882		453,334		4,684		(6,136)		(1,452)

Revenues - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Total revenues decreased $53.2 million, or 10%, compared with the same period in 2020. We have been unfavorably impacted by COVID-19 related global component constraints, which limited our ability to fulfill customer demand. Product revenues decreased by $59.7 million, while service revenues increased $6.5 million. Device Solutions decreased by $23.9 million; Networked Solution decreased by $32.2 million; and Outcomes increased by $2.8 million when compared with the same period last year. Changes in exchange rates favorably impacted total revenues by $4.2 million, of which $2.5 million favorably impacted Device Solutions.

Revenues - Nine months ended September 30, 2021 vs. Nine Months Ended September 30, 2020

Total revenues decreased $152.3 million, or 9%, compared with the same period in 2020. We have been unfavorably impacted by the timing of customer projects and COVID-19, particularly global component constraints, which limited our ability to fulfill customer demand. Product revenues decreased by $172.3 million, while service revenues increased by $20.1 million. Device Solutions decreased by $19.6 million; Networked Solutions decreased by $144.1 million; and Outcomes increased by

37

$11.4 million when compared with the same period last year. Changes in exchange rates favorably impacted total revenues by $37.5 million, of which $25.7 million favorably impacted Device Solutions.

Gross Margin - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Gross margin was 27.7%, compared with 26.5% in 2020. We were favorably impacted by product and solution mix and manufacturing efficiencies in 2021 compared with 2020, which was more unfavorably impacted by COVID-19. Product sales gross margin increased to 25.5%, compared with 23.9% in 2020. Gross margin on service revenues decreased to 39.7%, compared with 44.4% in 2020.

Gross Margin - Nine months ended September 30, 2021 vs. Nine Months Ended September 30, 2020

Gross margin was 30.2%, compared with 27.5% in 2020. We were favorably impacted by product and solution mix and operating efficiencies in 2021 compared with 2020, which was more unfavorably impacted by COVID-19. Product sales gross margin increased to 28.2%, compared with 25.4% in 2020, and gross margin on service revenues decreased to 41.4%, compared with 41.7% in 2020.

Refer to Operating Segment Results section below for further detail on total company revenues and gross margin.

Operating Expenses

The actual results of and effects of changes in foreign currency exchange rates on operating expenses were as follows:

						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Three Months Ended September 30,
In thousands		2021		2020
Total Company
	Sales, general and administrative	$	71,838	$	64,982	$	262	$	6,594	$	6,856
	Research and development	46,889		46,224		90		575		665
	Amortization of intangible assets	8,944		11,183		46		(2,285)		(2,239)
	Restructuring	958		44,462		(3)		(43,501)		(43,504)
	Loss on sale of business	2,171		380		(159)		1,950		1,791
	Total operating expenses	$	130,800	$	167,231	$	236	$	(36,667)	$	(36,431)
						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Nine Months Ended September 30,
In thousands		2021		2020
Total Company
	Sales, general and administrative	$	221,974	$	215,018	$	5,960	$	996	$	6,956
	Research and development	147,379		148,999		1,864		(3,484)		(1,620)
	Amortization of intangible assets	26,914		33,488		384		(6,958)		(6,574)
	Restructuring	(830)		41,531		(250)		(42,111)		(42,361)
	Loss on sale of business	28,274		57,295		3,502		(32,523)		(29,021)
	Total operating expenses	$	423,711	$	496,331	$	11,460	$	(84,080)	$	(72,620)

Operating expenses decreased $36.4 million for the third quarter of 2021 as compared with the same period in 2020. This was primarily the result of a reduction of $43.5 million in restructuring due to a new plan announced in 2020.

Operating expenses decreased $72.6 million for the nine months ended September 30, 2021 as compared with the same period in 2020. This was primarily the result of $42.4 million in lower restructuring costs due to the new plan announced in 2020 and $29.0 million decrease in the loss on sale of business.

38

Other Income (Expense)

The following table shows the components of other income (expense):

	Three Months Ended September 30,				% Change	Nine Months Ended September 30,				% Change
In thousands	2021		2020			2021		2020
Interest income	$	352	$	354	(1)%	$	1,326	$	2,165	(39)%
Amortization of prepaid debt fees	(1,949)		(1,016)		92%	(17,383)		(3,029)		NM
Other interest expense	(679)		(9,794)		(93)%	(9,724)		(30,742)		(68)%
Interest expense	(2,628)		(10,810)		(76)%	(27,107)		(33,771)		(20)%
Other income (expense), net	(1,761)		(2,607)		(32)%	(16,684)		(3,414)		NM
Total other income (expense)	$	(4,037)	$	(13,063)	(69)%	$	(42,465)	$	(35,020)	21%

Total other income (expense) for the three and nine months ended September 30, 2021 was a net expense of $4.0 million and $42.5 million, compared with net expense of $13.1 million and $35.0 million in the same period in 2020.

The lower total expense for the three months ended September 30, 2021, as compared with the same period in 2020, was primarily driven by repayment of all interest bearing debt, except $31.1 million of the term loan, prior to the start of the third quarter of 2021.

The higher total expense for the nine months ended September 30, 2021, as compared with the same period in 2020, was primarily driven by a $14.3 million increase related to a write-off of prepaid debt fees in 2021 associated with the repayment of senior subordinated notes and the term loan as well as increased amortization, and a $11.7 million charge related to the 2021 extinguishment of debt that is included in other income (expense). The increase was partially offset by lower interest costs of $9.6 million for the senior subordinated notes, $7.4 million for the term loan, and $3.8 million for the revolving credit.

Income Tax Provision

For the three and nine months ended September 30, 2021, our income tax expense was $1.1 million and $5.6 million, respectively, compared with income tax expense (benefit) of $(12.0) million and $0.4 million for the same period in 2020. Our tax rate for the three and nine months ended September 30, 2021 of 902% and (39)%, differed from the federal statutory rate of 21% due to losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets, the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to stock-based compensation, uncertain tax positions, and reserves recognized on deferred purchase price receivables. Our tax rate for the three and nine months ended September 30, 2020 of 32% and 0% differed from the federal statutory rate of 21% primarily due to a significant loss recognized in the second quarter for the divestiture of the majority of our Latin American business activities. This loss was recognized for tax as a discrete item and resulted in no tax benefit. A discrete tax benefit was recognized in the third quarter for $10.1 million related to the release of a valuation allowance on U.S. foreign tax credit deferred tax assets. This release was triggered by the carryforward of tax attributes due to the filing of amended tax returns in the third quarter. Other rate drivers include losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to stock-based compensation, and uncertain tax positions.

For additional discussion related to income taxes, see Item 1: Financial Statements (Unaudited), Note 10: Income Taxes included in this Quarterly Report on Form 10-Q.

39

Operating Segment Results

For a description of our operating segments, refer to Item 1: Financial Statements (Unaudited), Note 15: Segment Information included in this Quarterly Report on Form 10-Q. The following tables and discussion highlight significant changes in trends or components of each operating segment:

	Three Months Ended September 30,							Nine Months Ended September 30,
In thousands	2021		2020		% Change			2021		2020		% Change
Segment revenues
Device Solutions	$	152,234	$	176,128	(14)%			$	487,982	$	507,572	(4)%
Networked Solutions	274,498		306,659		(10)%			827,870		971,984		(15)%
Outcomes	60,217		57,397		5%			180,083		168,637		7%
Total revenues	$	486,949	$	540,184	(10)%			$	1,495,935	$	1,648,193	(9)%
	Three Months Ended September 30,							Nine Months Ended September 30,
	2021				2020			2021				2020
In thousands	Gross Profit		Gross Margin		Gross Profit		Gross Margin	Gross Profit		Gross Margin		Gross Profit		Gross Margin
Segment gross profit and margin
Device Solutions	$	22,480	14.8%		$	20,528	11.7%	$	85,228	17.5%		$	64,843	12.8%
Networked Solutions	89,915		32.8%		102,295		33.4%	298,627		36.1%		332,368		34.2%
Outcomes	22,568		37.5%		20,428		35.6%	68,027		37.8%		56,123		33.3%
Total gross profit and margin	$	134,963	27.7%		$	143,251	26.5%	$	451,882	30.2%		$	453,334	27.5%
	Three Months Ended September 30,							Nine Months Ended September 30,
In thousands	2021		2020		% Change			2021		2020		% Change
Segment operating expenses
Device Solutions	$	10,385	$	9,511	9%			$	31,444	$	36,748	(14)%
Networked Solutions	28,765		30,891		(7)%			93,556		94,902		(1)%
Outcomes	10,794		8,384		29%			33,380		26,655		25%
Corporate unallocated	80,856		118,445		(32)%			265,331		338,026		(22)%
Total operating expenses	$	130,800	$	167,231	(22)%			$	423,711	$	496,331	(15)%
	Three Months Ended September 30,							Nine Months Ended September 30,
	2021				2020			2021				2020
In thousands	Operating Income (Loss)		Operating Margin		Operating Income (Loss)		Operating Margin	Operating Income (Loss)		Operating Margin		Operating Income (Loss)		Operating Margin
Segment operating income (loss) and operating margin
Device Solutions	$	12,095	7.9%		$	11,017	6.3%	$	53,784	11.0%		$	28,095	5.5%
Networked Solutions	61,150		22.3%		71,404		23.3%	205,071		24.8%		237,466		24.4%
Outcomes	11,774		19.6%		12,044		21.0%	34,647		19.2%		29,468		17.5%
Corporate unallocated	(80,856)		NM		(118,445)		NM	(265,331)		NM		(338,026)		NM
Total operating income (loss) and operating margin	$	4,163	0.9%		$	(23,980)	(4.4)%	$	28,171	1.9%		$	(42,997)	(2.6)%

40

Device Solutions

The effects of changes in foreign currency exchange rates and the constant currency changes in certain Device Solutions segment financial results were as follows:

						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Three Months Ended September 30,
In thousands		2021		2020
Device Solutions Segment
	Revenues	$	152,234	$	176,128	$	2,514	$	(26,408)	$	(23,894)
	Gross profit	22,480		20,528		231		1,721		1,952
	Operating expenses	10,385		9,511		31		843		874
						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Nine Months Ended September 30,
In thousands		2021		2020
Device Solutions Segment
	Revenues	$	487,982	$	507,572	$	25,740	$	(45,330)	$	(19,590)
	Gross profit	85,228		64,843		2,073		18,312		20,385
	Operating expenses	31,444		36,748		710		(6,014)		(5,304)

Revenues - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Revenues decreased $23.9 million, or 14%. Changes in foreign currency exchange rates favorably impacted revenues by $2.5 million. Revenue was unfavorably impacted by decreased shipments in Europe, Middle East, and Africa (EMEA) in 2021 compared with 2020 primarily due to global component shortages, which limited our ability to ship all our customer demand.

Revenues - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Revenues decreased $19.6 million, or 4%, compared with 2020. Changes in foreign currency exchange rates favorably impacted revenues by $25.7 million. The first nine months of 2021 were impacted by COVID-19 reduced demand and global component shortages.

Gross Margin - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

For the three months ended September 30, 2021, gross margin was 14.8%, compared with 11.7% for the same period in 2020. The 310 basis point improvement over the prior year was primarily due to favorable product mix and reduced manufacturing inefficiencies related to COVID-19.

Gross Margin - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

For the nine months ended September 30, 2021, gross margin was 17.5%, compared with 12.8% for the same period in 2020. The 470 basis point increase over the prior year was primarily due to favorable product mix and reduced manufacturing inefficiencies as 2020 was impacted by COVID-19.

Operating Expenses - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Operating expenses in 2021 compared with the same period in 2020 increased $0.9 million, or 9%, due to higher sales and marketing and research and development expenses.

Operating Expenses - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Operating expenses decreased $5.3 million, or 14%, for the first nine months of 2021 compared with the same period in 2020. The decrease was primarily a result of lower research and development costs.

41

Networked Solutions

The effects of changes in foreign currency exchange rates and the constant currency changes in certain Networked Solutions segment financial results were as follows:

						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Three Months Ended September 30,
In thousands		2021		2020
Networked Solutions Segment
	Revenues	$	274,498	$	306,659	$	973	$	(33,134)	$	(32,161)
	Gross profit	89,915		102,295		(77)		(12,303)		(12,380)
	Operating expenses	28,765		30,891		25		(2,151)		(2,126)
						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Nine Months Ended September 30,
In thousands		2021		2020
Networked Solutions Segment
	Revenues	$	827,870	$	971,984	$	7,784	$	(151,898)	$	(144,114)
	Gross profit	298,627		332,368		977		(34,718)		(33,741)
	Operating expenses	93,556		94,902		229		(1,575)		(1,346)

Revenues - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Revenues decreased $32.2 million, or 10%, compared with 2020. The change was primarily due to global component shortages, which limited our ability to ship all our customer demand, partially offset by customer project timing. Lower product revenue of $40.2 million was partially offset by higher maintenance service revenue of $8.0 million.

Revenues - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Revenues decreased $144.1 million, or 15%, for the first nine months of 2021 compared with the same period in 2020. The change was primarily due to COVID-19 demand impacts and global component shortages, which limited our ability to ship all our customer demand. Lower product revenue of $162.1 million was partially offset by higher maintenance service revenue of $18.0 million.

Gross Margin - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Gross margin decreased to 32.8% for the period ending September 30, 2021, compared with 33.4% in 2020. The 60 basis point decrease was primarily driven by inefficiencies related to component shortages, partially offset by favorable product mix.

Gross Margin - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Gross margin increased to 36.1% for the 2021 period, compared with 34.2% in 2020. The 190 basis point increase was primarily driven by favorable product mix and reduced manufacturing inefficiencies related to COVID-19, partially offset by inefficiencies related to component shortages.

Operating Expenses - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Operating expenses decreased $2.1 million, or 7%, for the quarter in 2021, compared with the same period in 2020. The decrease was primarily related to reduced research and development expenses.

Operating Expenses - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Operating expenses decreased $1.3 million, or 1%, for the first nine months of 2021, compared with the same period in 2020. The decrease was primarily driven by a decreased investment in research and development.

42

Outcomes

The effects of changes in foreign currency exchange rates and the constant currency changes in certain Outcomes segment financial results were as follows:

						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Three Months Ended September 30,
In thousands		2021		2020
Outcomes Segment
	Revenues	$	60,217	$	57,397	$	670	$	2,150	$	2,820
	Gross profit	22,568		20,428		404		1,736		2,140
	Operating expenses	10,794		8,384		6		2,404		2,410
						Effect of Changes in Foreign Currency Exchange Rates		Constant Currency Change		Total Change
		Nine Months Ended September 30,
In thousands		2021		2020
Outcomes Segment
	Revenues	$	180,083	$	168,637	$	3,931	$	7,515	$	11,446
	Gross profit	68,027		56,123		1,634		10,270		11,904
	Operating expenses	33,380		26,655		72		6,653		6,725

Revenues - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Revenues increased $2.8 million, or 5%, compared with 2020. This increase was driven by an increase in product sales and software licensing.

Revenues - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Revenues increased $11.4 million, or 7%, for the first nine months of 2021 compared with the same period in 2020. This increase was driven by an increase in software license sales and higher managed and professional services.

Gross Margin - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Gross margin increased to 37.5% for the third quarter of 2021, compared with 35.6% for the same period last year. The 190 basis point increase was driven by favorable product and services mix and other cost efficiencies.

Gross Margin - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Gross margin increased to 37.8% for the period ending in 2021, compared with 33.3% for last year. The 450 basis point increase was driven by cost efficiencies.

Operating Expenses - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Operating expenses for the 2021 period increased $2.4 million, compared with the same period last year. The increase was primarily related to increased research and development investment of $2.0 million and higher product marketing expenses of $0.4 million.

Operating Expenses - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

Operating expenses for the first nine months of 2021 increased $6.7 million, or 25%, compared with the same period last year. This increase was primarily related to increased research and development investment of $5.2 million and higher product marketing expenses of $1.5 million.

Corporate Unallocated

Corporate Unallocated Expenses - Three months ended September 30, 2021 vs. Three months ended September 30, 2020

Operating expenses not directly associated with an operating segment are classified as Corporate unallocated. These expenses decreased $37.6 million, or 32%, for the three months ended September 30, 2021 compared with the same period in 2020. This was primarily the result of $43.5 million in reduced restructuring charges related to the plan announced in 2020.

43

Corporate Unallocated Expenses - Nine months ended September 30, 2021 vs. Nine months ended September 30, 2020

For the first nine months of 2021, Corporate unallocated expenses decreased $72.7 million, or 22%, as compared with the same period in 2020. This was primarily the result of decreases of $42.4 million in restructuring related to the plan announced in 2020 and $29.0 million related to the sale of business.

Bookings and Backlog of Orders

Bookings for a reported period represent customer contracts and purchase orders received during the period for hardware, software, and services that have met certain conditions, such as regulatory and/or contractual approval. Total backlog represents committed but undelivered products and services for contracts and purchase orders at period-end. Twelve-month backlog represents the portion of total backlog that we estimate will be recognized as revenue over the next 12 months. Backlog is not a complete measure of our future revenues as we also receive significant book-and-ship orders, as well as frame contracts. Bookings and backlog may fluctuate significantly due to the timing of large project awards. In addition, annual or multi-year contracts are subject to rescheduling and cancellation by customers due to the long-term nature of the contracts. Beginning total backlog, plus bookings, minus revenues, will not equal ending total backlog due to miscellaneous contract adjustments, foreign currency fluctuations, and other factors. Total bookings and backlog include certain contracts with termination for convenience clause, which will not agree to the total transaction price allocated to the remaining performance obligations disclosed in Item 1: Financial Statements (Unaudited), Note 16: Revenues included in this Quarterly Report on Form 10-Q.

Quarter Ended	Quarterly Bookings		Ending Total Backlog		Ending 12-Month Backlog
In millions
September 30, 2021	$	395	$	3,433	$	1,442
June 30, 2021	596		3,530		1,378
March 31, 2021	688		3,421		1,293
December 31, 2020	973		3,259		1,204
September 30, 2020	432		2,795		1,107

Financial Condition

Cash Flow Information

	Nine Months Ended September 30,
In thousands	2021		2020
Net cash provided by operating activities	$	141,147	$	70,571
Net cash used in investing activities	(21,819)		(33,472)
Net cash (used in) provided by financing activities	(136,808)		402,590
Effect of foreign exchange rate changes on cash and cash equivalents	(762)		(3,426)
Increase (decrease) in cash and cash equivalents	$	(18,242)	$	436,263

Cash and cash equivalents were $188.7 million at September 30, 2021, compared with $206.9 million at December 31, 2020. The $18.2 million decrease in cash and cash equivalents in the 2021 period was primarily the result of repayment of the term loan and the senior subordinated notes, purchases of equity classified derivative contract, and the acquisitions of property, plant, and equipment, partially offset by proceeds from the convertible senior note and equity offering in March 2021, along with cash flows from operating activities.

Operating activities

Cash provided by operating activities during the nine months in 2021 was $141.1 million compared with $70.6 million during the same period in 2020. The increase was primarily due to lower variable compensation payouts, net cash inflows for working capital, and lower interest payments.

Investing activities

Cash used in investing activities during the nine months in 2021 was $11.7 million lower than in 2020. This decrease in use of cash was primarily related to $8.5 million less purchases of property, plant, and equipment.

44

Financing activities

Net cash provided by financing activities during the nine months in 2021 was $136.8 million, compared with net cash provided of $402.6 million for the same period in 2020. In March 2021, we received $389.4 million from issuance of common stock related to the equity offering, after deducting underwriters’ discounts of the offering, purchased $84.1 million of the convertible note hedge contracts, and proceeds of $45.3 million from the sale of warrants. Also in March, we entered into the convertible senior notes with gross proceeds of $460 million, which was used to pay off the outstanding term loan balance. In April, we repaid the senior subordinated notes totaling $410 million (including $10 million early repayment premium) with proceeds from the equity offering and cash on hand. For the nine months ended September 30, 2021, we had net repayments of $486.1 million of debt. Cash payments for prepaid debt fees were $12.0 million.

Effect of exchange rates on cash and cash equivalents

The effect of exchange rates on the cash balances of currencies held in foreign denominations at September 30, 2021 was a decrease of $0.8 million, compared with a decrease of $3.4 million for the same period in 2020. Our foreign currency exposure relates to non-U.S. dollar denominated balances in our international subsidiary operations.

Free cash flow (Non-GAAP)

To supplement our Consolidated Statements of Cash Flows presented on a GAAP basis, we use the non-GAAP measure of free cash flow to analyze cash flows generated from our operations. The presentation of non-GAAP free cash flow is not meant to be considered in isolation or as an alternative to net income as an indicator of our performance, or as an alternative to cash flows from operating activities as a measure of liquidity. We calculate free cash flows, using amounts from our Consolidated Statements of Cash Flows, as follows:

	Nine Months Ended September 30,
In thousands	2021		2020
Net cash provided by operating activities	$	141,147	$	70,571
Acquisitions of property, plant, and equipment	(27,781)		(36,297)
Free cash flow	$	113,366	$	34,274

Free cash flow fluctuated primarily as a result of changes in cash provided by operating activities. See the cash flow discussion of operating activities above.

Off-balance sheet arrangements

We have no off-balance sheet financing agreements or guarantees as defined by Item 303 of Regulation S-K at September 30, 2021 and December 31, 2020 that we believe could reasonably likely have a current or future effect on our financial condition, results of operations, or cash flows.

Liquidity and Capital Resources

Our principal sources of liquidity are cash flows from operations, borrowings, and the sale of our common stock. Cash flows may fluctuate and are sensitive to many factors including changes in working capital and the timing and magnitude of capital expenditures and payments of debt. Working capital, which represents current assets less current liabilities, continues to be in a net favorable position.

Stock Offering

On March 12, 2021, we closed the sale of 4,472,222 shares of our common stock in a public offering, resulting in net proceeds to us of $389.4 million, after deducting underwriters’ discounts of the offering, as well as the sale of the Convertible Notes in a private placement to qualified institutional buyers, resulting in net proceeds to us of $448.5 million after deducting initial purchasers’ discounts of the offering. Concurrently with the issuance of the Convertible Notes, we entered into the Convertible Note Hedge Transactions and Warrant Transactions. For further description of these transactions, refer to Item 1: Financial Statements (Unaudited), Note 6: Debt and Item 1: Financial Statements (Unaudited), Note 7: Derivative Financial Instruments included in this Quarterly Report on Form 10-Q.

Borrowings

On October 18, 2019 we amended our credit facility that was initially entered on January 5, 2018 (together with the amendment, the "2018 credit facility"). The 2018 credit facility provides for committed credit facilities in the amount of $1.2 billion U.S. dollars. The 2018 credit facility consists of a $650 million U.S. dollar term loan (the term loan) and a multicurrency revolving line of credit (the revolver) with a principal amount of up to $500 million. The revolver also contains a

45

$300 million standby letter of credit sub-facility and a $50 million swingline sub-facility. The October 18, 2019, amendment extended the maturity date to October 18, 2024 and re-amortized the term loan based on the new balance as of the amendment date.

On October 19, 2020, we completed a second amendment to our 2018 credit facility. This amendment adjusts the maximum total net leverage ratio thresholds for the period beginning with the fourth quarter of 2020 through the fourth quarter of 2021 to allow for increased operational flexibility. The maximum leverage ratio is increased to 4.75:1 for the fourth quarter of 2020 and the first quarter of 2021 and 4.50:1 for the second quarter through the fourth quarter of 2021. An additional level of pricing was added to the existing pricing grid and is effective throughout the remaining term of the 2018 credit facility. Beginning with the fourth quarter of 2020, the commitment fee ranges from 0.15% to 0.30% and drawn amounts are subject to a margin ranging from 1.00% to 2.00%. Debt fees of approximately $1.4 million were incurred for the amendment, as well as other legal and advisory fees. Both the term loan and the revolver can be repaid without penalty. Amounts repaid on the term loan may not be reborrowed, and amounts borrowed under the revolver may be repaid and reborrowed until the revolver's maturity, at which time all outstanding loans together with all accrued and unpaid interest must be repaid.

On March 8, 2021, we entered into a third amendment to our 2018 credit facility, which modified provisions to permit cash settlement upon the conversion of the Convertible Notes, the Convertible Senior Note Hedge Transactions and Warrant Transactions and also to adjust certain settlement provisions for convertible indebtedness. See Item 1: Financial Statements (Unaudited), Note 7: Derivative Financial Instruments for further details of the Convertible Note Hedge Transactions and Warrant Transactions.

On March 9, 2021, we submitted a Notice of Redemption to the trustee to redeem all outstanding Senior Notes at a redemption price of 102.50%, in accordance with the indenture governing the Senior Notes, totaling $410 million. As of April 8, 2021, the Senior Notes were fully discharged and no principal or unpaid interest remains outstanding.

For further description of our borrowings, refer to Item 1: Financial Statements (Unaudited), Note 6: Debt included in this Quarterly Report on Form 10-Q.

For a description of our letters of credit and performance bonds, and the amounts available for additional borrowings or letters of credit under our lines of credit, including the revolver that is part of our credit facility, refer to Item 1: Financial Statements (Unaudited), Note 11: Commitments and Contingencies included in this Quarterly Report on Form 10-Q.

Silver Spring Networks, Inc. Acquisition

As part of the acquisition of SSNI, we achieved approximately $65 million of annualized savings by the end of the third quarter in 2021. For the nine months ended September 30, 2021, we paid out $1.1 million and we are expecting the remaining cash payment on the integration plan to be paid out in the next 12 months.

Restructuring

On September 17, 2020, our Board of Directors approved a restructuring plan (the 2020 Projects). The 2020 Projects include activities that continue our efforts to optimize its global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are scheduled to be substantially complete by the end of 2022. At the time of the approval, we estimated pre-tax restructuring charges of $55 million to $65 million. Of the total estimated charge, approximately $35 million to $45 million will result in cash expenditures, and the remainder related to non-cash charges. In the third quarter of 2021, expected remaining costs to be recognized were reduced by $13.0 million due to the removal of a previously planned non-cash cumulative translation adjustment charge, resulting from our recent reassessment of the legal entity and its related operations. The adjusted pre-tax restructuring charge expected would be $42 million to $52 million.

For the nine months ended September 30, 2021, we paid $21.2 million related to all our restructuring projects. As of September 30, 2021, $47.3 million was accrued for these restructuring projects, of which $28.7 million is expected to be paid within the next 12 months.

For further details regarding our restructuring activities, refer to Item 1: Financial Statements (Unaudited), Note 12: Restructuring included in this Quarterly Report on Form 10-Q.

46

On October 29, 2021, the Board of Directors of Itron approved a restructuring plan (the 2021 Projects). The 2021 Projects include activities, in conjunction with the announcement of the sale of certain of our Gas device manufacturing operations, which drive reductions in certain locations and functional support areas. These projects are to be substantially complete by the end of 2024. Itron estimates pre-tax restructuring charges of $65-75 million. Of the total estimated charge, approximately $60-65 million will result in cash expenditures, and the remainder to non-cash impairment charges. The majority of the expense will be recognized during the fourth quarter of 2021. Once the 2021 Projects are substantially completed, Itron estimates $15-20 million in annualized savings. Certain of Itron’s employees are represented by unions or works councils, which requires consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of planned savings in certain jurisdictions.

Reserve of Receivables from Sale of Business

On June 25, 2020, we closed on the sale of five subsidiaries comprising our manufacturing and sales operations in Latin America to buyers led by Instalación Profesional y Tecnologías del Centro S.A. de C.V., a Mexican company doing business as Accell in Brazil (Accell), through the execution of various definitive stock purchase agreements. The total sales price of $35.0 million included deferred payments of $21.1 million for working capital, which was to be paid in full by December 31, 2020, as evidenced by a promissory note, and the remainder in cash ($4.5 million) and other deferred consideration. In January 2021, we agreed to extend the payment terms on the remaining outstanding working capital balance of $18.4 million. Accell had agreed to make monthly payments, including interest, through September 2022, under which we received full payments for January through March and partial payments in April and May (totaling $3.8 million including $0.7 million in interest). In July 2021, we received a revised payment plan for the remaining working capital note receivable, as well as the other deferred transaction receivables. Based on Accell's failure to make timely payments, continued requests to defer payments significantly beyond the original maturity of the working capital note, and the unfavorable impact of the COVID-19 pandemic on the Latin American markets, we determined to fully reserve the working capital and other deferred consideration in the second quarter of 2021.

Approval of Share Repurchase Program

Effective November 1, 2021, the Board of Directors of Itron authorized a new share repurchase program of up to $100 million of Itron’s common stock over an 18-month period. Repurchases will be made in the open market and pursuant to the terms of any Rule 10b5-1 plans that Itron may enter into, and in accordance with applicable securities laws. The repurchase program is intended to comply with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice.

Other Liquidity Considerations

We have tax credits and net operating loss carryforwards in various jurisdictions that are available to reduce cash taxes. However, utilization of tax credits and net operating losses are limited in certain jurisdictions. Based on current projections, we expect to pay, net of refunds, approximately $1 million in state taxes, and $8 million in local and foreign taxes during 2021. We do not expect to pay any U.S. federal taxes. For a discussion of our tax provision and unrecognized tax benefits, see Item 1: Financial Statements (Unaudited), Note 10: Income Taxes included in this Quarterly Report on Form 10-Q.

As of September 30, 2021, we are under examination by certain tax authorities. We believe we have appropriately accrued for the expected outcome of all tax matters and do not currently anticipate that the ultimate resolution of these examinations will have a material adverse effect on our financial condition, future results of operations, or liquidity.

As of September 30, 2021, there was $46.8 million of cash and short-term investments held by certain foreign subsidiaries in which we are permanently reinvested for tax purposes. As a result of recent changes in U.S. tax legislation, any repatriation in the future would not result in U.S. federal income tax. Accordingly, there is no provision for U.S. deferred taxes on this cash. If this cash were repatriated to fund U.S. operations, additional withholding tax costs may be incurred. Tax is only one of the many factors that we consider in the management of global cash. Accordingly, the amount of taxes that we would need to accrue and pay to repatriate foreign cash could vary significantly.

On October 8, 2021 the G20/OECD Inclusive Framework on BEPS published a statement on the components of global tax reform agreed to by most member countries. The key components would allocate a portion of profits of the largest businesses amongst their markets, curtail new digital services taxes, and introduce a new global minimum tax of 15%. These components do not result in any financial impact until enacted, which is not currently expected until 2023. The Company is monitoring developments and additional details as they are released to determine the impacts these new components will have on our business.

In several of our consolidated international subsidiaries, we have joint venture partners, who are minority shareholders. Although these entities are not wholly-owned by Itron, Inc., we consolidate them because we have a greater than 50% ownership interest and/or because we exercise control over the operations. The noncontrolling interest balance in our

47

Consolidated Balance Sheets represents the proportional share of the equity of the joint venture entities, which is attributable to the minority shareholders. At September 30, 2021, $18.5 million of our consolidated cash balance was held in our joint venture entities. As a result, the minority shareholders of these entities have rights to their proportional share of this cash balance, and there may be limitations on our ability to repatriate cash to the United States from these entities.

General Liquidity Overview

Notwithstanding the expected short to mid-term impacts of the COVID-19 pandemic, we expect to grow through a combination of internal new research and development, licensing technology from and to others, distribution agreements, partnering arrangements, and acquisitions of technology or other companies. We expect these activities to be funded with existing cash, cash flow from operations, borrowings, or the sale of our common stock or other securities. We believe existing sources of liquidity will be sufficient to fund our existing operations and obligations for the next 12 months and into the foreseeable future, but offer no assurances. Our liquidity could be affected by the stability of the electricity, gas, and water utility industries, competitive pressures, our dependence on certain key vendors and components, changes in estimated liabilities for product warranties and/or litigation, duration of the COVID-19 pandemic, future business combinations, capital market fluctuations, international risks, and other factors described under Risk Factors within Item 1A of Part I of our 2020 Annual Report, as well as Quantitative and Qualitative Disclosures About Market Risk within Item 3 of Part I included in this Quarterly Report on Form 10-Q.

Contingencies

Refer to Item 1: Financial Statements (Unaudited), Note 11: Commitments and Contingencies included in this Quarterly Report on Form 10-Q.

Critical Accounting Estimates and Policies

Our consolidated financial statements and accompanying notes are prepared in accordance with GAAP. Preparing consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and assumptions are affected by management's application of accounting policies. Our critical accounting policies that require the use of estimates and assumptions were discussed in detail in the 2020 Annual Report and have not changed materially.

Refer to Item 1: Financial Statements (Unaudited), Note 1: Summary of Significant Accounting Policies included in this Quarterly Report on Form 10-Q for further disclosures regarding new accounting pronouncements.

48

Non-GAAP Measures

The accompanying schedule contains non-GAAP financial measures. To supplement our consolidated financial statements, which are prepared in accordance with GAAP, we use certain non-GAAP financial measures, including non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, non-GAAP diluted EPS, adjusted EBITDA, free cash flow, and constant currency. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP, and other companies may define such measures differently. For more information on these non-GAAP financial measures, please see the table captioned Reconciliations of Non-GAAP Financial Measures to the Most Directly Comparable GAAP Financial Measures.

We use these non-GAAP financial measures for financial and operational decision making and/or as a means for determining executive compensation. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and ability to service debt by excluding certain expenses that may not be indicative of our recurring core operating results. These non-GAAP financial measures facilitate management's internal comparisons to our historical performance, as well as comparisons to our competitors' operating results. Our executive compensation plans exclude non-cash charges related to amortization of intangibles and certain discrete cash and non-cash charges, such as acquisition and integration related expenses, loss on sale of business, or restructuring charges. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. We believe these non-GAAP financial measures are useful to investors because they provide greater transparency with respect to key metrics used by management in its financial and operational decision making and because they are used by our institutional investors and the analyst community to analyze the health of our business.

Non-GAAP operating expenses and non-GAAP operating income – We define non-GAAP operating expenses as operating expenses excluding certain expenses related to the amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, and acquisition and integration. We define non-GAAP operating income as operating income (loss) excluding the expenses related to the amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, and acquisition and integration. Acquisition and integration related expenses include costs, which are incurred to affect and integrate business combinations, such as professional fees, certain employee retention and salaries related to integration, severances, contract terminations, travel costs related to knowledge transfer, system conversion costs, and asset impairment charges. We consider these non-GAAP financial measures to be useful metrics for management and investors because they exclude the effect of expenses that are related to acquisitions and restructuring projects. By excluding these expenses, we believe that it is easier for management and investors to compare our financial results over multiple periods and analyze trends in our operations. For example, in certain periods, expenses related to amortization of intangible assets may decrease, which would improve GAAP operating margins, yet the improvement in GAAP operating margins due to this lower expense is not necessarily reflective of an improvement in our core business. There are some limitations related to the use of non-GAAP operating expenses and non-GAAP operating income versus operating expenses and operating income calculated in accordance with GAAP. We compensate for these limitations by providing specific information about the GAAP amounts excluded from non-GAAP operating expense and non-GAAP operating income and evaluating non-GAAP operating expense and non-GAAP operating income together with GAAP operating expense and operating income.

Non-GAAP net income and non-GAAP diluted EPS – We define non-GAAP net income as net income (loss) attributable to Itron, Inc. excluding the expenses associated with amortization of intangible assets, amortization of debt placement fees, debt extinguishment, restructuring, loss on sale of business, corporate transition cost, acquisition and integration, and the tax effect of excluding these expenses. We define non-GAAP diluted EPS as non-GAAP net income divided by diluted weighted-average shares outstanding during the period calculated on a GAAP basis and then reduced to reflect the anti-dilutive impact of the convertible note hedge transaction entered into in connection with the 0% Convertible Notes due 2026 issued in March 2021. We consider these financial measures to be useful metrics for management and investors for the same reasons that we use non-GAAP operating income. The same limitations described above regarding our use of non-GAAP operating income apply to our use of non-GAAP net income and non-GAAP diluted EPS. We compensate for these limitations by providing specific information regarding the GAAP amounts excluded from these non-GAAP measures and evaluating non-GAAP net income and non-GAAP diluted EPS together with GAAP net income attributable to Itron, Inc. and GAAP diluted EPS.

For interim periods the budgeted annual effective tax rate (AETR) is used, adjusted for any discrete items, as defined in Accounting Standards Codification (ASC) 740 - Income Taxes. The budgeted AETR is determined at the beginning of the fiscal year. The AETR is revised throughout the year based on changes to our full-year forecast. If the revised AETR increases or decreases by 200 basis points or more from the budgeted AETR due to changes in the full-year forecast during the year, the revised AETR is used in place of the budgeted AETR beginning with the quarter the 200 basis point threshold is exceeded and going forward for all subsequent interim quarters in the year. We continue to assess the AETR based on latest forecast

49

throughout the year and use the most recent AETR anytime it increases or decreases by 200 basis points or more from the prior interim period.

Adjusted EBITDA – We define adjusted EBITDA as net income (loss) (a) minus interest income, (b) plus interest expense, depreciation and amortization, debt extinguishment, restructuring, loss on sale of business, corporate transition cost, acquisition and integration, and (c) excluding income tax provision or benefit. Management uses adjusted EBITDA as a performance measure for executive compensation. A limitation to using adjusted EBITDA is that it does not represent the total increase or decrease in the cash balance for the period and the measure includes some non-cash items and excludes other non-cash items. Additionally, the items that we exclude in our calculation of adjusted EBITDA may differ from the items that our peer companies exclude when they report their results. We compensate for these limitations by providing a reconciliation of this measure to GAAP net income (loss).

Free cash flow – We define free cash flow as net cash provided by operating activities less cash used for acquisitions of property, plant and equipment. We believe free cash flow provides investors with a relevant measure of liquidity and a useful basis for assessing our ability to fund our operations and repay our debt. The same limitations described above regarding our use of adjusted EBITDA apply to our use of free cash flow. We compensate for these limitations by providing specific information regarding the GAAP amounts and reconciling to free cash flow.

Constant currency – We refer to the impact of foreign currency exchange rate fluctuations in our discussions of financial results, which references the differences between the foreign currency exchange rates used to translate operating results from the entity's functional currency into U.S. dollars for financial reporting purposes. We also use the term "constant currency", which represents financial results adjusted to exclude changes in foreign currency exchange rates as compared with the rates in the comparable prior year period. We calculate the constant currency change as the difference between the current period results and the comparable prior period's results restated using current period foreign currency exchange rates.

50

Reconciliations of Non-GAAP Financial Measures to the Most Directly Comparable GAAP Financial Measures

The tables below reconcile the non-GAAP financial measures of operating expenses, operating income, net income, diluted EPS, adjusted EBITDA, and free cash flow with the most directly comparable GAAP financial measures.

TOTAL COMPANY RECONCILIATIONS				Three Months Ended September 30,				Nine Months Ended September 30,
	In thousands, except per share data			2021		2020		2021		2020
	NON-GAAP OPERATING EXPENSES
		GAAP operating expenses		$	130,800	$	167,231	$	423,711	$	496,331
			Amortization of intangible assets	(8,944)		(11,183)		(26,914)		(33,488)
			Restructuring	(958)		(44,462)		830		(41,531)
			Loss on sale of business	(2,171)		(380)		(28,274)		(57,295)
			Corporate transition cost	—		—		—		33
			Acquisition and integration	(118)		2,348		368		738
		Non-GAAP operating expenses		$	118,609	$	113,554	$	369,721	$	364,788
	NON-GAAP OPERATING INCOME
		GAAP operating income (loss)		$	4,163	$	(23,980)	$	28,171	$	(42,997)
			Amortization of intangible assets	8,944		11,183		26,914		33,488
			Restructuring	958		44,462		(830)		41,531
			Loss on sale of business	2,171		380		28,274		57,295
			Corporate transition cost	—		—		—		(33)
			Acquisition and integration	118		(2,348)		(368)		(738)
		Non-GAAP operating income		$	16,354	$	29,697	$	82,161	$	88,546
	NON-GAAP NET INCOME & DILUTED EPS
		GAAP net loss attributable to Itron, Inc.		$	(1,869)	$	(25,357)	$	(22,389)	$	(79,475)
			Amortization of intangible assets	8,944		11,183		26,914		33,488
			Amortization of debt placement fees	1,905		972		17,252		2,898
			Debt extinguishment	—		—		11,681		—
			Restructuring	958		44,462		(830)		41,531
			Loss on sale of business	2,171		380		28,274		57,295
			Corporate transition cost	—		—		—		(33)
			Acquisition and integration	118		(2,348)		(368)		(738)
			Income tax effect of non-GAAP adjustments	(2,775)		(4,658)		(16,491)		(6,037)
		Non-GAAP net income attributable to Itron, Inc.		$	9,452	$	24,634	$	44,043	$	48,929
		Non-GAAP diluted EPS		$	0.21	$	0.61	$	0.99	$	1.21
		Non-GAAP weighted average common shares outstanding - Diluted		45,506		40,559		44,330		40,507
	ADJUSTED EBITDA
		GAAP net loss attributable to Itron, Inc.		$	(1,869)	$	(25,357)	$	(22,389)	$	(79,475)
			Interest income	(352)		(354)		(1,326)		(2,165)
			Interest expense	2,628		10,810		27,107		33,771
			Income tax provision (benefit)	1,136		(11,985)		5,581		366
			Debt extinguishment	—		—		11,681		—
			Depreciation and amortization	21,333		24,076		64,252		72,306
			Restructuring	958		44,462		(830)		41,531
			Loss on sale of business	2,171		380		28,274		57,295
			Corporate transition cost	—		—		—		(33)
			Acquisition and integration	118		(2,348)		(368)		(738)
		Adjusted EBITDA		$	26,123	$	39,684	$	111,982	$	122,858
	FREE CASH FLOW
			Net cash provided by operating activities	$	18,467	$	44,785	$	141,147	$	70,571
			Acquisitions of property, plant, and equipment	(7,305)		(7,248)		(27,781)		(36,297)
		Free Cash Flow		$	11,162	$	37,537	$	113,366	$	34,274

51

Item 3:    Quantitative and Qualitative Disclosures about Market Risk

In the normal course of business, we are exposed to interest rate and foreign currency exchange rate risks that could impact our financial position and results of operations. As part of our risk management strategy, we may use derivative financial instruments to hedge certain foreign currency and interest rate exposures. Our objective is to offset gains and losses resulting from these exposures with losses and gains on the derivative contracts used to hedge them, therefore reducing the impact of volatility on earnings or protecting the fair values of assets and liabilities. We use derivative contracts only to manage existing underlying exposures. Accordingly, we do not use derivative contracts for trading or speculative purposes.

Interest Rate Risk

We may be exposed to interest rate risk through our variable rate debt instruments. On August 12, 2021, the term loan under the credit facility was fully paid. At September 30, 2021, we had no outstanding variable rate debt.

We continually monitor and assess our interest rate risk and may institute additional interest rate swaps or other derivative instruments to manage such risk in the future if we were to have variable rate debt outstanding.

Foreign Currency Exchange Rate Risk

We conduct business in a number of countries. Revenues denominated in functional currencies other than the U.S. dollar were 36% and 38% of total revenues for the three and nine months ended September 30, 2021 compared with 37% and 36% for the same respective periods in 2020. These transactions expose our account balances to movements in foreign currency exchange rates that could have a material effect on our financial results. Our primary foreign currency exposure relates to non-U.S. dollar denominated transactions in our international subsidiary operations, the most significant of which is the euro.

We are also exposed to foreign exchange risk when we enter into non-functional currency transactions, both intercompany and third-party. At each period-end, non-functional currency monetary assets and liabilities are revalued with the change recognized within other income (expense) in our Consolidated Statements of Operations. We enter into monthly foreign exchange forward contracts, which are not designated for hedge accounting, with the intent to reduce earnings volatility associated with currency exposures. As of September 30, 2021, a total of 37 contracts were offsetting our exposures from the euro, pound sterling, Indonesian rupiah, Canadian dollar, Australian dollar and various other currencies, with notional amounts ranging from $150,000 to $56.4 million. Based on a sensitivity analysis as of September 30, 2021, we estimate that, if foreign currency exchange rates average ten percentage points higher in 2021 for these financial instruments, our financial results in 2021 would not be materially impacted.

In future periods, we may use additional derivative contracts to protect against foreign currency exchange rate risks.

Item 4:    Controls and Procedures

Evaluation of disclosure controls and procedures

An evaluation was performed under the supervision and with the participation of our Company's management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e)) under the Securities Exchange Act of 1934 as amended. Based on that evaluation, the Company's management, including the Chief Executive Officer and Chief Financial Officer, concluded that as of September 30, 2021, the Company's disclosure controls and procedures were effective to ensure the information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

Changes in internal controls over financial reporting

There have been no changes in our internal control over financial reporting during the three months ended September 30, 2021 that materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

52

PART II: OTHER INFORMATION

Item 1:    Legal Proceedings

Refer to Item 1: Financial Statements (Unaudited), Note 11: Commitments and Contingencies included in this Quarterly Report on Form 10-Q.

Item 1A:    Risk Factors

For a complete list of Risk Factors, refer to Part I, Item 1A: Risk Factors of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 24, 2021.

Item 2:    Unregistered Sales of Equity Securities and Use of Proceeds

(a)Not applicable.

(b)Not applicable.

(c)Issuer Repurchase of Equity Securities

Period	Total Number of Shares Purchased (1)	Average Price Paid per Share (2)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
					In thousands
July 1, 2021 through July 31, 2021	—	$	—	—	$	—
August 1, 2021 through August 31, 2021	194	77.74		—	—
September 1, 2021 through September 30, 2021	—	—		—	—
Total	194			—

(1)Shares repurchased represent shares transferred to us by certain employees who vested in restricted stock units and used shares to pay all, or a portion of, the related taxes.

(2)Includes commissions.

Item 5:    Other Information

(a)No information was required to be disclosed in a report on Form 8-K during the third quarter of 2021 that was not reported.

(b)Not applicable.

53

Item 6:    Exhibits

Exhibit Number	Description of Exhibits
31.1	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from Itron, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to the Consolidated Financial Statements.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

54

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ITRON, INC.
November 4, 2021	By:	/s/ JOAN S. HOOPER
Date		Joan S. Hooper
		Senior Vice President and Chief Financial Officer

55

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Thomas L. Deitrich, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Itron, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

ITRON, INC.
By:	/s/ THOMAS L. DEITRICH
	Thomas L. Deitrich President and Chief Executive Officer

Date: November 4, 2021

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Joan S. Hooper, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Itron, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

ITRON, INC.
By:	/s/ JOAN S. HOOPER
	Joan S. Hooper Senior Vice President and Chief Financial Officer

Date: November 4, 2021

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

The certification set forth below is being submitted in connection with the Quarterly Report of Itron, Inc. (the Company) on Form 10-Q for the quarterly period ended September 30, 2021 (the Report) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Thomas L. Deitrich, the Chief Executive Officer and Joan S. Hooper, the Chief Financial Officer of the Company, each certifies that to the best of his or her knowledge:

(1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ THOMAS L. DEITRICH	November 4, 2021
Thomas L. Deitrich President and Chief Executive Officer	Date
/s/ JOAN S. HOOPER	November 4, 2021
Joan S. Hooper Senior Vice President and Chief Financial Officer	Date

XML

Document and Entity Information Document - shares	9 Months Ended
	Sep. 30, 2021	Oct. 31, 2021
Document Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	000-22418
Entity Registrant Name	ITRON, INC.
Entity Address, Address Line One	2111 N Molter Road
Entity Incorporation, State or Country Code	WA
Entity Tax Identification Number	91-1011792
Entity Address, City or Town	Liberty Lake
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	99019
City Area Code	509
Local Phone Number	924-9900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common stock, no par value
Trading Symbol	ITRI
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		45,272,251
Entity Central Index Key	0000780571
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues
Revenues	$ 486,949	$ 540,184	$ 1,495,935	$ 1,648,193
Cost of revenues
Cost of revenues	351,986	396,933	1,044,053	1,194,859
Gross profit	134,963	143,251	451,882	453,334
Operating expenses
Sales, general and administrative	71,838	64,982	221,974	215,018
Research and development	46,889	46,224	147,379	148,999
Amortization of intangible assets	8,944	11,183	26,914	33,488
Restructuring	958	44,462	(830)	41,531
Loss on sale of business	2,171	380	28,274	57,295
Total operating expenses	130,800	167,231	423,711	496,331
Operating income (loss)	4,163	(23,980)	28,171	(42,997)
Other income (expense)
Interest income	352	354	1,326	2,165
Interest expense	(2,628)	(10,810)	(27,107)	(33,771)
Other income (expense), net	(1,761)	(2,607)	(16,684)	(3,414)
Total other income (expense)	(4,037)	(13,063)	(42,465)	(35,020)
Income (loss) before income taxes	126	(37,043)	(14,294)	(78,017)
Income tax benefit (provision)	(1,136)	11,985	(5,581)	(366)
Net loss	(1,010)	(25,058)	(19,875)	(78,383)
Net income attributable to noncontrolling interests	859	299	2,514	1,092
Net loss attributable to Itron, Inc.	$ (1,869)	$ (25,357)	$ (22,389)	$ (79,475)
Earnings (loss) per common share - Basic (in dollars per share)	$ (0.04)	$ (0.63)	$ (0.51)	$ (1.98)
Earnings (loss) per common share - Diluted (in dollars per share)	$ (0.04)	$ (0.63)	$ (0.51)	$ (1.98)
Weighted average common shares outstanding - Basic (in shares)	45,240	40,337	43,983	40,199
Weighted average common shares outstanding - Diluted (in shares)	45,240	40,337	43,983	40,199
Product [Member]
Revenues
Revenues	$ 410,947	$ 470,658	$ 1,265,470	$ 1,437,780
Cost of revenues
Cost of revenues	306,168	358,297	908,923	1,072,271
Service [Member]
Revenues
Revenues	76,002	69,526	230,465	210,413
Cost of revenues
Cost of revenues	$ 45,818	$ 38,636	$ 135,130	$ 122,588

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (1,010)	$ (25,058)	$ (19,875)	$ (78,383)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(7,764)	13,988	(17,118)	(147)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	0	(14)	0	52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	510	(1)	1,818	(2,157)
Pension benefit obligation adjustment	687	(159)	2,087	889
Total other comprehensive income (loss), net of tax	(6,567)	13,814	(13,213)	50,659
Total comprehensive income (loss), net of tax	(7,577)	(11,244)	(33,088)	(27,724)
Comprehensive income attributable to noncontrolling interests, net of tax	859	299	2,514	1,092
Comprehensive income (loss) attributable to Itron, Inc.	$ (8,436)	$ (11,543)	$ (35,602)	$ (28,816)

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 188,691	$ 206,933
Accounts receivable, net	320,994	369,828
Inventories	175,432	182,377
Other current assets	117,270	171,124
Total current assets	802,387	930,262
Property, plant, and equipment, net	189,748	207,816
Deferred tax assets, net	101,907	76,142
Other long-term assets	41,666	51,656
Operating lease right-of-use assets, net	67,599	76,276
Intangible assets, net	103,763	132,955
Goodwill	1,115,697	1,131,916
Total assets	2,422,767	2,607,023
Current liabilities
Accounts payable	188,663	215,639
Other current liabilities	74,718	72,591
Wages and benefits payable	99,347	86,249
Taxes payable	13,674	15,804
Current portion of debt	0	18,359
Current portion of warranty	18,089	28,329
Unearned revenue	101,263	112,928
Total current liabilities	495,754	549,899
Long-term debt, net	449,629	902,577
Long-term warranty	16,598	13,061
Pension benefit obligation	114,771	119,457
Deferred tax liabilities, net	1,792	1,921
Operating lease liabilities	59,149	66,823
Other long-term obligations	85,248	113,012
Total liabilities	1,222,941	1,766,750
Equity
Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding	0	0
Common stock, no par value, 75,000 shares authorized, 45,260 and 40,444 shares issued and outstanding	1,782,060	1,389,419
Accumulated other comprehensive loss, net	(151,739)	(138,526)
Accumulated deficit	(456,734)	(434,345)
Total Itron, Inc. shareholders' equity	1,173,587	816,548
Noncontrolling interests	26,239	23,725
Total equity	1,199,826	840,273
Total liabilities and equity	$ 2,422,767	$ 2,607,023
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Common stock, shares issued (in shares)	45,260,000	40,444,000
Common stock, shares outstanding (in shares)	45,260,000	40,444,000
Preferred stock, shares authorized (in share)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Common stock, shares issued (in shares)	45,260,000	40,444,000
Common stock, shares outstanding (in shares)	45,260,000	40,444,000
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in share)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

XML

Consolidated Statements of Equity Statement - USD ($) shares in Thousands, $ in Thousands	Total	Parent [Member]	Common Stock [Member]	Common Stock Including Additional Paid in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Beginning balance (in shares) at Dec. 31, 2019			39,941
Beginning balance at Dec. 31, 2019	$ 800,815	$ 776,538		$ 1,357,600	$ (204,672)	$ (376,390)	$ 24,277
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	9,162	8,684				8,684	478
Other comprehensive income (loss), net of tax	(25,211)	(25,211)			(25,211)
Net stock issuance and repurchases (in shares)			235
Net stock issued and repurchased	2,247	2,247		2,247
Stock-based compensation expense	8,482	8,482		8,482
Ending balance at Mar. 31, 2020	795,495	770,740		1,368,329	(229,883)	(367,706)	24,755
Ending balance (in shares) at Mar. 31, 2020			40,176
Beginning balance (in shares) at Dec. 31, 2019			39,941
Beginning balance at Dec. 31, 2019	800,815	776,538		1,357,600	(204,672)	(376,390)	24,277
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(78,383)
Other comprehensive income (loss), net of tax	50,659
Proceeds from sale of warrants	0
Ending balance at Sep. 30, 2020	797,265	771,896		1,381,774	(154,013)	(455,865)	25,369
Ending balance (in shares) at Sep. 30, 2020			40,356
Beginning balance (in shares) at Mar. 31, 2020			40,176
Beginning balance at Mar. 31, 2020	795,495	770,740		1,368,329	(229,883)	(367,706)	24,755
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(62,487)	(62,802)				(62,802)	315
Other comprehensive income (loss), net of tax	62,056	62,056			62,056
Net stock issuance and repurchases (in shares)			58
Net stock issued and repurchased	706	706		706
Stock-based compensation expense	7,099	7,099		7,099
Ending balance at Jun. 30, 2020	802,869	777,799		1,376,134	(167,827)	(430,508)	25,070
Ending balance (in shares) at Jun. 30, 2020			40,234
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,058)	(25,357)				(25,357)	299
Other comprehensive income (loss), net of tax	13,814	13,814			13,814
Net stock issuance and repurchases (in shares)			122
Net stock issued and repurchased	583	583		583
Stock-based compensation expense	5,057	5,057		5,057
Ending balance at Sep. 30, 2020	$ 797,265	771,896		1,381,774	(154,013)	(455,865)	25,369
Ending balance (in shares) at Sep. 30, 2020			40,356
Beginning balance (in shares) at Dec. 31, 2020	40,444		40,444
Beginning balance at Dec. 31, 2020	$ 840,273	816,548		1,389,419	(138,526)	(434,345)	23,725
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	13,580	12,603				12,603	977
Other comprehensive income (loss), net of tax	(11,783)	(11,783)			(11,783)
Net stock issuance and repurchases (in shares)			206
Net stock issued and repurchased	2,009	2,009		2,009
Stock-based compensation expense	6,270	6,270		6,270
Stock issued related to equity offering			4,472
Stock issued related to equity offering	389,419	389,419		389,419
Proceeds from sale of warrants	45,349	45,349		45,349
Purchases of convertible note hedge contracts, net of tax	(63,576)	(63,576)		(63,576)
Registration fee	373	373		373
Ending balance at Mar. 31, 2021	$ 1,221,168	1,196,466		1,768,517	(150,309)	(421,742)	24,702
Ending balance (in shares) at Mar. 31, 2021			45,122
Beginning balance (in shares) at Dec. 31, 2020	40,444		40,444
Beginning balance at Dec. 31, 2020	$ 840,273	816,548		1,389,419	(138,526)	(434,345)	23,725
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(19,875)
Other comprehensive income (loss), net of tax	(13,213)
Proceeds from sale of warrants	45,349
Ending balance at Sep. 30, 2021	$ 1,199,826	1,173,587		1,782,060	(151,739)	(456,734)	26,239
Ending balance (in shares) at Sep. 30, 2021	45,260		45,260
Beginning balance (in shares) at Mar. 31, 2021			45,122
Beginning balance at Mar. 31, 2021	$ 1,221,168	1,196,466		1,768,517	(150,309)	(421,742)	24,702
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(32,445)	(33,123)				(33,123)	678
Other comprehensive income (loss), net of tax	5,137	5,137			5,137
Net stock issuance and repurchases (in shares)			28
Net stock issued and repurchased	458	458		458
Stock-based compensation expense	6,316	6,316		6,316
Registration fee	24	24		24
Ending balance at Jun. 30, 2021	1,200,658	1,175,278		1,775,315	(145,172)	(454,865)	25,380
Ending balance (in shares) at Jun. 30, 2021			45,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,010)	(1,869)				(1,869)	859
Other comprehensive income (loss), net of tax	(6,567)	(6,567)			(6,567)
Net stock issuance and repurchases (in shares)			110
Net stock issued and repurchased	1,080	1,080		1,080
Stock-based compensation expense	5,665	5,665		5,665
Ending balance at Sep. 30, 2021	$ 1,199,826	$ 1,173,587		$ 1,782,060	$ (151,739)	$ (456,734)	$ 26,239
Ending balance (in shares) at Sep. 30, 2021	45,260		45,260

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities
Net loss	$ (19,875)	$ (78,383)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	64,252	72,306
Non-cash operating lease expense	12,962	15,252
Stock-based compensation	18,251	20,638
Amortization of prepaid debt fees	17,383	3,029
Deferred taxes, net	(5,170)	(9,439)
Loss on sale of business	28,274	57,295
Loss on extinguishment of debt	10,000	0
Restructuring, non-cash	951	6,518
Other adjustments, net	3,720	3,856
Changes in operating assets and liabilities, net of sale of business:
Accounts receivable	40,624	82,087
Inventories	2,150	8,978
Other current assets	26,072	(12,862)
Other long-term assets	5,058	(2,547)
Accounts payable, other current liabilities, and taxes payable	(27,124)	(82,775)
Wages and benefits payable	14,110	(28,446)
Unearned revenue	(13,158)	15,098
Warranty	(5,969)	(10,894)
Other operating, net	(31,364)	10,860
Net cash provided by operating activities	141,147	70,571
Investing activities
Net proceeds (payments) related to the sale of business	3,142	(748)
Acquisitions of property, plant, and equipment	(27,781)	(36,297)
Other investing, net	2,820	3,573
Net cash used in investing activities	(21,819)	(33,472)
Financing activities
Proceeds from borrowings	460,000	400,000
Payments on debt	(946,094)	0
Issuance of common stock	4,351	5,059
Proceeds from common stock offering	389,419	0
Proceeds from sale of warrants	45,349	0
Purchases of convertible note hedge contracts	(84,139)	0
Prepaid debt fees	(12,021)	(184)
Other financing, net	6,327	(2,285)
Net cash (used in) provided by financing activities	(136,808)	402,590
Effect of foreign exchange rate changes on cash and cash equivalents	(762)	(3,426)
Increase (decrease) in cash and cash equivalents	(18,242)	436,263
Cash and cash equivalents at beginning of period	206,933	149,904
Cash and cash equivalents at end of period	188,691	586,167
Supplemental disclosure of cash flow information:
Income taxes, net	5,989	(349)
Interest	$ 8,655	$ 34,327

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Financial Statement Preparation

The consolidated financial statements presented in this Quarterly Report on Form 10-Q are unaudited and reflect entries necessary for the fair presentation of the Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2021 and 2020, Consolidated Statements of Equity for the three months ended September 30, 2021 and 2020, June 30, 2021 and 2020, and March 31, 2021 and 2020, the Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020, and the Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020, of Itron, Inc. and its subsidiaries. All entries required for the fair presentation of the financial statements are of a normal recurring nature, except as disclosed. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results expected for the full year or for any other period.

Certain information and notes normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been partially or completely omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim results. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2020 filed with the SEC in our Annual Report on Form 10-K on February 24, 2021 (2020 Annual Report). There have been no significant changes in financial statement preparation or significant accounting policies since December 31, 2020.

Risks and Uncertainties

The COVID-19 pandemic has had global economic impacts including disrupting customer demand and global supply chains, resulting in market volatility. The extent of the recent pandemic and its ongoing impact on our operations is volatile, but is being monitored closely by our management. During portions of the first half of 2020 certain of our European factories were closed due to government actions and local conditions, and any further closures that may be imposed on us could impact our results for 2021. New variants of the virus may cause previously lifted restrictions to be reinstated, which could result in more disruptions. Incremental costs we have incurred related to COVID-19, such as personal protective equipment, increased cleaning and sanitizing of our facilities, and other such items, have not been material to date. As economies have reopened, global supply chains have struggled to keep pace with rapidly changing demand. The resulting supply constraints have manifested across a variety of areas including mechanical, electrical and logistics portions of the supply chain, which has impacted our ability to ship products in a timely manner. In particular, our ability to obtain adequate supply of semiconductor components has impacted our ability to service recovering customer demand. While the current imbalance in supply and demand is temporal, the timeline to recovery is uncertain. Efforts are ongoing with suppliers to increase supply, including the approval of alternate sources. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. However, certain of our customer projects have experienced delay in deliveries, with originally forecasted 2021 revenue pushed to future periods.

Recently Adopted Accounting Standards

In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which modifies certain provisions of Accounting Standards Codification (ASC) 740, to reduce the complexity of accounting for income taxes. ASU 2019-12 was effective for us beginning with our interim financial reports in 2021. The adoption of this standard had no impact to our year-to-date consolidated financial position, results of operations, or cash flows and is not expected to have a material impact on full year 2021 financial results.

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (ASU 2020-06). This amendment simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. We chose to early adopt ASU 2020-06 beginning January 1, 2021, due to the issuance of our convertible debt on March 9, 2021. This amendment had no retrospective changes but impacts how our newly issued convertible debt is both recognized and disclosed. ASU 2020-06 also amends the diluted earnings per share calculation for convertible instruments by requiring the use of the if-converted method. The treasury stock method is no longer available.

Recent Accounting Standards Not Yet Adopted

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. ASU 2020-04 applies to contracts that reference LIBOR or another reference rate expected to be terminated because of reference rate reform. An entity may elect certain optional expedients for hedging relationships that exist as of December 31, 2022 and maintain those optional expedients through the end of the hedging relationship. ASU 2020-04 could be adopted as of March 12, 2020 or thereafter. In January 2021, the FASB issued ASU 2021-01, which further updates the scope of Topic 848. We do not currently have any contracts that have been changed to a new reference rate, but we will continue to evaluate our contracts and the effects of this standard on our consolidated financial position, results of operations, and cash flows prior to adoption.

In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. The amendments in this update modify the lease classification requirements for lessors to align them with practice under Topic 840, particularly in the area of day-one loss accounting. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if certain criteria are met. The effective date for this amendment is January 1, 2022 and all interim periods thereafter. We have determined under existing leases where we are the lessor, this amendment will not have a material impact on our financial statements.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (EPS):

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands, except per share data	2021		2020		2021		2020
Net loss available to common shareholders	$	(1,869)	$	(25,357)	$	(22,389)	$	(79,475)
Weighted average common shares outstanding - Basic	45,240		40,337		43,983		40,199
Dilutive effect of stock-based awards	—		—		—		—
Dilutive effect of convertible notes	—		—		—		—
Weighted average common shares outstanding - Diluted	45,240		40,337		43,983		40,199
Net loss per common share - Basic	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)
Net loss per common share - Diluted	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)

Stock-based Awards

For stock-based awards, the dilutive effect is calculated using the treasury stock method. Under this method, the dilutive effect is computed as if the awards were exercised at the beginning of the period (or at time of issuance, if later) and assumes the related proceeds were used to repurchase our common stock at the average market price during the period. Related proceeds include the amount the employee must pay upon exercise and the future compensation cost associated with the stock award. Approximately 0.4 million and 0.5 million stock-based awards were excluded from the calculation of diluted EPS for the three and nine months ended September 30, 2021 because they were anti-dilutive. Approximately 0.8 million stock-based awards were excluded from the calculation of diluted EPS for the three and nine months ended September 30, 2020 because they were anti-dilutive. These stock-based awards could be dilutive in future periods.

Convertible Notes and Warrants

For our Convertible Notes issued in March 2021, the dilutive effect is calculated using the if-converted method. We are required, pursuant to the indenture governing our Convertible Notes, to settle the principal amount of the Convertible Notes in cash and may elect to settle the remaining conversion obligation (stock price in excess of conversion price) in cash, shares, or a combination thereof. Under the if-converted method, we include the number of shares required to satisfy the remaining conversion obligation, assuming all the Convertible Notes were converted. The average closing price of our common stock for the quarter ended September 30, 2021 is used as the basis for determining the dilutive effect on EPS. The average price of our common stock for the quarter ended September 30, 2021 was less than the conversion price of $126.00, and all associated shares were anti-dilutive.

In conjunction with the issuance of the Convertible Notes, we sold warrants to purchase 3.7 million shares of Itron common stock. The warrants have a strike price of $180.00 per share. For calculating the dilutive effect of the warrants, we use the treasury stock method. With this method, we assume exercise of the warrants at the beginning of the period, or at time of issuance if later, and the issuance of common stock upon exercise. Proceeds from the exercise of the warrants are assumed to be used to repurchase shares of our stock at the average market price during the period. The incremental shares, representing the number of shares assumed to be exercised with the warrants less the number of shares repurchased, are included in diluted weighted average common shares outstanding. For periods where the warrants strike price of $180.00 per share is greater than the average share price of Itron stock for the period, the warrants would be anti-dilutive. For the three and nine months ended September 30, 2021, the average share price was below the warrant strike price and therefore 3.7 million shares were considered anti-dilutive.

Convertible Note Hedge Transactions

In connection with the issuance of the Convertible Notes, we entered into privately negotiated call option contracts on our common stock (the Convertible Note Hedge Transactions) with certain commercial banks (the Counterparties). We paid an aggregate amount of $84.1 million for the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Convertible Notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the Convertible Notes, at a strike price of approximately $126.00, subject to customary adjustments. The Convertible Note Hedge Transactions will expire upon the maturity of the Convertible Notes, subject to earlier exercise or termination. Exercise of the Convertible Note Hedge Transactions would reduce the number of shares of our common stock outstanding and therefore would be anti-dilutive.

XML

Certain Balance Sheet Components

9 Months Ended

Sep. 30, 2021

Balance Sheet Related Disclosures [Abstract]

Certain Balance Sheet Components

Certain Balance Sheet Components

A summary of accounts receivable from contracts with customers is as follows:

Accounts receivable, net
In thousands	September 30, 2021		December 31, 2020
Trade receivables (net of allowance of $2,798 and $1,312)	$	274,385	$	318,269
Unbilled receivables	46,609		51,559
Total accounts receivable, net	$	320,994	$	369,828

Allowance for credit losses account activity	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Beginning balance	$	1,107	$	2,102	$	1,312	$	3,064
Provision for (release of) doubtful accounts, net	2,164		(21)		2,122		318
Accounts written-off	(440)		(278)		(582)		(1,489)
Effect of change in exchange rates	(33)		43		(54)		(47)
Ending balance	$	2,798	$	1,846	$	2,798	$	1,846

Inventories
In thousands	September 30, 2021		December 31, 2020
Raw materials	$	117,549	$	114,058
Work in process	8,539		8,094
Finished goods	49,344		60,225
Total inventories	$	175,432	$	182,377

Property, plant, and equipment, net
In thousands	September 30, 2021		December 31, 2020
Machinery and equipment	$	333,584	$	334,050
Computers and software	117,067		115,776
Buildings, furniture, and improvements	146,052		155,676
Land	11,976		14,303
Construction in progress, including purchased equipment	40,082		31,425
Total cost	648,761		651,230
Accumulated depreciation	(459,013)		(443,414)
Property, plant, and equipment, net	$	189,748	$	207,816

Depreciation expense	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Depreciation expense	$	12,389	$	12,893	$	37,338	$	38,818

XML

Intangible Assets and Liabilities

9 Months Ended

Sep. 30, 2021

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Intangible Assets and Liabilities

Intangible Assets and Liabilities

The gross carrying amount and accumulated amortization (accretion) of our intangible assets and liabilities, other than goodwill, were as follows:

	September 30, 2021						December 31, 2020
In thousands	Gross		Accumulated (Amortization) Accretion		Net		Gross		Accumulated (Amortization) Accretion		Net
Intangible Assets
Core-developed technology	$	511,885	$	(495,799)	$	16,086	$	525,051	$	(498,113)	$	26,938
Customer contracts and relationships	376,572		(291,783)		84,789		383,245		(280,497)		102,748
Trademarks and trade names	78,448		(75,933)		2,515		79,716		(76,912)		2,804
Other	12,023		(11,650)		373		12,025		(11,560)		465
Total intangible assets	$	978,928	$	(875,165)	$	103,763	$	1,000,037	$	(867,082)	$	132,955
Intangible Liabilities
Customer contracts and relationships	$	(23,900)	$	22,950	$	(950)	$	(23,900)	$	21,479	$	(2,421)

A summary of intangible assets and liabilities activity is as follows:

	Nine Months Ended September 30,
In thousands	2021		2020
Intangible assets, gross beginning balance	$	1,000,037	$	979,814
Intangibles disposed in sale of business	—		(18,140)
Effect of change in exchange rates	(21,109)		9,974
Intangible assets, gross ending balance	$	978,928	$	971,648
Intangible liabilities, gross beginning balance	$	(23,900)	$	(23,900)
Effect of change in exchange rates	—		—
Intangible liabilities, gross ending balance	$	(23,900)	$	(23,900)

Assumed intangible liabilities reflect the present value of the projected cash outflows for an existing contract where remaining costs are expected to exceed projected revenues.

The disposal of intangible assets was related to the sale of our Latin America business in June 2020. The net book value of these assets was $0.8 million at the disposal date. Refer to Note 17: Sale of Business for additional information on the transaction.

Estimated future annual amortization (accretion) is as follows:

Year Ending December 31,	Amortization		Accretion		Estimated Annual Amortization, net
In thousands
2021 (amount remaining at September 30, 2021)	$	9,450	$	(491)	$	8,959
2022	27,393		(459)		26,934
2023	19,811		—		19,811
2024	15,631		—		15,631
2025	14,655		—		14,655
Thereafter	16,823		—		16,823
Total intangible assets subject to amortization (accretion)	$	103,763	$	(950)	$	102,813

XML

Goodwill

9 Months Ended

Sep. 30, 2021

Goodwill Excluding Non Goodwill Intangibles [Abstract]

Goodwill

Goodwill

The following table reflects changes in the carrying amount of goodwill for the nine months ended September 30, 2021:

In thousands	Device Solutions		Networked Solutions		Outcomes		Total Company
Goodwill balance at January 1, 2021	$	53,214	$	933,814	$	144,888	$	1,131,916
Effect of change in exchange rates	(658)		(13,467)		(2,094)		(16,219)
Goodwill balance at September 30, 2021	$	52,556	$	920,347	$	142,794	$	1,115,697

XML

Debt

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Debt

Debt

The components of our borrowings were as follows:

In thousands	September 30, 2021		December 31, 2020
Credit facility
USD denominated term loan	$	—	$	536,094
Multicurrency revolving line of credit	—		—
Senior notes	—		400,000
Convertible notes	460,000		—
Total debt	460,000		936,094
Less: current portion of debt	—		18,359
Less: unamortized prepaid debt fees - term loan	—		3,469
Less: unamortized prepaid debt fees - senior notes	—		11,689
Less: unamortized prepaid debt fees - convertible notes	10,371		—
Long-term debt, net	$	449,629	$	902,577

Credit Facility

On October 18, 2019, we amended our credit facility that was initially entered on January 5, 2018 (as amended the 2018 credit facility). The 2018 credit facility provides for committed credit facilities in the amount of $1.2 billion U.S. dollars. The 2018 credit facility consists of a $650 million U.S. dollar term loan (the term loan) and a multicurrency revolving line of credit (the revolver) with a principal amount of up to $500 million. The revolver also contains a $300 million standby letter of credit sub-facility and a $50 million swingline sub-facility. The October 18, 2019 amendment extended the maturity date to October 18, 2024 and re-amortized the term loan based on the new balance as of the amendment date. The amendment also modified the required interest payments and made it based on total net leverage instead of total leverage. Through the third quarter of 2020, amounts not borrowed under the revolver were subject to a commitment fee, which was paid in arrears on the last day of each fiscal quarter, ranging from 0.15% to 0.25% and drawn amounts were subject to a margin ranging from 1.00% to 1.75%.

On October 19, 2020, we completed a second amendment to our 2018 credit facility. This amendment adjusts the maximum total net leverage ratio thresholds for the period beginning with the fourth quarter of 2020 through the fourth quarter of 2021 to allow for increased operational flexibility. The maximum leverage ratio is increased to 4.75:1 for the fourth quarter of 2020 and the first quarter of 2021 and 4.50:1 for the second quarter through the fourth quarter of 2021. An additional level of pricing was added to the existing pricing grid and is effective throughout the remaining term of the 2018 credit facility. Beginning with the fourth quarter of 2020, the commitment fee ranges from 0.15% to 0.30% and drawn amounts are subject to a margin ranging from 1.00% to 2.00%. Debt fees of approximately $1.4 million were incurred for the amendment, as well as other legal and advisory fees. Both the term loan and the revolver can be repaid without penalty. Amounts repaid on the term loan may not be reborrowed, and amounts borrowed under the revolver may be repaid and reborrowed until the revolver's maturity, at which time all outstanding loans together with all accrued and unpaid interest must be repaid.

On March 8, 2021, we entered into a third amendment to our 2018 credit facility, which modified provisions to permit cash settlement upon the conversion of the Convertible Notes, the Convertible Senior Note Hedge Transactions and Warrant Transactions and also to adjust certain settlement provisions for convertible indebtedness. See Note 7: Derivative Financial Instruments for further details of the Convertible Note Hedge Transactions and Warrant Transactions.

The 2018 credit facility permits us and certain of our foreign subsidiaries to borrow in U.S. dollars, euros, British pounds, or, with lender approval, other currencies readily convertible into U.S. dollars. All obligations under the 2018 credit facility are guaranteed by Itron, Inc. and material U.S. domestic subsidiaries and are secured by a pledge of substantially all of the assets of Itron, Inc. and material U.S. domestic subsidiaries. This includes a pledge of 100% of the capital stock of material U.S.

domestic subsidiaries and up to 66% of the voting stock (100% of the non-voting stock) of first-tier foreign subsidiaries. In addition, the obligations of any foreign subsidiary who is a foreign borrower, as defined by the 2018 credit facility, are guaranteed by the foreign subsidiary and by its direct and indirect foreign parents. The 2018 credit facility includes debt covenants, which contain certain financial thresholds and place certain restrictions on the incurrence of debt, investments, and the issuance of dividends. We were in compliance with the debt covenants under the 2018 credit facility at September 30, 2021.

Under the 2018 credit facility, we elect applicable market interest rates for both the term loan and any outstanding revolving loans. We also pay an applicable margin, which is based on our total net leverage ratio as defined in the credit agreement. The applicable rates per annum may be based on either: (1) the LIBOR rate or EURIBOR rate (subject to a floor of 0%), plus an applicable margin, or (2) the Alternate Base Rate, plus an applicable margin. The Alternate Base Rate election is equal to the greatest of three rates: (i) the prime rate, (ii) the Federal Reserve effective rate plus 0.50%, or (iii) one-month LIBOR plus 1.00%. On August 12, 2021, the term loan was fully paid. At September 30, 2021, there were no outstanding loan balances under the Credit Facility.

In March 2020, we drew $400 million in U.S. dollars under the revolving line of credit within the 2018 credit facility to increase our cash position and preserve future financial flexibility, which was fully repaid as of December 31, 2020. At September 30, 2021, there was no amount outstanding under the revolver, and $64.4 million was utilized by outstanding standby letters of credit, resulting in $435.6 million available for additional borrowings or standby letters of credit. At September 30, 2021, $235.6 million was available for additional standby letters of credit under the letter of credit sub-facility, and no amounts were outstanding under the swingline sub-facility.

Senior Notes

In December 2017 and January 2018, we issued $300 million and $100 million of aggregate principal amount of 5.00% senior notes maturing January 15, 2026 (Senior Notes). The proceeds were used to refinance existing indebtedness related to the acquisition of Silver Spring Networks, Inc., pay related fees and expenses, and for general corporate purposes. Interest on the Senior Notes was payable semi-annually in arrears on January 15 and July 15. The Senior Notes were fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by each of our subsidiaries that guarantee the senior credit facilities.

On March 9, 2021, we submitted a Notice of Redemption to the trustee to redeem all outstanding Senior Notes at a redemption price of 102.50%, in accordance with the indenture governing the Senior Notes, totaling $410.0 million. As of April 8, 2021 the Senior Notes were fully discharged, and no principal or unpaid interest remains outstanding. The 2.5%, or $10.0 million, early redemption premium and write off of $11.1 million prepaid debt fees were recognized upon redemption in the second quarter of 2021.

Convertible Notes

On March 12, 2021, we closed the sale of the Convertible Notes in a private placement to qualified institutional buyers, resulting in net proceeds to us of $448.5 million after deducting initial purchasers’ discounts of the offering. The Convertible Notes do not bear regular interest, and the principal amount does not accrete. The Convertible Notes will mature on March 15, 2026, unless earlier repurchased, redeemed, or converted in accordance with their terms. No sinking fund is provided for the Convertible Notes.

The initial conversion rate of the Convertible Notes is 7.9365 shares of our common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $126.00 per share. The conversion rate of the Convertible Notes is subject to adjustment upon the occurrence of certain specified events. In addition, upon the occurrence of a make-whole fundamental change (as defined in the indenture governing the Convertible Notes) or upon a notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change or notice of redemption, as the case may be.

Prior to the close of business on the business day immediately preceding December 15, 2025, the Convertible Notes are convertible at the option of the holders only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business-day period after any five consecutive trading-day period (the measurement period) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3) upon the occurrence of specified corporate events; or (4) upon redemption by us. On or after December 15, 2025, until the close of business on the second scheduled trading day immediately preceding March 15, 2026,

holders of the Convertible Notes may convert all or a portion of their notes at any time. Upon conversion, we will pay cash up to the aggregate principal amount of Convertible Notes to be converted and pay and/or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at our election, in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted.

On or after March 20, 2024 and prior to December 15, 2025, we may redeem for cash all or part of the Convertible Notes, at our option, if the last reported sales price of common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading days ending on, and including, the trading day immediately before the date we send the related notice of the redemption. The redemption price of each Convertible Notes to be redeemed will be the principal amount of such note, plus accrued and unpaid special interest, if any. Upon the occurrence of a fundamental change (as defined in the indenture governing the Convertible Notes), subject to a limited exception described in the indenture governing the Convertible Notes, holders may require us to repurchase all or a portion of their notes for cash at a price equal to plus accrued and unpaid special interest to, but not including, the fundamental change repurchase date (as defined in the indenture governing the Convertible Notes).

The Convertible Notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future unsubordinated debt and senior in right of payment to any future debt that is expressly subordinated in right of payment to the Convertible Notes. The Convertible Notes will be effectively subordinated to any of our existing and future secured debt to the extent of the assets securing such indebtedness. The Convertible Notes will be structurally subordinated to all existing debt and any future debt and any other liabilities of our subsidiaries.

Debt Maturities

The amount of required minimum principal payments on our debt in aggregate over the next five years is as follows:

Year Ending December 31,	Minimum Payments
In thousands
2021 (amount remaining at September 30, 2021)	$	—
2022	—
2023	—
2024	—
2025	—
Thereafter	460,000
Total minimum payments on debt	$	460,000

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

As part of our risk management strategy, we use derivative instruments to hedge certain foreign currency and interest rate exposures. Refer to Note 13: Shareholders' Equity and Note 14: Fair Value of Financial Instruments for additional disclosures on our derivative instruments.

The fair values of our derivative instruments are determined using the income approach and significant other observable inputs (and are classified as "Level 2" in the fair value hierarchy). We have used observable market inputs based on the type of derivative and the nature of the underlying instrument. The key inputs include interest rate yield curves (swap rates and futures) and foreign exchange spot and forward rates, all of which are available in an active market. We have utilized the mid-market pricing convention for these inputs. We include, as a discount to the derivative asset, the effect of our counterparty credit risk based on current published credit default swap rates when the net fair value of our derivative instruments is in a net asset position. We consider our own nonperformance risk when the net fair value of our derivative instruments is in a net liability position by discounting our derivative liabilities to reflect the potential credit risk to our counterparty through applying a current market indicative credit spread to all cash flows.

The fair values of our derivative instruments were as follows:

		Fair Value
Derivatives Assets	Balance Sheet Location	September 30, 2021		December 31, 2020
Derivatives designated as hedging instruments under ASC 815-20		In thousands
Foreign exchange options	Other current assets	$	329	$	—
Derivatives not designated as hedging instruments under ASC 815-20
Foreign exchange forward contracts	Other current assets	49		52
Total asset derivatives		$	378	$	52
Derivatives Liabilities
Derivatives designated as hedging instruments under ASC 815-20
Interest rate swap contracts	Other current liabilities	$	—	$	1,025
Interest rate swap contracts	Other long-term obligations	—		957
Cross currency swap contract	Other current liabilities	—		526
Derivatives not designated as hedging instruments under ASC 815-20
Foreign exchange forward contracts	Other current liabilities	166		128
Total liability derivatives		$	166	$	2,636

The changes in accumulated other comprehensive income (loss) (AOCI), net of tax, for our derivative and nonderivative hedging instruments designated as hedging instruments, net of tax, were as follows:

In thousands	2021		2020
Net unrealized loss on hedging instruments at January 1,	$	(16,001)	$	(15,103)
Unrealized gain (loss) on derivative instruments	1,085		(4,727)
Realized (gains) losses reclassified into net income (loss)	733		2,570
Net unrealized loss on hedging instruments at September 30,	$	(14,183)	$	(17,260)

Reclassification of amounts related to hedging instruments are included in interest expense in the Consolidated Statements of Operations. Included in the net unrealized gain (loss) on hedging instruments at September 30, 2021 and 2020 is a loss of $14.4 million, net of tax, related to our nonderivative net investment hedge, which terminated in 2011. This loss on our net investment hedge will remain in AOCI until earnings are impacted by a sale or liquidation of the associated foreign operation.

A summary of the effect of netting arrangements on our financial position related to the offsetting of our recognized derivative assets and liabilities under master netting arrangements or similar agreements is as follows:

Offsetting of Derivative Assets	Gross Amounts of Recognized Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the Consolidated Balance Sheets
In thousands			Derivative Financial Instruments		Cash Collateral Received		Net Amount
September 30, 2021	$	378	$	(28)	$	—	$	350
December 31, 2020	52		(52)		—		—

Offsetting of Derivative Liabilities	Gross Amounts of Recognized Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the Consolidated Balance Sheets
In thousands			Derivative Financial Instruments		Cash Collateral Pledged		Net Amount
September 30, 2021	$	166	$	(28)	$	—	$	138
December 31, 2020	2,636		(52)		—		2,584

Our derivative assets and liabilities subject to netting arrangements include foreign exchange forward and interest rate contracts with four counterparties at September 30, 2021 and six counterparties at December 31, 2020. No derivative asset or liability balance with any of our counterparties was individually significant at September 30, 2021 or December 31, 2020. Our derivative contracts with each of these counterparties exist under agreements that provide for the net settlement of all contracts through a single payment in a single currency in the event of default. We have no pledges of cash collateral against our

obligations, and we have not received pledges of cash collateral from our counterparties under the associated derivative contracts.

Cash Flow Hedges

As a result of our floating rate debt under our current credit facility, we are exposed to variability in our cash flows from changes in the applicable interest rate index. We enter into interest rate caps and swaps to reduce the variability of cash flows from increases in the LIBOR-based borrowing rates on our floating rate credit facility. These instruments do not protect us from changes to the applicable margin under our credit facility. On August 12, 2021, the term loan under the credit facility was fully repaid. At September 30, 2021, we have no LIBOR-based debt.

In October 2015, we entered into one interest rate swap, which was effective from August 31, 2016 and expired on June 23, 2020, to convert $214 million of our LIBOR-based debt from a floating LIBOR interest rate to a fixed interest rate of 1.42% (excluding the applicable margin on the debt). The notional balance amortized to maturity at the same rate as required minimum payments on the outstanding term loan. This cash flow hedge was expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk through the term of the hedge. Consequently, effective changes in the fair value of the interest rate swap were recognized as a component of other comprehensive income (loss) (OCI) and recognized in earnings when the hedged item affected earnings. The amounts paid or received on the hedge were recognized as adjustment to interest expense.

In March 2020, we entered into one interest rate swap, which was effective from June 30, 2020 to June 30, 2023, and converted $240 million of our LIBOR-based debt from a floating LIBOR interest rate to a fixed interest rate of 0.617% (excluding the applicable margin). The notional balance amortized to maturity at the same rate of originally required amortizations on our outstanding term loan. Changes in the fair value of the interest rate swap were recognized as a component of OCI and recognized in earnings when the hedged item affected earnings. The amounts paid or received on the hedge was recognized as an adjustment to interest expense along with the earnings effect of the hedged item. On March 17, 2021 following the paydown of the term loan within the 2018 credit facility, we terminated the interest rate swap, and paid a fee of $1.7 million to settle it, since the likelihood of LIBOR-based interest payments was no longer probable of occurring.

In April 2018, we entered into one cross-currency swap, which converted $56.0 million of floating LIBOR-based U.S. dollar- denominated debt into 1.38% fixed rate euro-denominated debt. This cross-currency swap matured on April 30, 2021 and mitigated the risk associated with fluctuations in currency rates impacting cash flows related to U.S. dollar-denominated debt in a euro functional currency entity. Changes in the fair value of the cross-currency swap were recognized as a component of OCI and were recognized in earnings when the hedged item affected earnings. The amounts paid or received on the hedge were recognized as an adjustment to interest expense along with the earnings effect of the hedged item.

As a result of our forecasted inventory purchases in a non-functional currency, we are exposed to foreign exchange risk. We hedge portions of these purchases. During February 2021, we entered into foreign exchange option contracts for a total notional amount of $77 million at a cost of $1.1 million. The contracts mature ratably through the year with final maturity in October 2021. Changes in the fair values of the option contracts are recognized as a component of OCI and are recognized in product cost of revenues when the hedged item affects earnings.

The before-tax effects of our accounting for derivative instruments designated as hedges on AOCI were as follows:

Derivatives in ASC 815-20 Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivative				Gain (Loss) Reclassified from  AOCI into Income
					Location	Amount
In thousands	2021		2020			2021		2020
Three Months Ended September 30,
Interest rate swap contracts	$	—	$	(302)	Interest expense	$	—	$	(274)
Foreign exchange options	478		(252)		Product cost of revenues	(32)		(450)
Cross currency swap contract	—		(2,326)		Interest expense	—		88
Cross currency swap contract	—		—		Other income (expense), net	—		(2,242)
Nine Months Ended September 30,
Interest rate swap contract	$	73	$	(2,818)	Interest expense	$	(229)	$	(467)
Interest rate swap contract	—		—		Other income (expense), net	(1,681)		—
Interest rate cap contracts	—		782		Interest expense	—		392
Foreign exchange options	367		(1,221)		Product cost of revenues	(40)		(612)
Cross currency swap contract	669		(1,969)		Interest expense	94		537
Cross currency swap contract	—		—		Other income (expense), net	656		(2,438)

Derivatives Not Designated as Hedging Relationships

We are also exposed to foreign exchange risk when we enter into non-functional currency transactions, both intercompany and third party. At each period-end, non-functional currency monetary assets and liabilities are revalued with the change recognized within other income (expense) in our Consolidated Statements of Operations. We enter into monthly foreign exchange forward contracts, which are not designated for hedge accounting, with the intent to reduce earnings volatility associated with currency exposures. As of September 30, 2021, a total of 37 contracts were offsetting our exposures from the euro, pound sterling, Indonesian rupiah, Canadian dollar, Australian dollar and various other currencies, with notional amounts ranging from $150,000 to $56.4 million.

The effect of our derivative instruments not designated as hedges on the Consolidated Statements of Operations was as follows:

Derivatives Not Designated as Hedging Instrument under ASC 815-20	Location	Gain (Loss) Recognized on Derivatives in Other Income (Expense)
In thousands		2021		2020
Three Months Ended September 30,
Foreign exchange forward contracts	Other income (expense), net	$	673	$	(1,646)
Nine Months Ended September 30,
Foreign exchange forward contracts	Other income (expense), net	$	210	$	(1,056)

We will continue to monitor and assess our interest rate and foreign exchange risk and may institute additional derivative instruments to manage such risk in the future.

Convertible Note Hedge Transactions

We paid an aggregate amount of $84.1 million for the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Convertible Notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the Convertible Notes, at a strike price of approximately $126.00, subject to customary adjustments. The Convertible Note Hedge Transactions will expire upon the maturity of the Convertible Notes, subject to earlier exercise or termination. The Convertible Note Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of the Convertible Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the Convertible Note Hedge Transactions, is greater than the strike price of those Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions meet the

criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore the transactions are not revalued after their issuance.

We made a tax election to integrate the Convertible Notes and the call options. We are retaining the identification statements in our books and records, together with a schedule providing the accruals on the synthetic debt instruments. The accounting impact of this tax election makes the call options deductible as original issue discount for tax purposes over the term of the Convertible Note, and results in a $20.6 million deferred tax asset recognized through equity.

Warrant Transactions

In addition, concurrently with entering into the Convertible Note Hedge Transactions, we separately entered into privately-negotiated Warrant Transactions (the Warrant Transactions), whereby we sold to the Counterparties warrants to acquire, collectively, subject to anti-dilution adjustments, 3.7 million shares of our common stock at an initial strike price of $180.00 per share, which represents a premium of 100% over the public offering price in the common stock issuance. We received aggregate proceeds of $45.3 million from the Warrant Transactions with the Counterparties, with such proceeds partially offsetting the costs of entering into the Convertible Note Hedge Transactions. The warrants expire in June 2026. If the market value per share of our common stock, as measured under the Warrants Transactions, exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless we elect, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, therefore the warrants are not revalued after issuance.

XML

Defined Benefit Pension Plans

9 Months Ended

Sep. 30, 2021

Retirement Benefits [Abstract]

Defined Benefit Pension Plans

Defined Benefit Pension Plans

We sponsor both funded and unfunded defined benefit pension plans offering death and disability, retirement, and special termination benefits for certain of our international employees, primarily in Germany, France, Indonesia, India, and Italy. The defined benefit obligation is calculated annually by using the projected unit credit method. The measurement date for the pension plans was December 31, 2020.

Amounts recognized on the Consolidated Balance Sheets consist of:

In thousands	September 30, 2021		December 31, 2020
Liabilities
Current portion of pension benefit obligation in wages and benefits payable	$	3,822	$	3,069
Long-term portion of pension benefit obligation	114,771		119,457
Pension benefit obligation, net	$	118,593	$	122,526

Our asset investment strategy focuses on maintaining a portfolio using primarily insurance funds, which are accounted for as investments and measured at fair value, in order to achieve our long-term investment objectives on a risk-adjusted basis. Our general funding policy for these qualified pension plans is to contribute amounts sufficient to satisfy regulatory funding standards of the respective countries for each plan.

Net periodic pension benefit cost for our plans include the following components:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Service cost	$	1,125	$	1,007	$	3,376	$	3,000
Interest cost	345		434		1,046		1,364
Expected return on plan assets	(87)		(85)		(264)		(365)
Amortization of prior service costs	17		17		51		49
Amortization of actuarial net loss	681		482		2,070		1,390
Settlement	—		286		—		286
Net periodic benefit cost	$	2,081	$	2,141	$	6,279	$	5,724

The components of net periodic benefit cost, other than the service cost component, are included in total other income (expense) on the Consolidated Statements of Operations.

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

We grant stock-based compensation awards, including stock options, restricted stock units, phantom stock, and unrestricted stock units, under the Second Amended and Restated 2010 Stock Incentive Plan (Stock Incentive Plan). In the Stock Incentive Plan, we have 12,623,538 shares of common stock reserved and authorized for issuance subject to stock splits, dividends, and other similar events. At September 30, 2021, 5,346,245 shares were available for grant. We issue new shares of common stock upon the exercise of stock options or when vesting conditions on restricted stock units are fully satisfied. These shares are subject to a fungible share provision such that the authorized share available for grant is reduced by (i) one share for every one share subject to a stock option or share appreciation right granted under the Plan and (ii) 1.7 shares for every one share of common stock that was subject to an award other than an option or share appreciation right.

We also periodically award phantom stock units, which are settled in cash upon vesting and accounted for as liability-based awards, with no impact to the shares available for grant.

In addition, we maintain the Employee Stock Purchase Plan (ESPP), for which 151,221 shares of common stock were available for future issuance at September 30, 2021.

ESPP activity and stock-based grants other than stock options and restricted stock units were not significant for the three and nine months ended September 30, 2021 and 2020.

Stock-Based Compensation Expense

Total stock-based compensation expense and the related tax benefit were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Stock options	$	344	$	452	$	1,055	$	1,445
Restricted stock units	5,104		4,399		16,546		18,575
Unrestricted stock awards	217		206		650		618
Phantom stock units	519		582		2,861		2,075
Total stock-based compensation	$	6,184	$	5,639	$	21,112	$	22,713
Related tax benefit	$	1,159	$	1,070	$	3,840	$	4,257

Stock Options

A summary of our stock option activity is as follows:

	Shares	Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value		Weighted Average Grant Date Fair Value
	(in thousands)			(years)	(in thousands)
Outstanding, January 1, 2020	458	$	56.38	7.0	$	12,641
Granted	80	84.38					$	26.21
Exercised	(49)	50.90			1,189
Forfeited	(5)	83.80
Outstanding, September 30, 2020	484	$	61.30	7.0	$	3,816
Outstanding, January 1, 2021	433	$	61.95	6.9	$	14,697
Granted	—						$	—
Exercised	(34)	67.21			1,215
Forfeited	(6)	83.33
Outstanding, September 30, 2021	393	$	61.18	6.1	$	6,496
Exercisable, September 30, 2021	317	$	56.51	5.6	$	6,361

At September 30, 2021, total unrecognized stock-based compensation expense related to nonvested stock options was $1.4 million, which is expected to be recognized over a weighted average period of approximately 1.3 years.

The weighted average assumptions used to estimate the fair value of stock options granted and the resulting weighted average fair value are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Expected volatility	—	%	41.5	%	—	%	32.1	%
Risk-free interest rate	—	%	0.3	%	—	%	1.3	%
Expected term (years)	N/A		5.3		N/A		5.3

There were no employee stock options granted for the three and nine months ended September 30, 2021.

Restricted Stock Units

The following table summarizes restricted stock unit activity:

In thousands, except fair value	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Outstanding, January 1, 2020	684
Granted	209	$	83.34
Released (1)	(338)			$	21,947
Forfeited	(23)
Outstanding, September 30, 2020	532
Outstanding, January 1, 2021	544	$	71.79
Granted	212	97.96
Released (1)	(288)	70.20		$	28,494
Forfeited	(46)	77.79
Outstanding, September 30, 2021	422	85.75
Vested but not released, September 30, 2021	10			$	733

(1)     Shares released is presented as gross shares and does not reflect shares withheld by us for employee payroll tax obligations.

At September 30, 2021, total unrecognized compensation expense on restricted stock units was $30.9 million, which is expected to be recognized over a weighted average period of approximately 1.8 years.

The weighted average assumptions used to estimate the fair value of performance-based restricted stock units granted with a service and market condition and the resulting weighted average fair value are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Expected volatility	—		%	52.6		%	50.5		%	38.2		%
Risk-free interest rate	—		%	0.2		%	0.2		%	1.5		%
Expected term (years)	N/A			2.3			2.9			1.8
Weighted average fair value	$	—		$	61.45		$	113.75		$	93.05

There were no performance-based restricted stock units granted for the three months ended September 30, 2021.

XML

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

We determine the interim tax benefit (provision) by applying an estimate of the annual effective tax rate to the year-to-date pretax book income (loss) and adjusting for discrete items during the reporting period, if any. Tax jurisdictions with losses for which tax benefits cannot be realized are excluded.

Our tax rate for the three and nine months ended September 30, 2021 of 902% and (39)%, respectively, differed from the federal statutory rate of 21% due to losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets, the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to stock-based compensation, uncertain tax positions, and reserves recognized on deferred purchase price receivables.

Our tax rate for the three and nine months ended September 30, 2020 of 32% and 0%, respectively, differed from the federal statutory rate of 21% primarily due to a significant loss recognized in the second quarter for the divestiture of the majority of our Latin American business activities. This loss was recognized for tax as a discrete item and resulted in no tax benefit. A discrete tax benefit was recognized in the third quarter for $10.1 million related to the release of a valuation allowance on U.S. foreign tax credit deferred tax assets. This release was triggered by the carryforward of tax attributes due to the filing of amended tax returns in the third quarter. Other rate drivers included losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to stock-based compensation, and uncertain tax positions.

We classify interest expense and penalties related to unrecognized tax liabilities and interest income on tax overpayments as components of income tax expense. The net interest and penalties expense amounts recognized were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Net interest and penalties expense	$	195	$	(198)	$	153	$	422

Accrued interest and penalties recognized were as follows:

In thousands	September 30, 2021		December 31, 2020
Accrued interest	$	3,663	$	3,432
Accrued penalties	1,405		1,645

Unrecognized tax benefits related to uncertain tax positions and the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate were as follows:

In thousands	September 30, 2021		December 31, 2020
Unrecognized tax benefits related to uncertain tax positions	$	134,110	$	135,910
The amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate	132,992		134,473

At September 30, 2021, we are under examination by certain tax authorities. We believe we have appropriately accrued for the expected outcome of all tax matters and do not currently anticipate that the ultimate resolution of these examinations will have a material adverse effect on our financial condition, future results of operations, or cash flows.

Based upon the timing and outcome of examinations, litigation, the impact of legislative, regulatory, and judicial developments, and the impact of these items on the statute of limitations, it is reasonably possible that the related unrecognized tax benefits could change from those recognized within the next twelve months. However, at this time, an estimate of the range of reasonably possible adjustments to the balance of unrecognized tax benefits cannot be made.

We file income tax returns in various jurisdictions. The material jurisdictions where we are subject to examination include, among others, the United States, France, Germany, Italy, Indonesia, and the United Kingdom.

On March 27, 2020, the U.S. Federal government passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act to provide economic relief from COVID-19. The CARES Act contains significant business tax provisions, which the Company has evaluated and determined will not have a material impact on the Company's financial statements or related disclosures.

The CARES Act also provides employer payroll tax credits for wages paid to employees who are unable to work during the COVID-19 outbreak and options to defer payroll tax payments. The Company has elected to defer remittances of payroll and other taxes into the future as provided for under the Act.

On October 8, 2021 the G20/OECD Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") published a statement on the components of global tax reform agreed to by most member countries. The key components would allocate a portion of profits of the largest businesses amongst their markets, curtail new digital services taxes, and introduce a new global minimum tax of 15%. These components do not result in any financial impact until enacted, which is not currently expected until 2023. The Company is monitoring developments and additional details as they are released to determine the impacts these new components will have on our business.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Guarantees and Indemnifications

We are often required to obtain standby letters of credit (LOCs) or bonds in support of our obligations for customer contracts. These standby LOCs or bonds typically provide a guarantee to the customer for our future performance, which usually covers the installation phase of a contract and may, on occasion, cover the operations and maintenance phase of outsourcing contracts.

Our available lines of credit, outstanding standby LOCs, and bonds were as follows:

In thousands	September 30, 2021		December 31, 2020
Credit facility
Multicurrency revolving line of credit	$	500,000	$	500,000
Standby LOCs issued and outstanding	(64,448)		(64,948)
Net available for additional borrowings under the multicurrency revolving line of credit	$	435,552	$	435,052
Net available for additional standby LOCs under sub-facility	$	235,552	$	235,052
Unsecured multicurrency revolving lines of credit with various financial institutions
Multicurrency revolving lines of credit	$	97,113	$	99,201
Standby LOCs issued and outstanding	(24,245)		(24,966)
Short-term borrowings	(8,764)		—
Net available for additional borrowings and LOCs	$	64,104	$	74,235
Unsecured surety bonds in force	$	169,293	$	162,912

In the event any such standby LOC or bond is called, we would be obligated to reimburse the issuer of the standby LOC or bond; however, as of November 4, 2021, we do not believe any outstanding standby LOCs or bonds will be called.

We generally provide an indemnification related to the infringement of any patent, copyright, trademark, or other intellectual property right on software or equipment within our sales contracts, which indemnifies the customer from, and pays the resulting costs, damages, and attorney's fees awarded against a customer with respect to, such a claim provided that (a) the customer promptly notifies us in writing of the claim and (b) we have the sole control of the defense and all related settlement negotiations. We may also provide an indemnification to our customers for third-party claims resulting from damages caused by the negligence or willful misconduct of our employees/agents in connection with the performance of certain contracts. The terms of our indemnifications generally do not limit the maximum potential payments. It is not possible to predict the maximum potential amount of future payments under these or similar agreements.

Legal Matters

We are subject to various legal proceedings and claims of which the outcomes are subject to significant uncertainty. Our policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. A determination of the amount of the liability required, if any, for these contingencies is made after an analysis of each known issue. A liability would be recognized and charged to operating expense when we determine that a loss is probable and the amount can be reasonably estimated. Additionally, we disclose contingencies for which a material loss is reasonably possible, but not probable.

Warranty

A summary of the warranty accrual account activity is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Beginning balance	$	36,210	$	44,757	$	41,390	$	53,242
New product warranties	1,925		785		3,611		2,855
Other adjustments and expirations, net	(975)		1,643		631		5,436
Claims activity	(2,156)		(5,044)		(10,040)		(19,349)
Effect of change in exchange rates	(317)		946		(905)		903
Ending balance	34,687		43,087		34,687		43,087
Less: current portion of warranty	18,089		32,118		18,089		32,118
Long-term warranty	$	16,598	$	10,969	$	16,598	$	10,969

Total warranty expense is classified within cost of revenues and consists of new product warranties issued, costs related to insurance and supplier recoveries, other changes and adjustments to warranties, and customer claims. Warranty expense was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Total warranty expense	$	950	$	2,428	$	4,242	$	8,321

Warranty expense decreased during the nine months ended September 30, 2021 compared with the same period in 2020. The lower costs in 2021 are primarily the result of incremental specific reserves recognized in 2020, including $1.7 million for electric and gas products in Europe, Middle East, and Africa (EMEA) Device Solutions and $1.1 million for electric and water products in North America (NAM) Networked Solutions.

XML

Restructuring (Notes)

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

Restructuring

2020 Projects

In September 2020, our Board of Directors approved a restructuring plan (the 2020 Projects), which includes activities that continue our efforts to optimize our global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are scheduled to be substantially complete by the end of 2022. Many of the affected employees are represented by unions or works councils, which require consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of charges, total expected charges, cost recognized, and planned savings in certain jurisdictions.

In the third quarter of 2021, expected remaining costs to be recognized were reduced by $13.0 million due to the removal of a previously planned non-cash cumulative translation adjustment charge, resulting from our recent reassessment of the legal entity and its related operations.

The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2020 Projects were as follows:

In thousands	Total Expected Costs at September 30, 2021		Costs Recognized in Prior Periods		Costs Recognized During the Nine Months Ended  September 30, 2021		Expected Remaining Costs to be Recognized at September 30, 2021
Employee severance costs	$	32,583	$	36,225	$	(3,642)	$	—
Asset impairments & net loss (gain) on sale or disposal	6,893		6,944		(51)		—
Other restructuring costs	4,546		63		1,920		2,563
Total	$	44,022	$	43,232	$	(1,773)	$	2,563

2018 Projects

In February 2018, our Board of Directors approved a restructuring plan (the 2018 Projects) to continue our efforts to optimize our global supply chain and manufacturing operations, research and development, and sales and marketing organizations. Actions under the 2018 Projects were substantially completed as of the end of 2020.

During the nine months ended September 30, 2021, we incurred additional legal costs related to a facility closure, partially offset by reduced severance costs.

The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2018 Projects were as follows:

In thousands	Total Expected Costs at September 30, 2021		Costs Recognized in Prior Periods		Costs Recognized During the Nine Months Ended  September 30, 2021		Expected Remaining Costs to be Recognized at September 30, 2021
Employee severance costs	$	59,229	$	63,173	$	(3,944)	$	—
Asset impairments & net loss (gain) on sale or disposal	3,788		2,786		1,002		—
Other restructuring costs	19,752		15,217		3,885		650
Total	$	82,769	$	81,176	$	943	$	650

The following table summarizes the activity within the restructuring-related balance sheet accounts for the 2020 Projects and 2018 Projects during the nine months ended September 30, 2021:

In thousands	Accrued Employee Severance		Asset Impairments & Net Loss (Gain) on Sale or Disposal		Other Accrued Costs		Total
Beginning balance, January 1, 2021	$	70,005	$	—	$	2,621	$	72,626
Costs charged to expense	(7,586)		951		5,805		(830)
Cash payments	(16,431)		—		(4,725)		(21,156)
Cash receipts	—		2,007		—		2,007
Net assets disposed and impaired	—		(2,958)		—		(2,958)
Effect of change in exchange rates	(2,377)		—		(47)		(2,424)
Ending balance, September 30, 2021	$	43,611	$	—	$	3,654	$	47,265

Asset impairments are determined at the asset group level. Revenues and net operating income from the activities we have exited or will exit under the restructuring projects are not material to our operating segments or consolidated results.

Other restructuring costs include expenses for employee relocation, professional fees associated with employee severance, costs to exit the facilities once the operations in those facilities have ceased, and other costs associated with the liquidation of any affected legal entities. Costs associated with restructuring activities are generally presented in the Consolidated Statements of Operations as restructuring, except for certain costs associated with inventory write-downs, which are classified within cost of revenues, and accelerated depreciation expense, which is recognized according to the use of the asset. Restructuring expense is part of the Corporate unallocated segment and does not impact the results of our operating segments.

The current portions of restructuring liabilities were $28.7 million and $31.7 million as of September 30, 2021 and December 31, 2020 and are classified within other current liabilities on the Consolidated Balance Sheets. The long-term portions of restructuring liabilities were $18.6 million and $40.9 million as of September 30, 2021 and December 31, 2020. The long-term portions of restructuring liabilities are classified within other long-term obligations on the Consolidated Balance Sheet and includes severance accruals and facility exit costs.

XML

Shareholders' Equity

9 Months Ended

Sep. 30, 2021

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Preferred Stock

We have authorized the issuance of 10 million shares of preferred stock with no par value. In the event of a liquidation, dissolution, or winding up of the affairs of the corporation, whether voluntary or involuntary, the holders of any outstanding preferred stock would be entitled to be paid a preferential amount per share to be determined by the Board of Directors prior to any payment to holders of common stock. There was no preferred stock issued or outstanding at September 30, 2021 or December 31, 2020.

Issuance of Common Stock

On March 12, 2021, we closed the sale of 4,472,222 shares of our common stock in a public offering, resulting in net proceeds to us of approximately $389.4 million, after deducting underwriters’ discounts of the offering.

Convertible Note Hedge Transactions

We paid an aggregate amount of $84.1 million for the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the Convertible Notes, approximately 3.7 million shares of our common stock, the same number of shares initially underlying the Convertible Notes, at a strike price of approximately $126.00, subject to customary adjustments. The Convertible Note Hedge Transactions will expire upon the maturity of the Convertible Notes, subject to earlier exercise or termination. The Convertible Note Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of our Convertible Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted notes, as the case may be, in the event the price per share of our common stock, as measured under the terms of the Convertible Note Hedge Transactions, is greater than the strike price of the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, therefore the Convertible Note Hedge Transactions are not revalued after their issuance.

We made a tax election to integrate the Convertible Notes and the call options. We are retaining the identification statements in our books and records, together with a schedule providing the accruals on the synthetic debt instruments. The accounting impact of this tax election makes the call options deductible as original issue discount for tax purposes over the term of the Convertible Note, and results in a $20.6 million deferred tax asset recognized through equity.

Warrant Transactions

In addition, concurrently with entering into the Convertible Note Hedge Transactions, we separately entered into privately-negotiated Warrant Transactions, whereby we sold to the Counterparties warrants to acquire, collectively, subject to anti-dilution adjustments, 3.7 million shares of our common stock at an initial strike price of $180.00 per share, which represents a premium of 100% over the public offering price in the common stock issuance. We received aggregate proceeds of $45.3 million from the Warrant Transactions with the Counterparties, with such proceeds partially offsetting the costs of entering into the Convertible Note Hedge Transactions. The warrants expire in June 2026. If the market value per share of our common stock, as measured under the Warrant Transactions, exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless we elect, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore the warrants are not revalued after issuance.

Accumulated Other Comprehensive Income (Loss)

The changes in the components of AOCI, net of tax, were as follows:

In thousands	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) on Derivative Instruments		Net Unrealized Gain (Loss) on Nonderivative Instruments		Pension Benefit Obligation Adjustments		Accumulated Other Comprehensive Income (Loss)
Balances at January 1, 2020	$	(157,999)	$	(723)	$	(14,380)	$	(31,570)	$	(204,672)
OCI before reclassifications	(147)		(4,727)		—		(1,151)		(6,025)
Amounts reclassified from AOCI	52,074		2,570		—		2,040		56,684
Total other comprehensive income (loss)	51,927		(2,157)		—		889		50,659
Balances at September 30, 2020	$	(106,072)	$	(2,880)	$	(14,380)	$	(30,681)	$	(154,013)
Balances at January 1, 2021	$	(84,843)	$	(1,621)	$	(14,380)	$	(37,682)	$	(138,526)
OCI before reclassifications	(17,118)		1,085		—		—		(16,033)
Amounts reclassified from AOCI	—		733		—		2,087		2,820
Total other comprehensive income (loss)	(17,118)		1,818		—		2,087		(13,213)
Balances at September 30, 2021	$	(101,961)	$	197	$	(14,380)	$	(35,595)	$	(151,739)

The before-tax, income tax (provision) benefit, and net-of-tax amounts related to each component of OCI were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Before-tax amount
Foreign currency translation adjustment	$	(7,827)	$	15,521	$	(16,941)	$	(387)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478		(2,887)		1,103		(5,228)
Net hedging (gain) loss reclassified to net income (loss)	32		2,879		1,200		2,588
Net unrealized gain (loss) on defined benefit plans	—		(893)		—		(812)
Net defined benefit plan (gain) loss reclassified to net income (loss)	698		499		2,121		1,439
Total other comprehensive income (loss), before tax	$	(6,619)	$	15,105	$	(12,517)	$	49,674
Tax (provision) benefit
Foreign currency translation adjustment	$	63	$	(1,533)	$	(177)	$	240
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		—		—		—
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	—		74		(18)		501
Net hedging (gain) loss reclassified to net income (loss)	—		(67)		(467)		(18)
Net unrealized gain (loss) on defined benefit plans	—		(341)		—		(339)
Net defined benefit plan (gain) loss reclassified to net income (loss)	(11)		576		(34)		601
Total other comprehensive income (loss) tax (provision) benefit	$	52	$	(1,291)	$	(696)	$	985
Net-of-tax amount
Foreign currency translation adjustment	$	(7,764)	$	13,988	$	(17,118)	$	(147)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478		(2,813)		1,085		(4,727)
Net hedging (gain) loss reclassified to net income (loss)	32		2,812		733		2,570
Net unrealized gain (loss) on defined benefit plans	—		(1,234)		—		(1,151)
Net defined benefit plan (gain) loss reclassified to net income (loss)	687		1,075		2,087		2,040
Total other comprehensive income (loss), net of tax	$	(6,567)	$	13,814	$	(13,213)	$	50,659

XML

Fair Values of Financial Instruments

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Fair Values of Financial Instruments

The fair values at September 30, 2021 and December 31, 2020 do not reflect subsequent changes in the economy, interest rates, tax rates, and other variables that may affect the determination of fair value.

	September 30, 2021				December 31, 2020
In thousands	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Credit facility
USD denominated term loan	$	—	$	—	$	532,625	$	520,347
Multicurrency revolving line of credit	—		—		—		—
Senior notes	—		—		388,311		410,000
Convertible notes	449,629		434,130		—		—

The following methods and assumptions were used in estimating fair values:

Cash and cash equivalents: Due to the liquid nature of these instruments, the carrying amount approximates fair value (Level 1).

Credit Facility - term loan and multicurrency revolving line of credit: The term loan and the revolver are not traded publicly. The fair values, which are determined based upon a hypothetical market participant, are calculated using a discounted cash flow model with Level 2 inputs, including estimates of incremental borrowing rates for debt with similar terms, maturities, and credit profiles. Refer to Note 6: Debt for a further discussion of our debt.

Senior Notes and Convertible Notes: The Senior Notes and Convertible Notes are not registered securities nor listed on any securities exchange but may be actively traded by qualified institutional buyers. The fair value is estimated using Level 1 inputs, as it is based on quoted prices for these instruments in active markets.

Derivatives: See Note 7: Derivative Financial Instruments for a description of our methods and assumptions in determining the fair value of our derivatives, which were determined using Level 2 inputs. Each derivative asset and liability has a carrying value equal to fair value.

XML

Segment Information

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Segment Information

We operate under the Itron brand worldwide and manage and report under three operating segments: Device Solutions, Networked Solutions, and Outcomes.

We have three GAAP measures of segment performance: revenues, gross profit (gross margin), and operating income (operating margin). Intersegment revenues are minimal. Certain operating expenses are allocated to the operating segments based upon internally established allocation methodologies. Corporate operating expenses, interest income, interest expense, other income (expense), and the income tax provision (benefit) are neither allocated to the segments, nor are they included in the measure of segment performance. In addition, we allocate only certain production assets and intangible assets to our operating segments. We do not manage the performance of the segments on a balance sheet basis.

Segment Products

Device Solutions – This segment primarily includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with our broader Itron systems, i.e., hardware-based products not part of a complete end-to-end solution. Examples from the Device Solutions portfolio include: standard endpoints that are shipped without Itron communications, such as our standard gas, electricity, and water meters for a variety of global markets and adhering to regulations and standards within those markets, as well as our heat and allocation products; communicating meters that are not a part of an Itron end-to-end solution such as Smart Spec meters and the implementation and installation of non-communicating devices, such as gas regulators.

Networked Solutions – This segment primarily includes a combination of communicating devices (e.g., smart meters, modules, endpoints, and sensors), network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. Networked Solutions includes products and software for the implementation, installation, and management of communicating devices and data networks. Examples from the Networked

Solutions portfolio include: communicating measurement, control, or sensing endpoints such as our Itron® OpenWay® Centron and Riva meters, Itron traditional ERT® technology, Intelis smart gas meters, 500G gas communication modules, 500W water communication modules; GenX networking infrastructure products and network interface cards (NICs); Smart City control and management software; Distribution Automation bridge devices, and specific network control and management software applications. The Industrial Internet of Things (IIoT) solutions supported by this segment include automated meter reading (AMR), advanced metering infrastructure (AMI), smart grid and distribution automation, smart street lighting and an ever-growing set of smart city applications such as traffic management, smart parking, air quality monitoring, electric vehicle charging, customer engagement, digital signage, acoustic (e.g., gunshot) detection, and leak detection and mitigation for both gas and water systems. Our IIoT platform allows all of these industry and smart city applications to be run and managed on a single, multi-purpose network.

Outcomes – This segment primarily includes our value-added, enhanced software and services in which we manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. Outcomes places an emphasis on delivering to Itron customers high-value, turn-key, digital experiences by leveraging the footprint of our Device Solutions and Networked Solutions segments. The revenues from these offerings are primarily recurring in nature and would include any direct management of Device Solutions, Networked Solutions, and other products on behalf of our end customers. Examples from the Outcomes portfolio include: our meter data management and analytics offerings; our managed service solutions including Network-as-a-Service (NaaS) and Platform-as-a-Service (PaaS), forecasting software and services; our Distributed Intelligence suite of applications and services; and any consulting-based engagement. Within the Outcomes segment, we also identify new business models, including performance-based contracting, to drive broader portfolio offerings across utilities and cities.

Revenues, gross profit, and operating income associated with our operating segments were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Product revenues
Device Solutions	$	149,830	$	174,039	$	480,808	$	501,157
Networked Solutions	242,527		282,677		736,397		898,465
Outcomes	18,590		13,942		48,265		38,158
Total Company	$	410,947	$	470,658	$	1,265,470	$	1,437,780
Service revenues
Device Solutions	$	2,404	$	2,089	$	7,174	$	6,415
Networked Solutions	31,971		23,982		91,473		73,519
Outcomes	41,627		43,455		131,818		130,479
Total Company	$	76,002	$	69,526	$	230,465	$	210,413
Total revenues
Device Solutions	$	152,234	$	176,128	$	487,982	$	507,572
Networked Solutions	274,498		306,659		827,870		971,984
Outcomes	60,217		57,397		180,083		168,637
Total Company	$	486,949	$	540,184	$	1,495,935	$	1,648,193
Gross profit
Device Solutions	$	22,480	$	20,528	$	85,228	$	64,843
Networked Solutions	89,915		102,295		298,627		332,368
Outcomes	22,568		20,428		68,027		56,123
Total Company	$	134,963	$	143,251	$	451,882	$	453,334
Operating income (loss)
Device Solutions	$	12,095	$	11,017	$	53,784	$	28,095
Networked Solutions	61,150		71,404		205,071		237,466
Outcomes	11,774		12,044		34,647		29,468
Corporate unallocated	(80,856)		(118,445)		(265,331)		(338,026)
Total Company	4,163		(23,980)		28,171		(42,997)
Total other income (expense)	(4,037)		(13,063)		(42,465)		(35,020)
Income (loss) before income taxes	$	126	$	(37,043)	$	(14,294)	$	(78,017)

For the three and nine months ended September 30, 2021 and the three months ended September 30, 2020, no customer represented more than 10% of total company revenue. During the nine months ended September 30, 2020, one customer represented 11% of total company revenues.

Revenues by region were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
United States and Canada	$	323,784	$	354,841	$	957,993	$	1,110,028
Europe, Middle East, and Africa	126,548		156,810		437,768		431,593
Asia Pacific and Latin America(1)	36,617		28,533		100,174		106,572
Total Company	$	486,949	$	540,184	$	1,495,935	$	1,648,193

(1) On June 25, 2020, we sold our Latin American operations. We continue to sell into the region through an exclusive distributor.

Depreciation expense is allocated to the operating segments based upon each segment's use of the assets. All amortization expense is recognized within Corporate unallocated. Depreciation and amortization of intangible assets expense associated with our operating segments was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Device Solutions	$	5,911	$	5,926	$	17,708	$	18,423
Networked Solutions	4,274		4,377		12,801		12,447
Outcomes	1,068		1,327		3,431		4,132
Corporate unallocated	10,080		12,446		30,312		37,304
Total Company	$	21,333	$	24,076	$	64,252	$	72,306

XML

Revenue Recognition

9 Months Ended

Sep. 30, 2021

Revenues [Abstract]

Revenue Recognition

A summary of significant net changes in the contract assets and the contract liabilities balances during the period is as follows:

In thousands	Contract Liabilities, Less Contract Assets
Beginning balance, January 1, 2021	$	98,388
Revenues recognized from beginning contract liability	(95,096)
Cumulative catch-up adjustments	16,722
Increases due to amounts collected or due	215,549
Revenues recognized from current period increases	(136,122)
Other	(908)
Ending balance, September 30, 2021	$	98,533

On January 1, 2021, total contract assets were $49.8 million and total contract liabilities were $148.2 million. On September 30, 2021, total contract assets were $35.3 million and total contract liabilities were $133.8 million. The contract assets primarily relate to contracts that include a retention clause and allocations related to contracts with multiple performance obligations. The contract liabilities primarily relate to deferred revenue, such as extended warranty and maintenance cost. The cumulative catch-up adjustments relate to contract modifications, measure-of-progress changes, and changes in the estimate of the transaction price.

Transaction price allocated to the remaining performance obligations

Total transaction price allocated to remaining performance obligations represents committed but undelivered products and services for contracts and purchase orders at period end. Twelve-month remaining performance obligations represent the portion of total transaction price allocated to remaining performance obligations that we estimate will be recognized as revenue over the next 12 months. Total transaction price allocated to remaining performance obligations is not a complete measure of our future revenues as we also receive orders where the customer may have legal termination rights but are not likely to terminate.

Total transaction price allocated to remaining performance obligations related to contracts is approximately $1.3 billion for the next twelve months and approximately $1.5 billion for periods longer than 12 months. The total remaining performance obligations consist of product and service components. The service component relates primarily to maintenance agreements for which customers pay a full year's maintenance in advance, and service revenues are generally recognized over the service period. Total transaction price allocated to remaining performance obligations also includes our extended warranty contracts,

for which revenue is recognized over the warranty period, and hardware, which is recognized as units are delivered. The estimate of when remaining performance obligations will be recognized requires significant judgment.

Cost to obtain a contract and cost to fulfill a contract with a customer

Cost to obtain a contract and costs to fulfill a contract were capitalized and amortized using a systematic rational approach to align with the transfer of control of underlying contracts with customers. While amounts were capitalized, they are not material.

Disaggregation of revenue

Refer to Note 15: Segment Information and the Consolidated Statements of Operations for disclosure regarding the disaggregation of revenue into categories, which depict how revenue and cash flows are affected by economic factors. Specifically, our operating segments and geographical regions as disclosed, and categories for products, which include hardware and software and services, are presented.

XML

Sale of Business

9 Months Ended

Sep. 30, 2021

Discontinued Operations and Disposal Groups [Abstract]

Sale of Business

Latin America Divestiture

On June 25, 2020, we closed on the sale of five subsidiaries comprising our manufacturing and sales operations in Latin America to buyers led by Instalación Profesional y Tecnologías del Centro S.A. de C.V., a Mexican company doing business as Accell in Brazil (Accell), through the execution of various definitive stock purchase agreements. The sale of these Latin America-based operations is part of our continued strategy to improve profitability and focus on growing our Networked Solutions and Outcomes businesses in Latin America and throughout the world. We retained the intellectual property rights to our products sold in Latin America. As part of the transaction, we entered into an intellectual property license agreement whereby Accell pays a royalty on certain products manufactured by Accell using licensed Company intellectual property. In addition, Accell serves as the exclusive distributor for our Device Solutions, Networked Solutions, and Outcomes product and service offerings in Latin America.

The total sales price of $35.0 million included deferred payments of $21.1 million for working capital, which was to be paid in full by December 31, 2020, as evidenced by a promissory note, and the remainder in cash ($4.5 million) and other deferred consideration.

In January 2021, we agreed to extend the payment terms on the remaining outstanding working capital balance of $18.4 million. Accell had agreed to make monthly payments, including interest, through September 2022, under which we received full payments for January through March and partial payments in April and May (totaling $3.8 million including $0.7 million in interest). In July 2021, we received a revised payment plan for the remaining working capital note receivable, as well as the other deferred transaction receivables. Based on Accell's failure to make timely payments, continued requests to defer payments significantly beyond the original maturity of the working capital note, and the unfavorable impact of the COVID-19 pandemic on the Latin American markets, we determined to fully reserve the working capital and other deferred receivables, recognizing an additional loss on sale of business of $24.7 million during the second quarter of 2021.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2021

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Business Acquisition

Subsequent to September 30, 2021, we completed the acquisition of 100% of the shares of SELC Group Limited (SELC), a private limited company incorporated in Ireland, on October 12, 2021. SELC was previously a technology supplier to Itron. The acquisition provides value to Itron through the leverage of SELC’s streetlight controls technology coupled with Itron’s Smart Cities network and software platform. The acquisition will increase the pace of Smart City growth and innovation within Itron’s Networked Solutions business for the benefit of our customers. The purchase was funded through cash on hand and resulted in immaterial additions of intangible assets and goodwill.

Sale of Business

On November 2, 2021, Itron entered into a definitive securities and asset purchase agreement to sell certain of its Gas device manufacturing and business operations in Europe and North America to Dresser Utility Solutions (Dresser). The sale includes one German subsidiary – Itron GmbH along with its business operations, personnel, and the owned manufacturing facility in Karlsruhe; the business operations, personnel, and assets associated with the leased manufacturing facility in Argenteuil, France; and the business and manufacturing assets maintained at one of our contract manufacturers in North America. The sale of these assets and operations is part of Itron’s continued strategy to improve profitability and focus on growing its higher value businesses throughout the world.

Based on the sales price and the net assets of the businesses sold, Itron concluded on November 2, 2021 that it will recognize a pre-tax loss with a range of $30-40 million upon closure of the sale, which is expected in the first half of 2022. The impairment is driven primarily by the required recognition of $58-62 million in foreign currency translation losses accumulated since the acquisition of the German subsidiary in 2007. The base sale price of this divestiture is $75 million, with adjustments for (1) pension liabilities assumed by Dresser for the active employees estimated at $12-13 million and (2) the final working capital balance, which will be determined as of the close date, and, if the balance is outside the targeted amount, the difference will be settled shortly thereafter. Net assets of the businesses, including allocated goodwill, are $35-40 million. Cash proceeds from the sale are currently estimated at $62-63 million.

Restructuring Plan Associated with Sale of Business

On October 29, 2021, the Board of Directors of Itron approved a restructuring plan (the 2021 Projects). The 2021 Projects include activities, in conjunction with the announcement of the sale of certain of our Gas device manufacturing operations, which drive reductions in certain locations and functional support areas. These projects are to be substantially complete by the end of 2024. Itron estimates pre-tax restructuring charges of $65-75 million. Of the total estimated charge, approximately $60-65 million will result in cash expenditures, and the remainder to non-cash impairment charges. The majority of the expense will be recognized during the fourth quarter of 2021. Once the 2021 Projects are substantially completed, Itron estimates $15-20 million in annualized savings. Certain of Itron’s employees are represented by unions or works councils, which requires consultation, and potential restructuring projects may be subject to regulatory approval, both of which could impact the timing of planned savings in certain jurisdictions.

Approval of Share Repurchase Program

Effective November 1, 2021, the Board of Directors of Itron authorized a new share repurchase program of up to $100 million of Itron’s common stock over a 18-month period. Repurchases will be made in the open market and pursuant to the terms of any Rule 10b5-1 plans that Itron may enter into, and in accordance with applicable securities laws. The repurchase program is intended to comply with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Basis of Presentation

Financial Statement Preparation

The consolidated financial statements presented in this Quarterly Report on Form 10-Q are unaudited and reflect entries necessary for the fair presentation of the Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2021 and 2020, Consolidated Statements of Equity for the three months ended September 30, 2021 and 2020, June 30, 2021 and 2020, and March 31, 2021 and 2020, the Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020, and the Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020, of Itron, Inc. and its subsidiaries. All entries required for the fair presentation of the financial statements are of a normal recurring nature, except as disclosed. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results expected for the full year or for any other period.

Certain information and notes normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been partially or completely omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim results. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2020 filed with the SEC in our Annual Report on Form 10-K on February 24, 2021 (2020 Annual Report). There have been no significant changes in financial statement preparation or significant accounting policies since December 31, 2020.

New Accounting Pronouncements

Recently Adopted Accounting Standards

In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which modifies certain provisions of Accounting Standards Codification (ASC) 740, to reduce the complexity of accounting for income taxes. ASU 2019-12 was effective for us beginning with our interim financial reports in 2021. The adoption of this standard had no impact to our year-to-date consolidated financial position, results of operations, or cash flows and is not expected to have a material impact on full year 2021 financial results.

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (ASU 2020-06). This amendment simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. We chose to early adopt ASU 2020-06 beginning January 1, 2021, due to the issuance of our convertible debt on March 9, 2021. This amendment had no retrospective changes but impacts how our newly issued convertible debt is both recognized and disclosed. ASU 2020-06 also amends the diluted earnings per share calculation for convertible instruments by requiring the use of the if-converted method. The treasury stock method is no longer available.

Recent Accounting Standards Not Yet Adopted

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. ASU 2020-04 applies to contracts that reference LIBOR or another reference rate expected to be terminated because of reference rate reform. An entity may elect certain optional expedients for hedging relationships that exist as of December 31, 2022 and maintain those optional expedients through the end of the hedging relationship. ASU 2020-04 could be adopted as of March 12, 2020 or thereafter. In January 2021, the FASB issued ASU 2021-01, which further updates the scope of Topic 848. We do not currently have any contracts that have been changed to a new reference rate, but we will continue to evaluate our contracts and the effects of this standard on our consolidated financial position, results of operations, and cash flows prior to adoption.

In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. The amendments in this update modify the lease classification requirements for lessors to align them with practice under Topic 840, particularly in the area of day-one loss accounting. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if certain criteria are met. The effective date for this amendment is January 1, 2022 and all interim periods thereafter. We have determined under existing leases where we are the lessor, this amendment will not have a material impact on our financial statements.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (EPS):

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands, except per share data	2021		2020		2021		2020
Net loss available to common shareholders	$	(1,869)	$	(25,357)	$	(22,389)	$	(79,475)
Weighted average common shares outstanding - Basic	45,240		40,337		43,983		40,199
Dilutive effect of stock-based awards	—		—		—		—
Dilutive effect of convertible notes	—		—		—		—
Weighted average common shares outstanding - Diluted	45,240		40,337		43,983		40,199
Net loss per common share - Basic	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)
Net loss per common share - Diluted	$	(0.04)	$	(0.63)	$	(0.51)	$	(1.98)

XML

Certain Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2021

Balance Sheet Related Disclosures [Abstract]

Accounts Receivable, Net

A summary of accounts receivable from contracts with customers is as follows:

Accounts receivable, net
In thousands	September 30, 2021		December 31, 2020
Trade receivables (net of allowance of $2,798 and $1,312)	$	274,385	$	318,269
Unbilled receivables	46,609		51,559
Total accounts receivable, net	$	320,994	$	369,828

Allowance for Credit Losses on Financing Receivables

Allowance for credit losses account activity	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Beginning balance	$	1,107	$	2,102	$	1,312	$	3,064
Provision for (release of) doubtful accounts, net	2,164		(21)		2,122		318
Accounts written-off	(440)		(278)		(582)		(1,489)
Effect of change in exchange rates	(33)		43		(54)		(47)
Ending balance	$	2,798	$	1,846	$	2,798	$	1,846

Inventories

Inventories
In thousands	September 30, 2021		December 31, 2020
Raw materials	$	117,549	$	114,058
Work in process	8,539		8,094
Finished goods	49,344		60,225
Total inventories	$	175,432	$	182,377

Property, Plant, and Equipment, Net

Property, plant, and equipment, net
In thousands	September 30, 2021		December 31, 2020
Machinery and equipment	$	333,584	$	334,050
Computers and software	117,067		115,776
Buildings, furniture, and improvements	146,052		155,676
Land	11,976		14,303
Construction in progress, including purchased equipment	40,082		31,425
Total cost	648,761		651,230
Accumulated depreciation	(459,013)		(443,414)
Property, plant, and equipment, net	$	189,748	$	207,816

Depreciation Expense

Depreciation expense	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Depreciation expense	$	12,389	$	12,893	$	37,338	$	38,818

XML

Intangible Assets and Liabilities (Tables)

9 Months Ended

Sep. 30, 2021

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Schedule of Intangible Assets by Major Class

The gross carrying amount and accumulated amortization (accretion) of our intangible assets and liabilities, other than goodwill, were as follows:

	September 30, 2021						December 31, 2020
In thousands	Gross		Accumulated (Amortization) Accretion		Net		Gross		Accumulated (Amortization) Accretion		Net
Intangible Assets
Core-developed technology	$	511,885	$	(495,799)	$	16,086	$	525,051	$	(498,113)	$	26,938
Customer contracts and relationships	376,572		(291,783)		84,789		383,245		(280,497)		102,748
Trademarks and trade names	78,448		(75,933)		2,515		79,716		(76,912)		2,804
Other	12,023		(11,650)		373		12,025		(11,560)		465
Total intangible assets	$	978,928	$	(875,165)	$	103,763	$	1,000,037	$	(867,082)	$	132,955
Intangible Liabilities
Customer contracts and relationships	$	(23,900)	$	22,950	$	(950)	$	(23,900)	$	21,479	$	(2,421)

Summary of Intangible Asset Account Activity

A summary of intangible assets and liabilities activity is as follows:

	Nine Months Ended September 30,
In thousands	2021		2020
Intangible assets, gross beginning balance	$	1,000,037	$	979,814
Intangibles disposed in sale of business	—		(18,140)
Effect of change in exchange rates	(21,109)		9,974
Intangible assets, gross ending balance	$	978,928	$	971,648
Intangible liabilities, gross beginning balance	$	(23,900)	$	(23,900)
Effect of change in exchange rates	—		—
Intangible liabilities, gross ending balance	$	(23,900)	$	(23,900)

Schedule of Intangible Assets, Future Amortization Expense

Estimated future annual amortization (accretion) is as follows:

Year Ending December 31,	Amortization		Accretion		Estimated Annual Amortization, net
In thousands
2021 (amount remaining at September 30, 2021)	$	9,450	$	(491)	$	8,959
2022	27,393		(459)		26,934
2023	19,811		—		19,811
2024	15,631		—		15,631
2025	14,655		—		14,655
Thereafter	16,823		—		16,823
Total intangible assets subject to amortization (accretion)	$	103,763	$	(950)	$	102,813

XML

Goodwill (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill Excluding Non Goodwill Intangibles [Abstract]

Schedule of Goodwill

The following table reflects changes in the carrying amount of goodwill for the nine months ended September 30, 2021:

In thousands	Device Solutions		Networked Solutions		Outcomes		Total Company
Goodwill balance at January 1, 2021	$	53,214	$	933,814	$	144,888	$	1,131,916
Effect of change in exchange rates	(658)		(13,467)		(2,094)		(16,219)
Goodwill balance at September 30, 2021	$	52,556	$	920,347	$	142,794	$	1,115,697

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Schedule of Debt

The components of our borrowings were as follows:

In thousands	September 30, 2021		December 31, 2020
Credit facility
USD denominated term loan	$	—	$	536,094
Multicurrency revolving line of credit	—		—
Senior notes	—		400,000
Convertible notes	460,000		—
Total debt	460,000		936,094
Less: current portion of debt	—		18,359
Less: unamortized prepaid debt fees - term loan	—		3,469
Less: unamortized prepaid debt fees - senior notes	—		11,689
Less: unamortized prepaid debt fees - convertible notes	10,371		—
Long-term debt, net	$	449,629	$	902,577

Schedule of Maturities of Long-term Debt

The amount of required minimum principal payments on our debt in aggregate over the next five years is as follows:

Year Ending December 31,	Minimum Payments
In thousands
2021 (amount remaining at September 30, 2021)	$	—
2022	—
2023	—
2024	—
2025	—
Thereafter	460,000
Total minimum payments on debt	$	460,000

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The fair values of our derivative instruments were as follows:

		Fair Value
Derivatives Assets	Balance Sheet Location	September 30, 2021		December 31, 2020
Derivatives designated as hedging instruments under ASC 815-20		In thousands
Foreign exchange options	Other current assets	$	329	$	—
Derivatives not designated as hedging instruments under ASC 815-20
Foreign exchange forward contracts	Other current assets	49		52
Total asset derivatives		$	378	$	52
Derivatives Liabilities
Derivatives designated as hedging instruments under ASC 815-20
Interest rate swap contracts	Other current liabilities	$	—	$	1,025
Interest rate swap contracts	Other long-term obligations	—		957
Cross currency swap contract	Other current liabilities	—		526
Derivatives not designated as hedging instruments under ASC 815-20
Foreign exchange forward contracts	Other current liabilities	166		128
Total liability derivatives		$	166	$	2,636

Accumulated OCI for Derivative and Nonderivative Instruments Designated as Hedging Instruments, Net of Tax

The changes in accumulated other comprehensive income (loss) (AOCI), net of tax, for our derivative and nonderivative hedging instruments designated as hedging instruments, net of tax, were as follows:

In thousands	2021		2020
Net unrealized loss on hedging instruments at January 1,	$	(16,001)	$	(15,103)
Unrealized gain (loss) on derivative instruments	1,085		(4,727)
Realized (gains) losses reclassified into net income (loss)	733		2,570
Net unrealized loss on hedging instruments at September 30,	$	(14,183)	$	(17,260)

Offsetting Assets

A summary of the effect of netting arrangements on our financial position related to the offsetting of our recognized derivative assets and liabilities under master netting arrangements or similar agreements is as follows:

Offsetting of Derivative Assets	Gross Amounts of Recognized Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the Consolidated Balance Sheets
In thousands			Derivative Financial Instruments		Cash Collateral Received		Net Amount
September 30, 2021	$	378	$	(28)	$	—	$	350
December 31, 2020	52		(52)		—		—

Offsetting Liabilities

Offsetting of Derivative Liabilities	Gross Amounts of Recognized Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the Consolidated Balance Sheets
In thousands			Derivative Financial Instruments		Cash Collateral Pledged		Net Amount
September 30, 2021	$	166	$	(28)	$	—	$	138
December 31, 2020	2,636		(52)		—		2,584

Effect of Cash Flow Derivatives on the Balance Sheet and Income Statement, Before Tax

The before-tax effects of our accounting for derivative instruments designated as hedges on AOCI were as follows:

Derivatives in ASC 815-20 Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivative				Gain (Loss) Reclassified from  AOCI into Income
					Location	Amount
In thousands	2021		2020			2021		2020
Three Months Ended September 30,
Interest rate swap contracts	$	—	$	(302)	Interest expense	$	—	$	(274)
Foreign exchange options	478		(252)		Product cost of revenues	(32)		(450)
Cross currency swap contract	—		(2,326)		Interest expense	—		88
Cross currency swap contract	—		—		Other income (expense), net	—		(2,242)
Nine Months Ended September 30,
Interest rate swap contract	$	73	$	(2,818)	Interest expense	$	(229)	$	(467)
Interest rate swap contract	—		—		Other income (expense), net	(1,681)		—
Interest rate cap contracts	—		782		Interest expense	—		392
Foreign exchange options	367		(1,221)		Product cost of revenues	(40)		(612)
Cross currency swap contract	669		(1,969)		Interest expense	94		537
Cross currency swap contract	—		—		Other income (expense), net	656		(2,438)

Foreign Exchange Derivatives Not Designated As Hedging Instruments

The effect of our derivative instruments not designated as hedges on the Consolidated Statements of Operations was as follows:

Derivatives Not Designated as Hedging Instrument under ASC 815-20	Location	Gain (Loss) Recognized on Derivatives in Other Income (Expense)
In thousands		2021		2020
Three Months Ended September 30,
Foreign exchange forward contracts	Other income (expense), net	$	673	$	(1,646)
Nine Months Ended September 30,
Foreign exchange forward contracts	Other income (expense), net	$	210	$	(1,056)

XML

Defined Benefit Pension Plans (Tables)

9 Months Ended

Sep. 30, 2021

Retirement Benefits [Abstract]

Schedule of Amounts Recognized in the Consolidated Balance Sheets

Amounts recognized on the Consolidated Balance Sheets consist of:

In thousands	September 30, 2021		December 31, 2020
Liabilities
Current portion of pension benefit obligation in wages and benefits payable	$	3,822	$	3,069
Long-term portion of pension benefit obligation	114,771		119,457
Pension benefit obligation, net	$	118,593	$	122,526

Schedule of Net Periodic Pension Benefit Costs

Net periodic pension benefit cost for our plans include the following components:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Service cost	$	1,125	$	1,007	$	3,376	$	3,000
Interest cost	345		434		1,046		1,364
Expected return on plan assets	(87)		(85)		(264)		(365)
Amortization of prior service costs	17		17		51		49
Amortization of actuarial net loss	681		482		2,070		1,390
Settlement	—		286		—		286
Net periodic benefit cost	$	2,081	$	2,141	$	6,279	$	5,724

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation Expense and Related Tax Benefit

Total stock-based compensation expense and the related tax benefit were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Stock options	$	344	$	452	$	1,055	$	1,445
Restricted stock units	5,104		4,399		16,546		18,575
Unrestricted stock awards	217		206		650		618
Phantom stock units	519		582		2,861		2,075
Total stock-based compensation	$	6,184	$	5,639	$	21,112	$	22,713
Related tax benefit	$	1,159	$	1,070	$	3,840	$	4,257

Employee Stock Options Activity

A summary of our stock option activity is as follows:

	Shares	Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value		Weighted Average Grant Date Fair Value
	(in thousands)			(years)	(in thousands)
Outstanding, January 1, 2020	458	$	56.38	7.0	$	12,641
Granted	80	84.38					$	26.21
Exercised	(49)	50.90			1,189
Forfeited	(5)	83.80
Outstanding, September 30, 2020	484	$	61.30	7.0	$	3,816
Outstanding, January 1, 2021	433	$	61.95	6.9	$	14,697
Granted	—						$	—
Exercised	(34)	67.21			1,215
Forfeited	(6)	83.33
Outstanding, September 30, 2021	393	$	61.18	6.1	$	6,496
Exercisable, September 30, 2021	317	$	56.51	5.6	$	6,361

Stock Options, Valuation Assumptions

The weighted average assumptions used to estimate the fair value of stock options granted and the resulting weighted average fair value are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Expected volatility	—	%	41.5	%	—	%	32.1	%
Risk-free interest rate	—	%	0.3	%	—	%	1.3	%
Expected term (years)	N/A		5.3		N/A		5.3

Restricted Stock Units Award Activity

The following table summarizes restricted stock unit activity:

In thousands, except fair value	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Outstanding, January 1, 2020	684
Granted	209	$	83.34
Released (1)	(338)			$	21,947
Forfeited	(23)
Outstanding, September 30, 2020	532
Outstanding, January 1, 2021	544	$	71.79
Granted	212	97.96
Released (1)	(288)	70.20		$	28,494
Forfeited	(46)	77.79
Outstanding, September 30, 2021	422	85.75
Vested but not released, September 30, 2021	10			$	733

(1)     Shares released is presented as gross shares and does not reflect shares withheld by us for employee payroll tax obligations.

Restricted Stock Units, Valuation Assumptions

The weighted average assumptions used to estimate the fair value of performance-based restricted stock units granted with a service and market condition and the resulting weighted average fair value are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Expected volatility	—		%	52.6		%	50.5		%	38.2		%
Risk-free interest rate	—		%	0.2		%	0.2		%	1.5		%
Expected term (years)	N/A			2.3			2.9			1.8
Weighted average fair value	$	—		$	61.45		$	113.75		$	93.05

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

Unrecognized Tax Benefits Related To Uncertain Tax Positions

The net interest and penalties expense amounts recognized were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Net interest and penalties expense	$	195	$	(198)	$	153	$	422

Accrued interest and penalties recognized were as follows:

In thousands	September 30, 2021		December 31, 2020
Accrued interest	$	3,663	$	3,432
Accrued penalties	1,405		1,645

Unrecognized tax benefits related to uncertain tax positions and the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate were as follows:

In thousands	September 30, 2021		December 31, 2020
Unrecognized tax benefits related to uncertain tax positions	$	134,110	$	135,910
The amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate	132,992		134,473

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Schedule of Line of Credit Facilities

Our available lines of credit, outstanding standby LOCs, and bonds were as follows:

In thousands	September 30, 2021		December 31, 2020
Credit facility
Multicurrency revolving line of credit	$	500,000	$	500,000
Standby LOCs issued and outstanding	(64,448)		(64,948)
Net available for additional borrowings under the multicurrency revolving line of credit	$	435,552	$	435,052
Net available for additional standby LOCs under sub-facility	$	235,552	$	235,052
Unsecured multicurrency revolving lines of credit with various financial institutions
Multicurrency revolving lines of credit	$	97,113	$	99,201
Standby LOCs issued and outstanding	(24,245)		(24,966)
Short-term borrowings	(8,764)		—
Net available for additional borrowings and LOCs	$	64,104	$	74,235
Unsecured surety bonds in force	$	169,293	$	162,912

Schedule of Warranty Accruals

A summary of the warranty accrual account activity is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Beginning balance	$	36,210	$	44,757	$	41,390	$	53,242
New product warranties	1,925		785		3,611		2,855
Other adjustments and expirations, net	(975)		1,643		631		5,436
Claims activity	(2,156)		(5,044)		(10,040)		(19,349)
Effect of change in exchange rates	(317)		946		(905)		903
Ending balance	34,687		43,087		34,687		43,087
Less: current portion of warranty	18,089		32,118		18,089		32,118
Long-term warranty	$	16,598	$	10,969	$	16,598	$	10,969

Warranty Expense

Warranty expense was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Total warranty expense	$	950	$	2,428	$	4,242	$	8,321

XML

Restructuring (Tables)

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2020 Projects were as follows:

In thousands	Total Expected Costs at September 30, 2021		Costs Recognized in Prior Periods		Costs Recognized During the Nine Months Ended  September 30, 2021		Expected Remaining Costs to be Recognized at September 30, 2021
Employee severance costs	$	32,583	$	36,225	$	(3,642)	$	—
Asset impairments & net loss (gain) on sale or disposal	6,893		6,944		(51)		—
Other restructuring costs	4,546		63		1,920		2,563
Total	$	44,022	$	43,232	$	(1,773)	$	2,563

The total expected restructuring costs, the restructuring costs recognized, and the remaining expected restructuring costs related to the 2018 Projects were as follows:

In thousands	Total Expected Costs at September 30, 2021		Costs Recognized in Prior Periods		Costs Recognized During the Nine Months Ended  September 30, 2021		Expected Remaining Costs to be Recognized at September 30, 2021
Employee severance costs	$	59,229	$	63,173	$	(3,944)	$	—
Asset impairments & net loss (gain) on sale or disposal	3,788		2,786		1,002		—
Other restructuring costs	19,752		15,217		3,885		650
Total	$	82,769	$	81,176	$	943	$	650

Restructuring and Related Costs

The following table summarizes the activity within the restructuring-related balance sheet accounts for the 2020 Projects and 2018 Projects during the nine months ended September 30, 2021:

In thousands	Accrued Employee Severance		Asset Impairments & Net Loss (Gain) on Sale or Disposal		Other Accrued Costs		Total
Beginning balance, January 1, 2021	$	70,005	$	—	$	2,621	$	72,626
Costs charged to expense	(7,586)		951		5,805		(830)
Cash payments	(16,431)		—		(4,725)		(21,156)
Cash receipts	—		2,007		—		2,007
Net assets disposed and impaired	—		(2,958)		—		(2,958)
Effect of change in exchange rates	(2,377)		—		(47)		(2,424)
Ending balance, September 30, 2021	$	43,611	$	—	$	3,654	$	47,265

XML

Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2021

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The changes in the components of AOCI, net of tax, were as follows:

In thousands	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) on Derivative Instruments		Net Unrealized Gain (Loss) on Nonderivative Instruments		Pension Benefit Obligation Adjustments		Accumulated Other Comprehensive Income (Loss)
Balances at January 1, 2020	$	(157,999)	$	(723)	$	(14,380)	$	(31,570)	$	(204,672)
OCI before reclassifications	(147)		(4,727)		—		(1,151)		(6,025)
Amounts reclassified from AOCI	52,074		2,570		—		2,040		56,684
Total other comprehensive income (loss)	51,927		(2,157)		—		889		50,659
Balances at September 30, 2020	$	(106,072)	$	(2,880)	$	(14,380)	$	(30,681)	$	(154,013)
Balances at January 1, 2021	$	(84,843)	$	(1,621)	$	(14,380)	$	(37,682)	$	(138,526)
OCI before reclassifications	(17,118)		1,085		—		—		(16,033)
Amounts reclassified from AOCI	—		733		—		2,087		2,820
Total other comprehensive income (loss)	(17,118)		1,818		—		2,087		(13,213)
Balances at September 30, 2021	$	(101,961)	$	197	$	(14,380)	$	(35,595)	$	(151,739)

Total Comprehensive Income (Loss)

The before-tax, income tax (provision) benefit, and net-of-tax amounts related to each component of OCI were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Before-tax amount
Foreign currency translation adjustment	$	(7,827)	$	15,521	$	(16,941)	$	(387)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478		(2,887)		1,103		(5,228)
Net hedging (gain) loss reclassified to net income (loss)	32		2,879		1,200		2,588
Net unrealized gain (loss) on defined benefit plans	—		(893)		—		(812)
Net defined benefit plan (gain) loss reclassified to net income (loss)	698		499		2,121		1,439
Total other comprehensive income (loss), before tax	$	(6,619)	$	15,105	$	(12,517)	$	49,674
Tax (provision) benefit
Foreign currency translation adjustment	$	63	$	(1,533)	$	(177)	$	240
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		—		—		—
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	—		74		(18)		501
Net hedging (gain) loss reclassified to net income (loss)	—		(67)		(467)		(18)
Net unrealized gain (loss) on defined benefit plans	—		(341)		—		(339)
Net defined benefit plan (gain) loss reclassified to net income (loss)	(11)		576		(34)		601
Total other comprehensive income (loss) tax (provision) benefit	$	52	$	(1,291)	$	(696)	$	985
Net-of-tax amount
Foreign currency translation adjustment	$	(7,764)	$	13,988	$	(17,118)	$	(147)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	—		(14)		—		52,074
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478		(2,813)		1,085		(4,727)
Net hedging (gain) loss reclassified to net income (loss)	32		2,812		733		2,570
Net unrealized gain (loss) on defined benefit plans	—		(1,234)		—		(1,151)
Net defined benefit plan (gain) loss reclassified to net income (loss)	687		1,075		2,087		2,040
Total other comprehensive income (loss), net of tax	$	(6,567)	$	13,814	$	(13,213)	$	50,659

XML

Fair Values of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Schedule of Fair Values Of Financial Instruments by Balance Sheet Grouping

The fair values at September 30, 2021 and December 31, 2020 do not reflect subsequent changes in the economy, interest rates, tax rates, and other variables that may affect the determination of fair value.

	September 30, 2021				December 31, 2020
In thousands	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Credit facility
USD denominated term loan	$	—	$	—	$	532,625	$	520,347
Multicurrency revolving line of credit	—		—		—		—
Senior notes	—		—		388,311		410,000
Convertible notes	449,629		434,130		—		—

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Revenues Gross Profit And Operating Income By Segment

Revenues, gross profit, and operating income associated with our operating segments were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Product revenues
Device Solutions	$	149,830	$	174,039	$	480,808	$	501,157
Networked Solutions	242,527		282,677		736,397		898,465
Outcomes	18,590		13,942		48,265		38,158
Total Company	$	410,947	$	470,658	$	1,265,470	$	1,437,780
Service revenues
Device Solutions	$	2,404	$	2,089	$	7,174	$	6,415
Networked Solutions	31,971		23,982		91,473		73,519
Outcomes	41,627		43,455		131,818		130,479
Total Company	$	76,002	$	69,526	$	230,465	$	210,413
Total revenues
Device Solutions	$	152,234	$	176,128	$	487,982	$	507,572
Networked Solutions	274,498		306,659		827,870		971,984
Outcomes	60,217		57,397		180,083		168,637
Total Company	$	486,949	$	540,184	$	1,495,935	$	1,648,193
Gross profit
Device Solutions	$	22,480	$	20,528	$	85,228	$	64,843
Networked Solutions	89,915		102,295		298,627		332,368
Outcomes	22,568		20,428		68,027		56,123
Total Company	$	134,963	$	143,251	$	451,882	$	453,334
Operating income (loss)
Device Solutions	$	12,095	$	11,017	$	53,784	$	28,095
Networked Solutions	61,150		71,404		205,071		237,466
Outcomes	11,774		12,044		34,647		29,468
Corporate unallocated	(80,856)		(118,445)		(265,331)		(338,026)
Total Company	4,163		(23,980)		28,171		(42,997)
Total other income (expense)	(4,037)		(13,063)		(42,465)		(35,020)
Income (loss) before income taxes	$	126	$	(37,043)	$	(14,294)	$	(78,017)

Revenues By Region

Revenues by region were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
United States and Canada	$	323,784	$	354,841	$	957,993	$	1,110,028
Europe, Middle East, and Africa	126,548		156,810		437,768		431,593
Asia Pacific and Latin America(1)	36,617		28,533		100,174		106,572
Total Company	$	486,949	$	540,184	$	1,495,935	$	1,648,193

(1) On June 25, 2020, we sold our Latin American operations. We continue to sell into the region through an exclusive distributor.

Depreciation expense is allocated to the operating segments based upon each segment's use of the assets. All amortization expense is recognized within Corporate unallocated.

Depreciation And Amortization Expense Associated With Segments

Depreciation and amortization of intangible assets expense associated with our operating segments was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
In thousands	2021		2020		2021		2020
Device Solutions	$	5,911	$	5,926	$	17,708	$	18,423
Networked Solutions	4,274		4,377		12,801		12,447
Outcomes	1,068		1,327		3,431		4,132
Corporate unallocated	10,080		12,446		30,312		37,304
Total Company	$	21,333	$	24,076	$	64,252	$	72,306

XML

Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2021

Revenues [Abstract]

Contract with Customer, Asset and Liability

A summary of significant net changes in the contract assets and the contract liabilities balances during the period is as follows:

In thousands	Contract Liabilities, Less Contract Assets
Beginning balance, January 1, 2021	$	98,388
Revenues recognized from beginning contract liability	(95,096)
Cumulative catch-up adjustments	16,722
Increases due to amounts collected or due	215,549
Revenues recognized from current period increases	(136,122)
Other	(908)
Ending balance, September 30, 2021	$	98,533

XML

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Risks and uncertainties in entity's business	Risks and UncertaintiesThe COVID-19 pandemic has had global economic impacts including disrupting customer demand and global supply chains, resulting in market volatility. The extent of the recent pandemic and its ongoing impact on our operations is volatile, but is being monitored closely by our management. During portions of the first half of 2020 certain of our European factories were closed due to government actions and local conditions, and any further closures that may be imposed on us could impact our results for 2021. New variants of the virus may cause previously lifted restrictions to be reinstated, which could result in more disruptions. Incremental costs we have incurred related to COVID-19, such as personal protective equipment, increased cleaning and sanitizing of our facilities, and other such items, have not been material to date. As economies have reopened, global supply chains have struggled to keep pace with rapidly changing demand. The resulting supply constraints have manifested across a variety of areas including mechanical, electrical and logistics portions of the supply chain, which has impacted our ability to ship products in a timely manner. In particular, our ability to obtain adequate supply of semiconductor components has impacted our ability to service recovering customer demand. While the current imbalance in supply and demand is temporal, the timeline to recovery is uncertain. Efforts are ongoing with suppliers to increase supply, including the approval of alternate sources. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. However, certain of our customer projects have experienced delay in deliveries, with originally forecasted 2021 revenue pushed to future periods.

XML

Computation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Net loss available to common shareholders	$ (1,869)	$ (25,357)	$ (22,389)	$ (79,475)
Weighted average common shares outstanding - Basic (in shares)	45,240	40,337	43,983	40,199
Dilutive effect of stock-based awards (in shares)	0	0	0	0
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	0	0	0	0
Weighted average common shares outstanding - Diluted (in shares)	45,240	40,337	43,983	40,199
Earnings (loss) per common share - Basic (in dollars per share)	$ (0.04)	$ (0.63)	$ (0.51)	$ (1.98)
Earnings (loss) per common share - Diluted (in dollars per share)	$ (0.04)	$ (0.63)	$ (0.51)	$ (1.98)

XML

Earnings Per Share Stock-based Awards (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Stock-based awards excluded from diluted EPS calculation (antidilutive) (in shares)	0.4	0.8	0.5	0.8

XML

Earnings Per Share - Convertible Senior Notes and Warrants (Details) - $ / shares shares in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Stock-based awards excluded from diluted EPS calculation (antidilutive) (in shares)	0.4		0.8	0.5	0.8
Treasury stock, shares, acquired		3.7
Class of warrant or right, exercise price of warrants or rights		$ 180.00
Convertible Debt Securities
Debt Instrument [Line Items]
Stock-based awards excluded from diluted EPS calculation (antidilutive) (in shares)	3.7	3.7		3.7
Common stock, conversion price (in dollars per share)	$ 126.00	$ 126.00

XML

Earnings Per Share - Convertible Note Hedge Transactions (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021
Debt Instrument [Line Items]
Derivative, notional amount		$ 84.1
Treasury stock, shares, acquired		3.7
Convertible Debt Securities
Debt Instrument [Line Items]
Common stock, conversion price (in dollars per share)	$ 126.00	$ 126.00

XML

Certain Balance Sheet Components Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]
Trade receivables (net of allowance of $2,798 and $1,312)	$ 274,385	$ 318,269
Unbilled receivables	46,609	51,559
Total accounts receivable, net	$ 320,994	$ 369,828

XML

Certain Balance Sheet Components Summary of the Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]
Beginning balance	$ 1,107	$ 2,102	$ 1,312	$ 3,064
Provision for (release of) doubtful accounts, net	2,164	(21)	2,122	318
Accounts written-off	(440)	(278)	(582)	(1,489)
Effect of change in exchange rates	(33)	43	(54)	(47)
Ending balance	$ 2,798	$ 1,846	$ 2,798	$ 1,846

XML

Certain Balance Sheet Components Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventory, Net [Abstract]
Raw materials	$ 117,549	$ 114,058
Work in process	8,539	8,094
Finished goods	49,344	60,225
Total inventories	$ 175,432	$ 182,377

XML

Certain Balance Sheet Components Property, Plant, and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment, Net [Abstract]
Machinery and equipment	$ 333,584	$ 334,050
Computers and software	117,067	115,776
Buildings, furniture, and improvements	146,052	155,676
Land	11,976	14,303
Construction in progress, including purchased equipment	40,082	31,425
Total cost	648,761	651,230
Accumulated depreciation	(459,013)	(443,414)
Property, plant, and equipment, net	$ 189,748	$ 207,816

XML

Certain Balance Sheet Components Depreciation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 12,389	$ 12,893	$ 37,338	$ 38,818

XML

Intangible Assets and Liabilities Gross Carrying Amount and Accumulated Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Intangible Assets [Line Items]
Intangible assets, Accumulated (Amortization) Accretion	$ (875,165)	$ (867,082)
Intangible assets, Net	103,763
Intangible assets, Gross	978,928	1,000,037	$ 971,648	$ 979,814
Intangible assets, Net	103,763	132,955
Intangible liabilities, Gross	(23,900)	(23,900)	$ (23,900)	$ (23,900)
Intangible liabilities, Accumulated (Amortization) Accretion	22,950	21,479
Intangible liabilities, Net	(950)	(2,421)
Core-developed technology [Member]
Intangible Assets [Line Items]
Intangible assets, Gross	511,885	525,051
Intangible assets, Accumulated (Amortization) Accretion	(495,799)	(498,113)
Intangible assets, Net	16,086	26,938
Customer contracts and relationships [Member]
Intangible Assets [Line Items]
Intangible assets, Gross	376,572	383,245
Intangible assets, Accumulated (Amortization) Accretion	(291,783)	(280,497)
Intangible assets, Net	84,789	102,748
Trademarks and trade names [Member]
Intangible Assets [Line Items]
Intangible assets, Gross	78,448	79,716
Intangible assets, Accumulated (Amortization) Accretion	(75,933)	(76,912)
Intangible assets, Net	2,515	2,804
Other Intangible Assets [Member]
Intangible Assets [Line Items]
Intangible assets, Gross	12,023	12,025
Intangible assets, Accumulated (Amortization) Accretion	(11,650)	(11,560)
Intangible assets, Net	$ 373	$ 465

XML

Summary of Intangible Asset Account Activity (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Total Intangible Assets [Abstract]
Intangible assets, gross beginning balance	$ 1,000,037	$ 979,814
Intangibles disposed in sale of business	0	(18,140)
Effect of change in exchange rates	(21,109)	9,974
Intangible assets, gross ending balance	978,928	971,648
Intangible liabilities, gross beginning balance	23,900	23,900
Effect of change in exchange rates	0	0
Intangible liabilities, gross ending balance	$ 23,900	$ 23,900

XML

Intangible Assets and Liabilities Intangible Assets Narrative (Details) $ in Millions	Jun. 25, 2020 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Disposal Group, Including Discontinued Operation, Intangible Assets	$ 0.8

XML

Intangible Assets and Liabilities Estimated Future Annual Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Intangible Assets [Abstract]
2021 (amount remaining at September 30, 2021)	$ 9,450
2022	27,393
2023	19,811
2024	15,631
2025	14,655
Thereafter	16,823
Total intangible assets subject to amortization (accretion)	103,763
2021 (amount remaining at September 30, 2021)	(491)
2022	(459)
2023	0
2024	0
2025	0
Thereafter	0
Intangible liabilities, Net	(950)	$ (2,421)
2021 (amount remaining at September 30, 2021)	8,959
2022	26,934
2023	19,811
2024	15,631
2025	14,655
Thereafter	16,823
Total intangible assets (liabilities), net	$ 102,813

XML

Schedule of Goodwill Allocated to Reporting Segments (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Goodwill [Roll Forward]
Goodwill, net, at beginning of period	$ 1,131,916
Effect of change in exchange rates	(16,219)
Goodwill, Ending Balance	1,115,697
Device Solutions
Goodwill [Roll Forward]
Goodwill, net, at beginning of period	53,214
Effect of change in exchange rates	(658)
Goodwill, Ending Balance	52,556
Networked Solutions Segment
Goodwill [Roll Forward]
Goodwill, net, at beginning of period	933,814
Effect of change in exchange rates	(13,467)
Goodwill, Ending Balance	920,347
Outcomes Segment [Member]
Goodwill [Roll Forward]
Goodwill, net, at beginning of period	144,888
Effect of change in exchange rates	(2,094)
Goodwill, Ending Balance	$ 142,794

XML

Debt - Schedule of Debt Components of Borrowing (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Apr. 08, 2021	Mar. 09, 2021	Dec. 31, 2020	Jan. 19, 2018	Dec. 22, 2017
Debt Instrument [Line Items]
Senior notes		$ 0	$ 410,000		$ 100,000	$ 300,000
Convertible Debt	$ 460,000			$ 0
Total debt	460,000
Current portion of debt	0			18,359
Long-term debt, net	449,629			902,577
Secured Debt
Debt Instrument [Line Items]
Total debt	460,000			936,094
Current portion of debt	0			18,359
Long-term debt, net	449,629			902,577
USD Denominated Term Loan
Debt Instrument [Line Items]
USD denominated term loan	0			536,094
Unamortized prepaid debt fees	0			3,469
Line of Credit
Debt Instrument [Line Items]
Multicurrency revolving line of credit	0			0
Senior Notes
Debt Instrument [Line Items]
Senior notes	0			400,000
Unamortized prepaid debt fees	0			11,689
Convertible Debt Securities
Debt Instrument [Line Items]
Unamortized prepaid debt fees	$ 10,371			$ 0

XML

Debt - Credit Facility Additional Information (Details)			3 Months Ended	9 Months Ended
	Oct. 19, 2020 USD ($)	Mar. 25, 2020 USD ($)	Mar. 31, 2021	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)	Oct. 18, 2019 USD ($)
Debt Instrument [Line Items]
Debt instrument, face amount						$ 1,200,000,000
Line of credit facility, maximum borrowing capacity						500,000,000
Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				$ 500,000,000	$ 500,000,000
Letters of credit outstanding, amount				64,448,000	64,948,000
Line of credit facility, remaining borrowing capacity				$ 235,600,000
London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis				the LIBOR rate
EURIBOR [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis				EURIBOR rate
Alternate base rate [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis				Alternate Base Rate
Alternate base rate (1) [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis				the prime rate
Alternate base rate (2) [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis				the Federal Reserve effective rate
Fed Funds Effective Rate Overnight Index Swap Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate				0.50%
Alternate base rate (3) [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis				one-month LIBOR
Debt instrument, basis spread on variable rate				1.00%
Minimum
Debt Instrument [Line Items]
Line of credit facility, unused capacity, commitment fee percentage			0.15%
Debt Instrument, Interest Rate, Effective Percentage			1.00%
Maximum
Debt Instrument [Line Items]
Line of credit facility, unused capacity, commitment fee percentage			0.25%
Debt Instrument, Interest Rate, Effective Percentage			1.75%
USD Denominated Term Loan [Member]
Debt Instrument [Line Items]
Debt instrument, face amount						650,000,000
USD denominated term loan				$ 0	536,094,000
Standby Letters of Credit [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity						300,000,000
Letters of credit outstanding, amount				64,400,000
Swingline sub-facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity						$ 50,000,000
Multicurrency revolving line of credit				0
Line of Credit
Debt Instrument [Line Items]
Debt instrument, fee amount	$ 1,400,000
Multicurrency revolving line of credit				0	0
Proceeds from Lines of Credit		$ 400,000,000
Line of credit facility, remaining borrowing capacity				$ 435,552,000	$ 435,052,000
Line of Credit | Fourth Quarter 2020
Debt Instrument [Line Items]
Debt instrument, debt covenant. required rate	4.75
Line of Credit | First Quarter 2021
Debt Instrument [Line Items]
Debt instrument, debt covenant. required rate	4.50
Line of Credit | Minimum
Debt Instrument [Line Items]
Line of credit facility, unused capacity, commitment fee percentage	0.15%
Debt Instrument, Interest Rate, Effective Percentage	1.00%
Line of Credit | Maximum
Debt Instrument [Line Items]
Line of credit facility, unused capacity, commitment fee percentage	0.30%
Debt Instrument, Interest Rate, Effective Percentage	2.00%
Secured Debt
Debt Instrument [Line Items]
Debt instrument, collateral				All obligations under the 2018 credit facility are guaranteed by Itron, Inc. and material U.S. domestic subsidiaries and are secured by a pledge of substantially all of the assets of Itron, Inc. and material U.S. domestic subsidiaries. This includes a pledge of 100% of the capital stock of material U.S. domestic subsidiaries and up to 66% of the voting stock (100% of the non-voting stock) of first-tier foreign subsidiaries. In addition, the obligations of any foreign subsidiary who is a foreign borrower, as defined by the 2018 credit facility, are guaranteed by the foreign subsidiary and by its direct and indirect foreign parents.

XML

Debt - Senior Note Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2021	Jan. 14, 2022	Apr. 08, 2021	Mar. 09, 2021	Dec. 31, 2020	Jan. 19, 2018	Dec. 22, 2017
Debt Instrument [Line Items]
Senior notes			$ 0	$ 410,000		$ 100,000	$ 300,000
Senior notes, early redemption, premium percentage			2.50%
Early repayment of senior debt	$ 10,000
Write off of prepaid debt fees on senior notes	11,100
Forecast | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		102.50%
Senior Notes
Debt Instrument [Line Items]
Senior notes	$ 0				$ 400,000
Debt Instrument, interest rate, stated percentage					5.00%

XML

Debt - Convertible Note Additional Information (Details) $ / shares in Units, $ in Millions		37 Months Ended
	Mar. 12, 2021 USD ($) $ / shares	Jan. 14, 2021
Maximum
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		98.00%
Debt Instrument, Redemption, Period Four
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		130.00%
Convertible Debt
Debt Instrument [Line Items]
Proceeds from convertible debt | $	$ 448.5
Debt instrument, convertible, conversion ratio	0.0079365
Debt instrument, convertible, conversion price | $ / shares	$ 126.00

XML

Debt - Minimum Required Principal Payments (Details) $ in Thousands	Sep. 30, 2021 USD ($)
Text Block [Abstract]
2021 (amount remaining at September 30, 2021)	$ 0
2022	0
2023	0
2024	0
2025	0
Thereafter	460,000
Total debt	$ 460,000

XML

Derivative and Nonderivative Hedging Instrument Fair Value Disclosure (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Asset Derivatives [Abstract]
Total asset derivatives	$ 378	$ 52
Liability Derivatives [Abstract]
Total liability derivatives	166	2,636
Designated as Hedging Instrument [Member] | Other Current Assets [Member]
Asset Derivatives [Abstract]
Foreign currency fair value hedge asset at fair value	329	0
Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]
Asset Derivatives [Abstract]
Foreign currency derivative instruments not designated as hedging instruments, asset at fair value	49	52
Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]
Liability Derivatives [Abstract]
Foreign exchange forward contracts	166	128
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]
Liability Derivatives [Abstract]
Interest Rate Derivative Liabilities, at Fair Value	0	1,025
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities
Liability Derivatives [Abstract]
Interest Rate Derivative Liabilities, at Fair Value	0	957
Currency Swap [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities
Liability Derivatives [Abstract]
Interest Rate Derivative Liabilities, at Fair Value	$ 0	$ 526

XML

Activity of Hedging Instruments in Accumulated OCI (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net unrealized loss on hedging instruments at January 1,			$ (138,526)
Realized losses reclassified into net income (loss)	$ 32	$ 2,812	733	$ 2,570
Net unrealized loss on hedging instruments at September 30,	(151,739)		(151,739)
Accumulated Net Gain (Loss) from Derivative and Nonderivative Instruments Designated as Hedging Instruments [Member]
Net unrealized loss on hedging instruments at January 1,			(16,001)	(15,103)
Unrealized gain (loss) on derivative instruments			1,085	(4,727)
Realized losses reclassified into net income (loss)			733	2,570
Net unrealized loss on hedging instruments at September 30,	$ (14,183)	$ (17,260)	$ (14,183)	$ (17,260)

XML

Offsetting of Derivative Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Total asset derivatives	$ 378	$ 52
Derivative Financial Instruments Not Offset in the Consolidated Balance Sheets	(28)	(52)
Cash Collateral Received Not Offset in the Consolidated Balance Sheets	0	0
Derivative Asset, Fair Value, Amount Offset Against Collateral	$ 350	$ 0

XML

Offsetting of Derivative Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability, Fair Value, Gross Liability	$ 166	$ 2,636
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	(28)	(52)
Cash Collateral Pledged Not Offset in the Consolidated Balance Sheets	0	0
Derivative Liability, Fair Value, Amount Offset Against Collateral	$ 138	$ 2,584

XML

Derivative Financial Instruments Narrative (Details) $ / shares in Units, shares in Millions		3 Months Ended			9 Months Ended
	Feb. 28, 2021 USD ($)	Sep. 30, 2021 USD ($) contracts $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) shares	Sep. 30, 2021 USD ($) contracts shares	Sep. 30, 2020 USD ($) shares	Mar. 17, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Apr. 30, 2018 USD ($)	Oct. 31, 2015 USD ($)
Accumulated Other Comprehensive Income (Loss), Net of Tax		$ 151,739,000			$ 151,739,000			$ 138,526,000
Derivative, notional amount			$ 84,100,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares		0.4		0.8	0.5	0.8
Deferred tax assets, derivative instruments		$ 20,600,000	$ 20,600,000		$ 20,600,000
Treasury stock, shares, acquired | shares			3.7
Class of warrant or right, exercise price of warrants or rights | $ / shares			$ 180.00
Class of Warrant or Right, Premium, Percentage			1
Class of Warrant or Right, Aggregate Proceeds From Transaction			$ 45,300,000
Number of Counterparties [Member]
Derivative counterparties		4			4			6
Net Unrealized Gain (Loss) on Nonderivative Instruments
Accumulated Other Comprehensive Income (Loss), Net of Tax		$ 14,400,000		$ 14,400,000	$ 14,400,000	$ 14,400,000
Convertible Debt Securities
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares		3.7	3.7		3.7
Common stock, conversion price (in dollars per share) | $ / shares		$ 126.00	$ 126.00
Forward Contracts [Member]
Number of foreign exchange contracts | contracts		37			37
Foreign Exchange Contract [Member] | Minimum | Not Designated as Hedging Instrument [Member]
Derivative, notional amount		$ 150,000			$ 150,000
Foreign Exchange Contract [Member] | Maximum | Not Designated as Hedging Instrument [Member]
Derivative, notional amount		$ 56,400,000			$ 56,400,000
Interest Rate Swap [Member]
Derivative, notional amount									$ 240,000,000		$ 214,000,000
Number of interest rate derivatives held									1		1
Derivative, fixed interest rate									0.617%		1.42%
Derivative, termination fee							$ 1,700,000
Currency Swap [Member]
Derivative, notional amount										$ 56,000,000
Number of interest rate derivatives held										1
Derivative, fixed interest rate										1.38%
Foreign Exchange Option [Member]
Derivative, notional amount	$ 77,000,000
Derivative purchase price	$ 1,100,000

XML

Effect of Cash Flow Derivatives on the Balance Sheet and Income Statement, Before Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income	$ (32)	$ (2,879)	$ (1,200)	$ (2,588)
Interest Rate Swap [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Amount of Gain (Loss) Recognized in OCI on Derivative	0	(302)	73	(2,818)
Interest Rate Swap [Member] | Interest Expense [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income	0	(274)	(229)	(467)
Interest Rate Swap 2
Derivative Instruments Designated as Hedging Instruments [Abstract]
Amount of Gain (Loss) Recognized in OCI on Derivative			0	0
Interest Rate Swap 2 | Interest Expense [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income			(1,681)	0
Interest Rate Cap [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Amount of Gain (Loss) Recognized in OCI on Derivative			0	782
Interest Rate Cap [Member] | Interest Expense [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income			0	392
Foreign Exchange Option [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Amount of Gain (Loss) Recognized in OCI on Derivative	478	(252)	367	(1,221)
Foreign Exchange Option [Member] | Cost of Sales [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income	(32)	(450)	(40)	(612)
Currency Swap 1 [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Amount of Gain (Loss) Recognized in OCI on Derivative	0	(2,326)	669	(1,969)
Currency Swap 2 [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Amount of Gain (Loss) Recognized in OCI on Derivative	0		0	0
Currency Swap [Member] | Interest Expense [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income	0	88	94	537
Currency Swap [Member] | Other Income (Expense) [Member]
Derivative Instruments Designated as Hedging Instruments [Abstract]
Gain (Loss) Reclassified from  AOCI into Income	$ 0	$ (2,242)	$ 656	$ (2,438)

XML

Derivatives Not Designated as Hedging Relationships (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Other Income (Expense) [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Foreign exchange forward contracts	$ 673	$ (1,646)	$ 210	$ (1,056)

XML

Schedule of Amounts Recognized in the Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Current portion of pension benefit obligation in wages and benefits payable	$ 3,822	$ 3,069
Long-term portion of pension benefit obligation	114,771	119,457
Pension benefit obligation, net	$ 118,593	$ 122,526

XML

Schedule of Net Periodic Pension Benefit Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Retirement Benefits [Abstract]
Service cost	$ 1,125	$ 1,007	$ 3,376	$ 3,000
Interest cost	345	434	1,046	1,364
Expected return on plan assets	(87)	(85)	(264)	(365)
Amortization of prior service costs	17	17	51	49
Amortization of actuarial net loss	681	482	2,070	1,390
Settlement	0	286	0	286
Net periodic benefit cost	$ 2,081	$ 2,141	$ 6,279	$ 5,724

XML

Stock-Based Compensation Expense and Related Tax Benefit (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options	$ 344	$ 452	$ 1,055	$ 1,445
Restricted stock units	5,104	4,399	16,546	18,575
Unrestricted stock awards	217	206	650	618
Total stock-based compensation	6,184	5,639	21,112	22,713
Related tax benefit	1,159	1,070	3,840	4,257
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Phantom stock units	$ 519	$ 582	$ 2,861	$ 2,075

XML

Stock Option Summary (Details) - Share-based Payment Arrangement, Option [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
[Line Items]
Outstanding, beginning balance (in shares)	433	458	458
Outstanding, beginning balance, weighted average exercise price per share (in dollars per share)	$ 61.95	$ 56.38	$ 56.38
Outstanding, weighted average remaining contractual life	6 years 1 month 6 days	7 years	6 years 10 months 24 days	7 years
Outstanding, beginning balance, aggregate intrinsic value	$ 14,697	$ 12,641	$ 12,641
Granted (in shares)	0	80
Granted, weighted average exercise price (in dollars per share)		$ 84.38
Granted, weighted average grant date fair value	$ 0	$ 26.21
Exercised (in shares)	(34)	(49)
Exercised, weighted average exercise price (in dollars per share)	$ 67.21	$ 50.90
Exercised, aggregate intrinsic value	$ 1,215	$ 1,189
Forfeited (in share)	(6)	(5)
Forfeited, weighted average grant date fair value (in dollars per share)	$ 83.33	$ 83.80
Outstanding, ending balance (in shares)	393	484	433	458
Outstanding, ending balance, weighted average exercise price per share (in dollars per share)	$ 61.18	$ 61.30	$ 61.95	$ 56.38
Outstanding, weighted average remaining contractual life	6 years 1 month 6 days	7 years	6 years 10 months 24 days	7 years
Outstanding, ending balance, aggregate intrinsic value	$ 6,496	$ 3,816	$ 14,697	$ 12,641
Exercisable (in shares)	317
Exercisable, weighted average exercise price (in dollars per share)	$ 56.51
Exercisable, weighted average remaining contractual term	5 years 7 months 6 days
Exercisable, aggregate intrinsic value	$ 6,361

XML

Stock Option Black Scholes Option Pricing Model Assumptions (Details) - Share-based Payment Arrangement, Option [Member]	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Expected volatility	0.00%	41.50%	0.00%	32.10%
Risk-free interest rate	0.00%	0.30%	0.00%	1.30%
Expected term (years)		5 years 3 months 18 days		5 years 3 months 18 days

XML

Stock-Based Compensation Restricted Stock Units Summary (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
[Line Items]
Outstanding, beginning balance (in shares)				544	684
Outstanding, beginning balance, weighted average grant date fair value (in dollars per share)				$ 71.79
Granted (in shares)				212	209
Granted, weighted average grant date fair value (in dollars per share)				$ 97.96	$ 83.34
Forfeited (in shares)				(46)	(23)
Forfeited, weighted average grant date fair value (in dollars per share)				$ 77.79
Outstanding, ending balance (in shares)		422	532	422	532
Outstanding, ending balance, weighted average grant date fair value (in dollars per share)		$ 85.75		$ 85.75
Vested and Released [Member]
[Line Items]
Released (in shares)	[1]			(288)	(338)
Released, weighted average grant date fair value (in dollars per share)				$ 70.20
Released, aggregate intrinsic value				$ 28,494	$ 21,947
Vested but Not Released [Member]
[Line Items]
Released (in shares)				(10)
Released, aggregate intrinsic value				$ 733
Long Term Performance Restricted Stock Award [Member]
[Line Items]
Granted, weighted average grant date fair value (in dollars per share)		$ 0	$ 61.45	$ 113.75	$ 93.05

[1] (1)     Shares released is presented as gross shares and does not reflect shares withheld by us for employee payroll tax obligations.

XML

Stock-Based Compensation Long-Term Performance Restricted Stock Unit Award Monte Carlo Pricing Model Assumptions (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, weighted average grant date fair value (in dollars per share)			$ 97.96	$ 83.34
Long Term Performance Restricted Stock Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	0.00%	52.60%	50.50%	38.20%
Risk-free interest rate	0.00%	0.20%	0.20%	1.50%
Expected term (years)		2 years 3 months 18 days	2 years 10 months 24 days	1 year 9 months 18 days
Granted, weighted average grant date fair value (in dollars per share)	$ 0	$ 61.45	$ 113.75	$ 93.05

XML

Stock-Based Compensation Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($) shares
Share-based Payment Arrangement, Option [Member]
[Line Items]
Compensation cost not yet recognized | $	$ 1.4
Unrecognized compensation expense, Expected weighted average period for recognition (years)	1 year 3 months 18 days
Restricted Stock Units (RSUs) [Member]
[Line Items]
Compensation cost not yet recognized | $	$ 30.9
Unrecognized compensation expense, Expected weighted average period for recognition (years)	1 year 9 months 18 days
Employee Stock Purchase Plan [Member]
[Line Items]
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)	151,221
Stock Incentive Plan [Member]
[Line Items]
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	12,623,538
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)	5,346,245
Reduction in stock options available for issue	1
Authorized share reserve reduction in awards other than stock options or share appreciation rights available for issue, conversion ratio	1.7

XML

Income Tax Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Net interest and penalties expense	$ 195	$ (198)	$ 153	$ 422
Accrued interest	3,663		3,663		$ 3,432
Accrued penalties	1,405		1,405		1,645
Unrecognized tax benefits related to uncertain tax positions	134,110		134,110		135,910
The amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate	$ 132,992		$ 132,992		$ 134,473

XML

Income Taxes Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Examination [Line Items]
Discrete tax benefit	$ 10.1
Effective income tax rate reconciliation, percent	902.00%	32.00%	(39.00%)	0.00%
Effective income tax rate reconciliation, at federal statutory income tax rate, percent	21.00%	21.00%	21.00%	21.00%

XML

Commitments and Contingencies Available Lines of Credit, Outstanding Standby Letter of Credits, and Bonds (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Oct. 18, 2019
Line of Credit Facility [Line Items]
Multicurrency revolving line of credit			$ 500,000
Net available for additional standby LOCs under sub-facility	$ 235,552	$ 235,052
Credit Facility [Member]
Line of Credit Facility [Line Items]
Multicurrency revolving line of credit	500,000	500,000
Letters of Credit Outstanding, Amount	(64,448)	(64,948)
Line of Credit Facility, Remaining Borrowing Capacity	235,600
Unsecured Multicurrency Revolving Lines of Credit [Member]
Line of Credit Facility [Line Items]
Multicurrency revolving line of credit	97,113	99,201
Letters of Credit Outstanding, Amount	(24,245)	(24,966)
Short-term borrowings	(8,764)	0
Line of Credit Facility, Remaining Borrowing Capacity	64,104	74,235
Surety Bond [Member]
Line of Credit Facility [Line Items]
Unsecured surety bonds in force	169,293	162,912
Line of Credit
Line of Credit Facility [Line Items]
Long-term Line of Credit	0	0
Line of Credit Facility, Remaining Borrowing Capacity	$ 435,552	$ 435,052

XML

Commitments and Contingencies Warranty Account Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Beginning balance	$ 36,210	$ 44,757	$ 41,390	$ 53,242
New product warranties	1,925	785	3,611	2,855
Other changes/adjustments to warranties	(975)	1,643	631	5,436
Claims activity	(2,156)	(5,044)	(10,040)	(19,349)
Effect of change in exchange rates	(317)	946	(905)	903
Ending balance	34,687	43,087	34,687	43,087
Less: current portion of warranty	18,089	32,118	18,089	32,118
Long-term warranty	$ 16,598	$ 10,969	$ 16,598	$ 10,969

XML

Commitments and Contingencies Warranty Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Total warranty expense	$ 950	$ 2,428	$ 4,242	$ 8,321

XML

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Line of Credit Facility [Line Items]
Other changes/adjustments to warranties	$ (975)	$ 1,643	$ 631	$ 5,436
Device Solutions
Line of Credit Facility [Line Items]
Other changes/adjustments to warranties				1,700
Networked Solutions Segment
Line of Credit Facility [Line Items]
Other changes/adjustments to warranties				$ 1,100

XML

Restructuring Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Costs, Expected Costs, Increase (Decrease)	$ 13.0
Restructuring reserve, current	28.7	$ 31.7
Restructuring reserve, noncurrent	$ 18.6	$ 40.9

XML

Restructuring Expected Costs - 2020 Projects (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring	$ (830)
2020 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	44,022
Restructuring and Related Cost, Cost Incurred to Date		$ 43,232
Restructuring	(1,773)
Restructuring and Related Cost, Expected Cost Remaining	2,563
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring	(7,586)
Employee Severance [Member] | 2020 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	32,583
Restructuring and Related Cost, Cost Incurred to Date		36,225
Restructuring	(3,642)
Restructuring and Related Cost, Expected Cost Remaining	0
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring	951
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | 2020 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	6,893
Restructuring and Related Cost, Cost Incurred to Date		6,944
Restructuring	(51)
Restructuring and Related Cost, Expected Cost Remaining	0
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring	5,805
Other Restructuring [Member] | 2020 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	4,546
Restructuring and Related Cost, Cost Incurred to Date		$ 63
Restructuring	1,920
Restructuring and Related Cost, Expected Cost Remaining	$ 2,563

XML

Restructuring Expected Costs - 2018 Projects (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring	$ (830)
2018 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	82,769
Restructuring and Related Cost, Cost Incurred to Date		$ 81,176
Restructuring	943
Restructuring and Related Cost, Expected Cost Remaining	650
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring	(7,586)
Employee Severance [Member] | 2018 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	59,229
Restructuring and Related Cost, Cost Incurred to Date		63,173
Restructuring	(3,944)
Restructuring and Related Cost, Expected Cost Remaining	0
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring	951
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member] | 2018 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	3,788
Restructuring and Related Cost, Cost Incurred to Date		2,786
Restructuring	1,002
Restructuring and Related Cost, Expected Cost Remaining	0
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring	5,805
Other Restructuring [Member] | 2018 Projects [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost	19,752
Restructuring and Related Cost, Cost Incurred to Date		$ 15,217
Restructuring	3,885
Restructuring and Related Cost, Expected Cost Remaining	$ 650

XML

Restructuring Related Balance Sheet Activity (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Restructuring Cost and Reserve [Line Items]
Beginning balance, January 1, 2021	$ 72,626
Costs charged to expense	(830)
Cash payments	(21,156)
Cash receipts	2,007
Net assets disposed and impaired	(2,958)
Effect of change in exchange rates	(2,424)
Ending balance, September 30, 2021	47,265
Accrued Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance, January 1, 2021	70,005
Costs charged to expense	(7,586)
Cash payments	(16,431)
Cash receipts	0
Net assets disposed and impaired	0
Effect of change in exchange rates	(2,377)
Ending balance, September 30, 2021	43,611
Asset Impairment and Net (Gain) Loss on Sale or Disposal [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance, January 1, 2021	0
Costs charged to expense	951
Cash payments	0
Cash receipts	2,007
Net assets disposed and impaired	(2,958)
Effect of change in exchange rates	0
Ending balance, September 30, 2021	0
Other Accrued Costs [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance, January 1, 2021	2,621
Costs charged to expense	5,805
Cash payments	(4,725)
Cash receipts	0
Net assets disposed and impaired	0
Effect of change in exchange rates	(47)
Ending balance, September 30, 2021	$ 3,654

XML

Shareholders' Equity Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended			9 Months Ended
	Mar. 12, 2021	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in share)		10,000,000			10,000,000		10,000,000
Preferred stock, no par value (in dollars per share)		$ 0			$ 0		$ 0
Preferred stock, shares issued (in shares)		0			0		0
Preferred stock, shares outstanding (in shares)		0			0		0
Derivative, notional amount			$ 84.1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		400,000		800,000	500,000	800,000
Deferred tax assets, derivative instruments		$ 20.6	$ 20.6		$ 20.6
Convertible Debt Securities
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		3,700,000	3,700,000		3,700,000
Common stock, conversion price (in dollars per share)		$ 126.00	$ 126.00
Over-Allotment Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, number of shares issued in transaction	4,472,222
Sale of stock, consideration received on transaction	$ 389.4

XML

Shareholders' Equity Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,200,658	$ 1,221,168	$ 840,273	$ 802,869	$ 795,495	$ 800,815	$ 840,273	$ 800,815
OCI before reclassifications							(16,033)	(6,025)
Amounts reclassified from AOCI							2,820	56,684
Total other comprehensive income (loss), net of tax	(6,567)	5,137	(11,783)	13,814	62,056	(25,211)	(13,213)	50,659
Ending balance	1,199,826	1,200,658	1,221,168	797,265	802,869	795,495	1,199,826	797,265
Parent [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	1,175,278	1,196,466	816,548	777,799	770,740	776,538	816,548	776,538
Total other comprehensive income (loss), net of tax	(6,567)	5,137	(11,783)	13,814	62,056	(25,211)
Ending balance	1,173,587	$ 1,175,278	1,196,466	771,896	$ 777,799	770,740	1,173,587	771,896
Foreign Currency Translation Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(84,843)			(157,999)	(84,843)	(157,999)
OCI before reclassifications							(17,118)	(147)
Amounts reclassified from AOCI							0	52,074
Total other comprehensive income (loss), net of tax							(17,118)	51,927
Ending balance	(101,961)			(106,072)			(101,961)	(106,072)
Net Unrealized Gain (Loss) on Derivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(1,621)			(723)	(1,621)	(723)
OCI before reclassifications							1,085	(4,727)
Amounts reclassified from AOCI							733	2,570
Total other comprehensive income (loss), net of tax							1,818	(2,157)
Ending balance	197			(2,880)			197	(2,880)
Net Unrealized Gain (Loss) on Nonderivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(14,380)			(14,380)	(14,380)	(14,380)
OCI before reclassifications							0	0
Amounts reclassified from AOCI							0	0
Total other comprehensive income (loss), net of tax							0	0
Ending balance	(14,380)			(14,380)			(14,380)	(14,380)
Pension Benefit Obligation Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(37,682)			(31,570)	(37,682)	(31,570)
OCI before reclassifications							0	(1,151)
Amounts reclassified from AOCI							2,087	2,040
Total other comprehensive income (loss), net of tax							2,087	889
Ending balance	(35,595)			(30,681)			(35,595)	(30,681)
Accumulated Other Comprehensive Income (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			$ (138,526)			$ (204,672)	(138,526)	(204,672)
Ending balance	$ (151,739)			$ (154,013)			$ (151,739)	$ (154,013)

XML

Shareholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Before-tax amount [Abstract]
Foreign currency translation adjustment	$ (7,827,000)	$ 15,521,000	$ (16,941,000)	$ (387,000)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	0	(14,000)	0	52,074,000
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478,000	(2,887,000)	1,103,000	(5,228,000)
Net hedging (gain) loss reclassified to net income (loss)	32,000	2,879,000	1,200,000	2,588,000
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax	0	(893,000)	0	(812,000)
Net defined benefit plan (gain) loss reclassified to net income (loss)	698,000	499,000	2,121,000	1,439,000
Total other comprehensive income (loss), before tax	(6,619,000)	15,105,000	(12,517,000)	49,674,000
Tax (provision) benefit [Abstract]
Foreign currency translation adjustment	63,000	(1,533,000)	(177,000)	240,000
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	0	0	0	0
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	0	74,000	(18,000)	501,000
Net hedging (gain) loss reclassified to net income (loss)	0	(67,000)	(467,000)	(18,000)
Net unrealized gain (loss) on defined benefit plans	0	(341,000)	0	(339,000)
Net defined benefit plan (gain) loss reclassified to net income (loss)	(11,000)	576,000	(34,000)	601,000
Total other comprehensive income (loss) tax (provision) benefit	52,000	(1,291,000)	(696,000)	985,000
Net-of-tax amount [Abstract]
Foreign currency translation adjustment	(7,764,000)	13,988,000	(17,118,000)	(147,000)
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	0	(14,000)	0	52,074,000
Net unrealized gain (loss) on derivative instruments, designated as cash flow hedges	478,000	(2,813,000)	1,085,000	(4,727,000)
Net hedging (gain) loss reclassified to net income (loss)	32,000	2,812,000	733,000	2,570,000
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax	0	(1,234,000)	0	(1,151,000)
Net defined benefit plan (gain) loss reclassified to net income (loss)	687,000	1,075,000	2,087,000	2,040,000
Total other comprehensive income (loss), net of tax	$ (6,567,000)	$ 13,814,000	$ (13,213,000)	$ 50,659,000

XML

Schedule of Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Apr. 08, 2021	Mar. 09, 2021	Dec. 31, 2020	Jan. 19, 2018	Dec. 22, 2017
Liabilities
Senior notes		$ 0	$ 410,000		$ 100,000	$ 300,000
USD Denominated Term Loan
Liabilities
USD denominated term loan	$ 0			$ 536,094
Line of Credit
Liabilities
Multicurrency revolving line of credit	0			0
Reported Value Measurement [Member]
Liabilities
Senior notes	0			388,311
Convertible Notes Payable	449,629			0
Reported Value Measurement [Member] | USD Denominated Term Loan
Liabilities
USD denominated term loan	0			532,625
Reported Value Measurement [Member] | Line of Credit
Liabilities
Multicurrency revolving line of credit	0			0
Estimate of Fair Value Measurement [Member]
Liabilities
Senior notes	0			410,000
Convertible Notes Payable	434,130			0
Estimate of Fair Value Measurement [Member] | USD Denominated Term Loan
Liabilities
USD denominated term loan, fair value	0			520,347
Estimate of Fair Value Measurement [Member] | Line of Credit
Liabilities
Multicurrency revolving line of credit, fair value	$ 0			$ 0

XML

Segment Information Narrative (Details)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Revenue, Major Customer [Line Items]
Number of reportable segments	3
Sales | Customer Concentration Risk | Customer A [Member]
Revenue, Major Customer [Line Items]
Segment Reporting, Disclosure of Major Customers		one
Concentration Risk, Percentage		11.00%

XML

Information By Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Revenues	$ 486,949	$ 540,184	$ 1,495,935	$ 1,648,193
Gross profit	134,963	143,251	451,882	453,334
Operating income (loss)	4,163	(23,980)	28,171	(42,997)
Total other income (expense)	(4,037)	(13,063)	(42,465)	(35,020)
Income (loss) before income taxes	126	(37,043)	(14,294)	(78,017)
Device Solutions
Segment Reporting Information [Line Items]
Revenues	152,234	176,128	487,982	507,572
Gross profit	22,480	20,528	85,228	64,843
Operating income (loss)	12,095	11,017	53,784	28,095
Networked Solutions Segment
Segment Reporting Information [Line Items]
Revenues	274,498	306,659	827,870	971,984
Gross profit	89,915	102,295	298,627	332,368
Operating income (loss)	61,150	71,404	205,071	237,466
Outcomes Segment [Member]
Segment Reporting Information [Line Items]
Revenues	60,217	57,397	180,083	168,637
Gross profit	22,568	20,428	68,027	56,123
Operating income (loss)	11,774	12,044	34,647	29,468
Corporate Unallocated [Member]
Segment Reporting Information [Line Items]
Operating income (loss)	(80,856)	(118,445)	(265,331)	(338,026)
Product [Member]
Segment Reporting Information [Line Items]
Revenues	410,947	470,658	1,265,470	1,437,780
Product [Member] | Device Solutions
Segment Reporting Information [Line Items]
Revenues	149,830	174,039	480,808	501,157
Product [Member] | Networked Solutions Segment
Segment Reporting Information [Line Items]
Revenues	242,527	282,677	736,397	898,465
Product [Member] | Outcomes Segment [Member]
Segment Reporting Information [Line Items]
Revenues	18,590	13,942	48,265	38,158
Service [Member]
Segment Reporting Information [Line Items]
Revenues	76,002	69,526	230,465	210,413
Service [Member] | Device Solutions
Segment Reporting Information [Line Items]
Revenues	2,404	2,089	7,174	6,415
Service [Member] | Networked Solutions Segment
Segment Reporting Information [Line Items]
Revenues	31,971	23,982	91,473	73,519
Service [Member] | Outcomes Segment [Member]
Segment Reporting Information [Line Items]
Revenues	$ 41,627	$ 43,455	$ 131,818	$ 130,479

XML

Segment Information Revenues By Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues from External Customers [Line Items]
Revenues	$ 486,949	$ 540,184	$ 1,495,935	$ 1,648,193
United States and Canada [Member]
Revenues from External Customers [Line Items]
Revenues	323,784	354,841	957,993	1,110,028
Europe, Middle East, and Africa [Member]
Revenues from External Customers [Line Items]
Revenues	126,548	156,810	437,768	431,593
Other [Member]
Revenues from External Customers [Line Items]
Revenues	$ 36,617	$ 28,533	$ 100,174	$ 106,572

XML

Depreciation and Amortization, by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 21,333	$ 24,076	$ 64,252	$ 72,306
Corporate, Non-Segment [Member]
Property, Plant and Equipment [Line Items]
Depreciation and amortization	10,080	12,446	30,312	37,304
Device Solutions
Property, Plant and Equipment [Line Items]
Depreciation and amortization	5,911	5,926	17,708	18,423
Networked Solutions Segment
Property, Plant and Equipment [Line Items]
Depreciation and amortization	4,274	4,377	12,801	12,447
Outcomes Segment [Member]
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 1,068	$ 1,327	$ 3,431	$ 4,132

XML

Revenue Recognition Revenue Contract Assets and Liabilities Rollforward (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Revenue Recognition and Deferred Revenue [Abstract]
Beginning balance, January 1, 2021	$ 98,388
Revenues recognized from beginning contract liability	(95,096)
Cumulative catch-up adjustments	16,722
Increases due to amounts collected or due	215,549
Revenues recognized from current period increases	(136,122)
Other	(908)
Ending balance, September 30, 2021	$ 98,533

XML

Revenue Recognition Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Revenue Recognition and Deferred Revenue [Abstract]
Contract with customer, asset, gross	$ 35.3	$ 49.8
Contract with customer, liability	$ 133.8	$ 148.2

XML

Revenue Recognition Remaing Performance Obligation (Details) $ in Millions	Sep. 30, 2021 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 1,300
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 1,500
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year

XML

Sale of Business - Narrative (Details) $ in Thousands		3 Months Ended			9 Months Ended
	Jun. 25, 2020 numberOfSubsidiaries	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)		$ 0		$ (14)	$ 0	$ 52,074
Disposal Group, Including Discontinued, Interest Received					700
Loss on sale of business		$ 2,171		380	28,274	$ 57,295
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of subsidiaries sold | numberOfSubsidiaries	5
Disposal Group, Including Discontinued Operation, Sales Price				35,000
Disposal Group, Including Discontinued Operation, Working Capital			$ 18,400	21,100
Cash outflow at closing				$ 4,500
Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)					(24,700)
Payments received from disposal					$ 3,800

XML

Subsequent Events (Details) - USD ($) $ in Thousands, shares in Millions			3 Months Ended		9 Months Ended
	Nov. 02, 2021	Oct. 29, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Nov. 04, 2021	Nov. 01, 2021
Subsequent Event [Line Items]
Loss on sale of business					$ 28,274	$ 57,295
Foreign currency translation adjustment reclassified to net income (loss) on sale of business			$ 0	$ 14	0	$ (52,074)
Restructuring					(830)
Payments for Restructuring					$ 21,156
Subsequent Event
Subsequent Event [Line Items]
Number of shares authorized to be repurchased								100
Subsequent Event | SELC
Subsequent Event [Line Items]
Business acquisition, percentage of voting interests acquired							100.00%
Subsequent Event | Minimum | 2021 Projects
Subsequent Event [Line Items]
Restructuring		$ 65,000
Payments for Restructuring		60,000
Restructuring, estimated annualized savings		15,000
Subsequent Event | Maximum | 2021 Projects
Subsequent Event [Line Items]
Restructuring		75,000
Payments for Restructuring		65,000
Restructuring, estimated annualized savings		$ 20,000
Subsequent Event | Dresser
Subsequent Event [Line Items]
Disposal group, including discontinued operation, consideration	$ 75,000
Subsequent Event | Dresser | Minimum
Subsequent Event [Line Items]
Loss on sale of business	30,000
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	58,000
Disposal group, including discontinued operation, pension plan benefit obligation	12,000
Goodwill allocated	35,000
Proceeds from divestiture of businesses	62,000
Subsequent Event | Dresser | Maximum
Subsequent Event [Line Items]
Loss on sale of business	40,000
Foreign currency translation adjustment reclassified to net income (loss) on sale of business	62,000
Disposal group, including discontinued operation, pension plan benefit obligation	13,000
Goodwill allocated	40,000
Proceeds from divestiture of businesses	$ 63,000